2017 Annual Meeting | P4 - Poster Session IV

Date Wednesday 04/26/17

Time 08:30 AM - 07:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Scientific Poster Session

Topic(s) Aging, Dementia, and Behavioral Neurology, Cerebrovascular Disease and Interventional Neurology, Child Neurology and Developmental Neurology, Epilepsy/Clinical Neurophysiology (EEG), General Neurology, Movement Disorders, Multiple Sclerosis, Neuromuscular and Clinical Neurophysiology (EMG), Neuro-rehabilitation

CME Available 0.00 credit

Event Timeline
08:30 AM - 07:00 PM	Abstract	001 - Reliability of Continuous Parkinson’s Assessment Using Wearables Dustin A. Heldman, PhD
08:30 AM - 07:00 PM	Abstract	002 - Exploring the use of wearable sensors to monitor drug response of patients with Parkinson’s disease in the home setting Jean-Francois Daneault, PhD
08:30 AM - 07:00 PM	Abstract	003 - Telemedicine vs Office visits in a Movement Disorder Specialty Clinic: Comparative Satisfaction of physicians and patients. Ryan Hanson, MD
08:30 AM - 07:00 PM	Abstract	004 - Telehealth Management of Parkinson’s Disease Using Wearable Sensors: An Exploratory Study Dustin A. Heldman, PhD
08:30 AM - 07:00 PM	Abstract	005 - Virtual research visits in individuals with Parkinson disease enrolled in a clinical trial: REACT-PD Study Interim Analysis Christopher Tarolli, MD, FAAN
08:30 AM - 07:00 PM	Abstract	006 - ND0701: A novel safe concentrated apomorphine formulation for continuous subcutaneous administration via a patch pump
08:30 AM - 07:00 PM	Abstract	007 - Fox Insight: a Large-Scale Web-Enabled Parkinson’s Disease Study Lana Chahine, MD, FAAN
08:30 AM - 07:00 PM	Abstract	008 - Improvements in activities of daily living and quality of life measures in Hoehn & Yahr subgroups of advanced Parkinson’s disease patients following treatment with IPX066, extended-release carbidopa-levodopa Rohit Dhall, MD, FAAN
08:30 AM - 07:00 PM	Abstract	009 - Human factors testing of the levodopa-carbidopa intestinal gel delivery system in advanced Parkinson’s disease patients and healthcare providers Ramon L. Rodriguez Cruz, MD, FAAN
08:30 AM - 07:00 PM	Abstract	010 - Optimizing Recruitment of Racial and Ethnic minority population in Clinical Trials in Parkinson's Disease: Potential Barriers and Prospective Strategies Pinky H. Agarwal, MD, FAAN
08:30 AM - 07:00 PM	Abstract	011 - Predictors of survival in progressive supranuclear palsy and multiple system atrophy - a systematic review and meta-analysis Stella Glasmacher
08:30 AM - 07:00 PM	Abstract	012 - Pre- and post-synaptic dopaminergic dysfunction and clinical features in cerebellar type of multiple system atrophy Chaewon Lee, MD
08:30 AM - 07:00 PM	Abstract	013 - Instrumented Gait and Balance Analyses in Progressive Supranuclear Palsy and Mild Cognitive Impairment compared with Parkinson Disease Trung P. Nguyen, MD
08:30 AM - 07:00 PM	Abstract	014 - Inflammatory pathology and rapidly progressive dementia contribute to the classic PSP phenotype Marian L. Dale, MD, FAAN
08:30 AM - 07:00 PM	Abstract	015 - Correlation of Clinical and Neuroimaging Features in Progressive Supranuclear Palsy David French
08:30 AM - 07:00 PM	Abstract	016 - Whole-brain atrophy rates add a retrospective application to improve the diagnostic accuracy of multiple system atrophy and progressive supranuclear palsy vs idiopathic Parkinson's disease Carlos Guevara Oliva, MD
08:30 AM - 07:00 PM	Abstract	017 - The identification of molecular-genetic background of familial atypical parkinsonism in "Hornacko", a specific region of the south-eastern Moravia, Czech Republic. Katerina Mensikova
08:30 AM - 07:00 PM	Abstract	018 - Patient Quality of Life and Caregiver Burden in a multidisciplinary MSA clinic Pravin Khemani, MD, FAAN
08:30 AM - 07:00 PM	Abstract	019 - Subcortical Volumes differences among LRRK2, GBA and idiopathic Parkinson's disease patients and non-manifesting first-degree relatives Avner Thaler, MD
08:30 AM - 07:00 PM	Abstract	020 - Comparative Analyses in Brain's MRI (Nigrosome and Neuromelanin) Versus 00mmTc-TRODAT-1 Spect in Movement Disorders Alex Baeta
08:30 AM - 07:00 PM	Abstract	021 - White matter tract alterations in Parkinson’s disease patients with punding
08:30 AM - 07:00 PM	Abstract	022 - Evolution in Dopamine Transporter (DaT) Scan Utilization Patterns and its Effect on Treatment Decisions: Results of the Next 200 Scans Xin Xin Yu, MD
08:30 AM - 07:00 PM	Abstract	023 - Cortical tissue deterioration in PD: a longitudinal DTI study Richa Tripathi, MD
08:30 AM - 07:00 PM	Abstract	024 - A Retrospective Chart Review of Patients with Parkinsonism who underwent DaTSPECT Imaging to Distinguish Drug Induced Parkinsonism from Idiopathic Parkinson’s Disease Katherine D. Amodeo, MD
08:30 AM - 07:00 PM	Abstract	025 - Patient-Based Quantitative Analysis of DaT-SPECT uptake: Application in Patients with Parkinson and Asymptomatic Carriers of the G2019S LRRK2 Mutation Running title: Quantitative DaT in Parkinson’s disease Avner Thaler, MD
08:30 AM - 07:00 PM	Abstract	026 - Autonomic Testing Profiles in Scans Without Evidence of Dopaminergic Deficit (SWEDD) Derek W. Stitt, MD
08:30 AM - 07:00 PM	Abstract	027 - Dopaminergic neuronal oxidative stress is increased with disease progression in patients with Parkinson’s disease: A study with PET and SPECT Masamichi Ikawa
08:30 AM - 07:00 PM	Abstract	028 - White matter microstructural damage as predictor of cognitive decline in Parkinson’s disease Sebastiano Galantucci
08:30 AM - 07:00 PM	Abstract	029 - Diffusion tensor imaging changes in the corpus callosum and cognitive impairment in Parkinson's disease Ian Bledsoe, MD
08:30 AM - 07:00 PM	Abstract	030 - NA
08:30 AM - 07:00 PM	Abstract	031 - High-intensity interval ergometer training improves aerobic capacity and fatigue in patients with Multiple Sclerosis Stephan Schmidt, MD
08:30 AM - 07:00 PM	Abstract	032 - Effect of early use of AbobotulinumtoxinA (Dysport®) after stroke on spasticity progression: first results of a pilot study Raymond Rosales
08:30 AM - 07:00 PM	Abstract	033 - Neuromuscular Electrostimulation (NMES) used for increasing quadriceps strength may also provide mild analgesia William H. Mays III, MD
08:30 AM - 07:00 PM	Abstract	034 - The Adult Spasticity International Registry (ASPIRE) Study: 1-Year Results
08:30 AM - 07:00 PM	Abstract	035 - Efficacy of IncobotulinumtoxinA in Treatment of Lower Limb Spasticity in Adults David M. Simpson, MD, FAAN
08:30 AM - 07:00 PM	Abstract	036 - Duration of Treatment Effect of IncobotulinumtoxinA in Upper Limb Spasticity Bruce S. Rubin, MD, FAAN
08:30 AM - 07:00 PM	Abstract	037 - Efficacy of IncobotulinumtoxinA In The Treatment Of Shoulder Spasticity David M. Simpson, MD, FAAN
08:30 AM - 07:00 PM	Abstract	038 - Duration of Effect of Abobotulinumtoxina (Dysport®) In Adult Patients with Upper Limb Spasticity (ULS) Post-Stroke or Traumatic Brain Injury Jean-Michel Gracies, MD
08:30 AM - 07:00 PM	Abstract	039 - Effect of Rhythmic Auditory Stimulation On Gait In Patients With Stroke
08:30 AM - 07:00 PM	Abstract	040 - The Effect of SSRIs in the Outcomes of ICARE Trial Samir Belagaje, MD, FAAN
08:30 AM - 07:00 PM	Abstract	041 - Diffusion-Tensor-Imaging MR-Neurography for the detection of polyneuropathy in Type 1 diabetes
08:30 AM - 07:00 PM	Abstract	042 - Diffusion Tensor Imaging of Peripheral Nerves in Patients with CMT Type 1A
08:30 AM - 07:00 PM	Abstract	043 - A case of peripheral neuropathy due to pyridoxine toxicity in association with NOS energy drink consumption Kaitlyn M. Blackburn, DO
08:30 AM - 07:00 PM	Abstract	044 - Incomplete spinal cord lesions: probably the commonest cause of radicular syndromes but difficult to diagnose Paul F. Teychenne, MD, FAAN
08:30 AM - 07:00 PM	Abstract	045 - Bilateral sural neuropathy during pregnancy: A case report Derek Yuan, MD
08:30 AM - 07:00 PM	Abstract	046 - Quantitative and qualitative normative dataset for intraepidermal nerve fibers at distal leg Jerome De Seze
08:30 AM - 07:00 PM	Abstract	047 - Hypothyroidism Presenting with Dysarthria and Intermittent Weakness of the Extremities Alicia S. Parker, MD
08:30 AM - 07:00 PM	Abstract	048 - Clinico-radiological spectrum of intranasal heroin myelopathy: a case series Alina Masters-Israilov, MD
08:30 AM - 07:00 PM	Abstract	049 - Imaging of Acute Quadriparesis from Spinal Epidural Induced Pneumorrhachis
08:30 AM - 07:00 PM	Abstract	050 - Prevalence and treatment options for diabetic neuropathic pain in Kuwait. Samar F. Ahmed, MD
08:30 AM - 07:00 PM	Abstract	051 - Hypertrophic Cranial Polyneuropathies and Pituitary Lesions Ninad Desai, MBBS
08:30 AM - 07:00 PM	Abstract	052 - Eslicarbazepine Acetate in Neuralgic Pain Pino Lopez Mendez
08:30 AM - 07:00 PM	Abstract	053 - Recurrent postpartum bilateral bell's palsy Tanaporn Rasameesoraj, MD
08:30 AM - 07:00 PM	Abstract	054 - Bilateral Bell's Palsy Associated with Vogt-Koyanagi-Harada Disease : A Case Report George Lai, MD
08:30 AM - 07:00 PM	Abstract	055 - Data-driven modelling of diffusion MRI changes in ALS indicates evolution of distal prior to proximal corticospinal tract pathology
08:30 AM - 07:00 PM	Abstract	056 - Takotsubo syndrome complicated with amyotrophic lateral sclerosis Yuishin Izumi, MD, PhD
08:30 AM - 07:00 PM	Abstract	057 - Tissue-engineered skin model derived from neurofibromatosis type 1 (NF1) patients to study tumor genesis and to predict response to therapy Vincent Roy, MSc
08:30 AM - 07:00 PM	Abstract	058 - Albumin neuroprotection in focal cerebral ischemia in humans: Another look at ALIAS trial subgroup Rakesh Khatri, MD, FAAN
08:30 AM - 07:00 PM	Abstract	059 - Developmental Venous Anomalies in Neurological Disease: A Report of Six Cases Ahmed Z. Obeidat, MD, PhD
08:30 AM - 07:00 PM	Abstract	060 - Intravascular T cell Lymphoma: A Rare, Poorly Characterized Entity with Cytotoxic Phenotype Tara Sharma, DO
08:30 AM - 07:00 PM	Abstract	061 - Primary Angiitis of the Central Nervous System Bader A. Alenzi, MD
08:30 AM - 07:00 PM	Abstract	062 - Achieving better detection of vascular risk factors for stroke prevention Man Mohan Mehndiratta, MD, MBBS, FAAN
08:30 AM - 07:00 PM	Abstract	063 - Intraventricular bleed or foreign body? Nilofar Dudha, MD
08:30 AM - 07:00 PM	Abstract	064 - Ischemic stroke in a patient with Parry-Romberg syndrome Victoria A. Ebiana, MD
08:30 AM - 07:00 PM	Abstract	065 - Rapidly Progressive atypical Posterior Reversible Encephalopathy Syndrome (PRES) associated with B-cell lymphoma Yuri Bronstein, MD
08:30 AM - 07:00 PM	Abstract	066 - Case Report: Posterior reversible encephalopathy syndrome (PRES) associated with aseptic meningitis Qiang J. Zhang, MD
08:30 AM - 07:00 PM	Abstract	067 - Hyperthermia induced posterior reversible encephalopathy syndrome: a rare presentation. Rafael Rodriguez, MD
08:30 AM - 07:00 PM	Abstract	068 - A Proposed Mechanism for Hypobaric-induced Neuronal Injury: A Swine Model Philippine Dana Peralta, MD
08:30 AM - 07:00 PM	Abstract	069 - VCAM_1 as a endothelial factor for diagnosis of dementia in Parkinson's disease
08:30 AM - 07:00 PM	Abstract	070 - NA
08:30 AM - 07:00 PM	Abstract	071 - Automated Seizure Detection on the Median Power Spectrogram Using Computer Vision and Machine Learning Methods Peter Z. Yan, MD, MS
08:30 AM - 07:00 PM	Abstract	072 - PRES related reversible epileptic Anton’s syndrome Junaid H. Siddiqui, MD
08:30 AM - 07:00 PM	Abstract	073 - Morphometric Analysis on T1-Weighted MRI Complements Visual MRI Review in Focal Cortical Dysplasia Alexandra R. Santana Almansa, MD
08:30 AM - 07:00 PM	Abstract	074 - Postictal Clinical Features of Focal Dyscognitive Seizures David P. Harris, MD
08:30 AM - 07:00 PM	Abstract	075 - Early epileptiform discharges as predictor of seizures in the pediatric intensive care unit Ryan M. Hodgeman
08:30 AM - 07:00 PM	Abstract	076 - EEG findings in a Case of Congenital Zika Virus Syndrome GURCHARANJEET KAUR, MBBS
08:30 AM - 07:00 PM	Abstract	077 - Efficacy of Cannabidiol in Children with Intractable Epilepsy GURCHARANJEET KAUR, MBBS
08:30 AM - 07:00 PM	Abstract	078 - Further Delineation of Clinical Phenotype of Cerebellar Ataxia, Mental Retardation, and Disequilibrium Syndrome type 4 (CAMRQ4); Report of 5 New Patients and Review of Previously Reported Cases. Saud Alsahli, MD
08:30 AM - 07:00 PM	Abstract	079 - SCALP/Schimmelpenning Syndrome (SNS) Presenting with Aneurysms and Neonatal Status Epilepticus Elizabeth A. Ng, MD, FAAP, FAANEM, FACNS, FAES
08:30 AM - 07:00 PM	Abstract	080 - A novel pediatric presentation of epilepsy, nonanesthetic malignant hyperthermia, and congenital developmental delay associated with likely pathologic RYR1 variant. Anisha C. Schwarz, MD
08:30 AM - 07:00 PM	Abstract	081 - Validity of DSM V Major Neurocognitive disorder criteria for population research in India Aashrai S. Gudlavalleti, MBBS
08:30 AM - 07:00 PM	Abstract	082 - Is Mini Mental State Examination the best test for lower educated individuals? Mariane de Moraes Monteiro
08:30 AM - 07:00 PM	Abstract	083 - Neuropsychiatric Symptoms Related to Neuropathologic vs. Clinical Diagnosis of Dementia Letizia G. Borges, MD
08:30 AM - 07:00 PM	Abstract	084 - Neuropsychiatric symptoms in Latino patients with Alzheimer’s disease: an analysis of the NACC database Katya Rascovsky
08:30 AM - 07:00 PM	Abstract	085 - Digital Self-Administered Gerocognitive Examination (eSAGE): Correlations with Neuropsychological Evaluations Douglas W. Scharre, MD, FAAN
08:30 AM - 07:00 PM	Abstract	086 - Mining Data from Verbal Fluency Word Lists for Prediction of Amyloid Status David G. Clark, MD
08:30 AM - 07:00 PM	Abstract	087 - Measuring an Individual’s Degree of Semantic Impairment due to Temporal Pole Damage
08:30 AM - 07:00 PM	Abstract	088 - Dementia & Amyloid Detection in Lewy Body Disorders Using The Philadelphia Brief Assessment of Cognition (PBAC)
08:30 AM - 07:00 PM	Abstract	089 - Clinical utility of memory measures in the differential diagnosis of mild cognitive impairment and major depressive disorder Bonnie Scott, PhD
08:30 AM - 07:00 PM	Abstract	090 - A new treatment Paradigm for Neurodegeneration: Peroxidation-resistant polyunsaturated fatty acids (D-PUFA) lower brain amyloid beta and oxidation markers, and reverse cognition impairment in vivo Mikhail S. Shchepinov, PhD
08:30 AM - 07:00 PM	Abstract	091 - Structural and functional brain connectome architecture in Alzheimer’s disease and amnesic mild cognitive impairment patients Massimo Filippi, MD, FAAN
08:30 AM - 07:00 PM	Abstract	092 - Common and differential patterns of brain atrophy in Alzheimer’s disease-related and non-related variants of posterior cortical atrophy Maxime Montembeault, PhD
08:30 AM - 07:00 PM	Abstract	093 - Advanced 1H-MRS detects decreased glutamate levels in amnestic MCI
08:30 AM - 07:00 PM	Abstract	094 - ApoE-dependent differences in functional connectivity support memory performance in early-stage Alzheimer’s disease Matteo De Marco, PhD
08:30 AM - 07:00 PM	Abstract	095 - Gait parameters as useful proxies in the early stage of Alzheimer’s disease: a Voxel Based Morphometry study Micaela Mitolo, PhD
08:30 AM - 07:00 PM	Abstract	096 - An efficient approach to obtain optimized metabolic PET and morphological MR data in dementia patients Kevin T. Chen
08:30 AM - 07:00 PM	Abstract	097 - Comparative Value of ASL-MRI and FDG-PET Imaging in Neurodegenerative Diseases: Cerebral Blood Flow vs. Glucose Metabolism Gustavo C. Roman, MD, FAAN
08:30 AM - 07:00 PM	Abstract	098 - Brain Atrophy in Early and Late Onset Alzheimer’s Disease and Suspected Non-Alzheimer’s Pathophysiology Eddie Stage, Jr.
08:30 AM - 07:00 PM	Abstract	099 - Differences in brain metabolism in Early and Late Onset Alzheimer’s Disease and Suspected Non-Alzheimer’s Pathophysiology
08:30 AM - 07:00 PM	Abstract	100 - The synergistic interaction between amyloid and tau PET in the brain’s default mode network determines the clinical status in early Alzheimer’s disease. Tharick A. Pascoal, Sr., MD, PhD
08:30 AM - 07:00 PM	Abstract	101 - The Association of Uncontrolled Seizures with Health-Related Quality of Life by Age Group among Patients with Epilepsy Fulton Velez
08:30 AM - 07:00 PM	Abstract	102 - Temporal and spectral characteristics of dynamic functional connectivity between resting-state networks in temporal lobe epilepsy Sharon Chiang, MD, PhD
08:30 AM - 07:00 PM	Abstract	103 - Healthcare Resource Utilization Among Patients With Lennox-Gastaut Syndrome Treated With Clobazam Jesus E. Pina-Garza, MD
08:30 AM - 07:00 PM	Abstract	104 - Healthcare Resource Utilization and Projected Long-Term Cost Savings Following Clobazam Initiation in Patients With Lennox-Gastaut Syndrome John M. Stern, MD, FAAN
08:30 AM - 07:00 PM	Abstract	105 - Analysis of Changes in Plasma Sodium Levels and Related Treatment-Emergent Adverse Events During Short- and Long-Term Use of Eslicarbazepine Acetate as Adjunctive and Monotherapy Robert T. Wechsler, MD, PhD, FAAN
08:30 AM - 07:00 PM	Abstract	106 - Etiologies and developmental outcomes in infants with new onset epilepsy: report of 40 consecutive patients Sandra Reiter-Campeau, MD
08:30 AM - 07:00 PM	Abstract	107 - Long-term Postoperative Outcomes in Patients with Focal Cortical Dysplasia: Predictive Factors and AED Withdrawal Emily Stanford
08:30 AM - 07:00 PM	Abstract	108 - A dose ranging safety and pharmacokinetic study of cannabidol (CBD) in children with Dravet syndrome (GWPCARE1) Anup D. Patel, MD, FAAN
08:30 AM - 07:00 PM	Abstract	109 - A review of the drug–drug interactions of the new antiepileptic drug brivaracetam Brian D. Moseley, MD
08:30 AM - 07:00 PM	Abstract	110 - Randomized double-blind non-inferiority trial of lacosamide versus controlled-release carbamazepine monotherapy - subgroup analysis of unclassified patients with initial generalized tonic-clonic seizures only Konrad J. Werhahn, MD
08:30 AM - 07:00 PM	Abstract	111 - Mutational analysis of CCNF in ALS patients in Taiwan Yi-Chung Lee, MD, FAAN
08:30 AM - 07:00 PM	Abstract	112 - Role of MicroRNA in Amyotrophic Lateral Sclerosis:evidence for gender and age of onset difference
08:30 AM - 07:00 PM	Abstract	113 - Motor unit number estimation recording from the tongue: a pilot study Courtney E. McIlduff, MD
08:30 AM - 07:00 PM	Abstract	114 - An approach for optimizing muscle assessment with surface electrode array configurations used in electrical impedance myography Benjamin Sanchez, PhD
08:30 AM - 07:00 PM	Abstract	115 - Development of Biomarkers for the Diagnosis of Amyotrophic Lateral Sclerosis Scott M. Lewis, MD, PhD
08:30 AM - 07:00 PM	Abstract	116 - Edaravone (MCI-186) for the Treatment of Amyotrophic Lateral Sclerosis (ALS): A Posthoc Assessment of the 40-Item ALS Assessment Questionnaire (ALSAQ-40) by Domain Koji Takei
08:30 AM - 07:00 PM	Abstract	117 - Electrical Impedance Myography as a Surrogate Measure of Myofiber Size
08:30 AM - 07:00 PM	Abstract	118 - Generational Variance in Phenotypic Expression of Autosomal Dominant Spinal Muscular Atrophy Due to BICD2 Mutation Evan A. Jameyfield, MD
08:30 AM - 07:00 PM	Abstract	119 - Use of Big Data Analytics for Early Diagnosis of Amyotrophic Lateral Sclerosis (ALS) Tara Grabowsky
08:30 AM - 07:00 PM	Abstract	120 - Counting the uncounted costs of Spinal muscular atrophy Michelle A. Farrar
08:30 AM - 07:00 PM	Abstract	121 - Evaluation of Cognitive Reserve in Amyotrophic lateral Sclerosis
08:30 AM - 07:00 PM	Abstract	123 - Axonal RNA Profiling of Human Motor Neurons as a Novel Approach to Study Axonopathies Mario A. Saporta, MD, PhD, FAAN
08:30 AM - 07:00 PM	Abstract	124 - EEG Measures of Altered Cortico-Cortical Connectivity Correlate with Structural MRI Changes in Amyotrophic Lateral Sclerosis
08:30 AM - 07:00 PM	Abstract	125 - Subjective perception of health in ALS: A moving target? Nimish Thakore, MD
08:30 AM - 07:00 PM	Abstract	126 - Differentiating Flail Limb Syndrome from Amyotrophic Lateral Sclerosis Jeffrey M. Kornitzer, MD, FAAN
08:30 AM - 07:00 PM	Abstract	127 - CLINICOSOCIAL FACTORS THAT INFLUENCE DIAGNOSTIC DELAY IN ALS Drew Young
08:30 AM - 07:00 PM	Abstract	128 - Correlations of a novel strength-based endpoint for tracking disease progression in amyotrophic lateral sclerosis with quality of life and functioning outcomes Jennifer Petrillo Billet, PhD
08:30 AM - 07:00 PM	Abstract	129 - Assessment of olfactory dysfunction as a potential biomarker in Amyotrophic Lateral Sclerosis Cristina Viguera Altolaguirre, MD
08:30 AM - 07:00 PM	Abstract	130 - Predictors of Mortality in Patients with Amyotrophic Lateral Sclerosis Akanksha Sharma, MD
08:30 AM - 07:00 PM	Abstract	131 - Effectiveness of automatic intratracheal suctioning system for amyotrophic lateral sclerosis patients with tracheostomy-invasive ventilation Kiyonobu Komai, MD
08:30 AM - 07:00 PM	Abstract	132 - Radiological "Snake Eyes" Sign Due to Anterior Epidural Spinal Cyst Mimicking Hirayama Disease Abdallah M. Hamdallah, MD
08:30 AM - 07:00 PM	Abstract	133 - Immune Mediators as Biomarker Candidates in Familial Amyotrophic Lateral Sclerosis Anupama Kumar, PhD
08:30 AM - 07:00 PM	Abstract	134 - Ultra-High Field Proton MR Spectroscopy in Amyotrophic Lateral Sclerosis Ian Cheong, MD
08:30 AM - 07:00 PM	Abstract	135 - Haemodialysis Alters Peripheral Nerve Morphology in End-stage Kidney Disease Adeniyi A. Borire, MD
08:30 AM - 07:00 PM	Abstract	136 - Prominent Distal demyelination is a feature of Zika-Associated Guillain Barre Syndrome Natalia Betances, MD
08:30 AM - 07:00 PM	Abstract	137 - Identification of a Novel Immune Mediated Cause for Small Fiber Neuropathy Todd D. Levine, MD
08:30 AM - 07:00 PM	Abstract	138 - Diffusion Tensor Imagine of the Brachial Plexus and Cervical Spinal Nerve Roots: Case Controls Study in CIDP Patients and Controls Eve Chanson
08:30 AM - 07:00 PM	Abstract	139 - Long-term course of idiopathic small fiber neuropathy Walter F. Haupt, MD, Prof, FAAN
08:30 AM - 07:00 PM	Abstract	140 - The evaluation of small fiber neuropathy: a survey of ��ɫ�� members Sujata P. Thawani, MD
08:30 AM - 07:00 PM	Abstract	141 - Effects of Plasmapheresis in Neuropathic Pain, Local Inflammatory Cytokines, and Skin-Wrinkling-Response in Patients with Painful Peripheral Neuropathies. Eduardo A. De Sousa, MD, FAAN
08:30 AM - 07:00 PM	Abstract	142 - Alternate resistance and endurance training improves muscle strength and aerobic capacity in patients with chronic inflammatory demyelinating polyneuropathy Lars Markvardsen
08:30 AM - 07:00 PM	Abstract	143 - NA
08:30 AM - 07:00 PM	Abstract	144 - NA
08:30 AM - 07:00 PM	Abstract	145 - Case Report: A transverse spinal cord infarct in a 15 year old male following lumbar epidural catheter placement Daniel Savitt, MD
08:30 AM - 07:00 PM	Abstract	146 - Readmissions within Pediatric Neurology: A Quality Improvement Initiative Involving Discharge Optimization Jamie L. Palaganas, MD, FAAN
08:30 AM - 07:00 PM	Abstract	147 - Defining Hand Stereotypies in Rett Syndrome: A Movement Disorders Perspective Marisela E. Dy-Hollins, MD, MSCR, FAAN
08:30 AM - 07:00 PM	Abstract	148 - The Muscular Dystrophy Association (MDA) U.S. Neuromuscular Disease (NMD) Registry: Initial Data on Patients with Spinal Muscular Atrophy (SMA)
08:30 AM - 07:00 PM	Abstract	149 - Pediatric Thrombectomy: Case Presentation and Standardizing the INR process. Ittai Bushlin, MD, PhD
08:30 AM - 07:00 PM	Abstract	150 - Fetal central nervous system malformations: a ten year review of prenatal consultations at a tertiary care center Sonika Agarwal, MD, FAAN
08:30 AM - 07:00 PM	Abstract	151 - A ten year profile of plasmapheresis use in pediatric neurologic disorders at a tertiary care center
08:30 AM - 07:00 PM	Abstract	152 - Detection rate of chromosomal microarray genetic testing in patients with cerebral palsy Rena Vanzo
08:30 AM - 07:00 PM	Abstract	153 - Electroencephalographic Spectral Power in Girls with Rett Syndrome Katherine Roche, MD
08:30 AM - 07:00 PM	Abstract	154 - Prophylactic therapy of cyclic vomiting syndrome in children: comparison of amitriptyline, cyproheptadine, and topiramate Shervin Badihian, MD
08:30 AM - 07:00 PM	Abstract	155 - Neuropsychological Profiles in Pediatric Neuromyelitis Optica Spectrum Disorder Eliza M. Gordon-Lipkin, MD
08:30 AM - 07:00 PM	Abstract	156 - Association Between Affective Symptoms and School Bullying Experiences in Adults with Autism Spectrum Disorders Bryan K. Woodruff, MD
08:30 AM - 07:00 PM	Abstract	157 - D-DEMO, A Novel and Distinct Phenotype Caused by ATP1A3 Mutations , Elie Abdelnour
08:30 AM - 07:00 PM	Abstract	158 - Healthcare Resource Use in Patients with Diagnosis of Spinal Muscular Atrophy (SMA) in Optum™ U.S. Claims Database Megan Teynor
08:30 AM - 07:00 PM	Abstract	159 - Truven Health MarketScan commercial claims database for Juvenile Myasthenia Gravis (JMG) Saahith Pochiraju
08:30 AM - 07:00 PM	Abstract	160 - Autism Spectrum Disorder in Cerebrotendinous Xanthomatosis.
08:30 AM - 07:00 PM	Abstract	161 - Hypoperfusion, vascular pruning, and transient hemiparesis mimicking stroke in transient erythroblastopenia of childhood Christopher F. Calahan
08:30 AM - 07:00 PM	Abstract	162 - Malformations of cortical development: a case series of prenatal neurologic consultations and outcomes
08:30 AM - 07:00 PM	Abstract	163 - A Pilot Study to Assess the Feasibility and Impact of a Home Exercise Program on Heart Rate and Heart Rate Variability in Children with Muscular Dystrophy Aaron Zelikovich, MD
08:30 AM - 07:00 PM	Abstract	164 - Diagnostic Challenges in Pediatric Onset Hereditary Spastic Paraparesis (HSP) Gyula Acsadi, MD, FAAN
08:30 AM - 07:00 PM	Abstract	165 - Disruptive Behavior Problems in Levetiracetam-Treated Youth with Epilepsy Michelle D. Lally, MD
08:30 AM - 07:00 PM	Abstract	166 - Acute Flaccid Myelitis (AFM): 4 cases in 4 weeks Rahul P. Sinha, MD
08:30 AM - 07:00 PM	Abstract	167 - Decorticate posturing with unresponsiveness- expanding the spectrum of Anti-VGKC antibody mediated autoimmune encephalitis in pediatrics Daniel Reiff
08:30 AM - 07:00 PM	Abstract	168 - Novel mutations in RMND1 presenting with dystonia and seizures
08:30 AM - 07:00 PM	Abstract	169 - A Case of GLUT1 Deficiency Associated Episodic Ataxia Without Epilepsy Dmitry Tchapyjnikov, MD
08:30 AM - 07:00 PM	Abstract	170 - Severe auto-immune sensory-autonomic neuropathy in an adolescent Zeyad Aljuhni
08:30 AM - 07:00 PM	Abstract	171 - Outcome Of Revascularization In Patients With ACTA2 Cerebral Vasculopathy Trishna Kantamneni, MBBS
08:30 AM - 07:00 PM	Abstract	172 - Rasmussen’s Encephalitis Treated with Responsive Neurostimulation System
08:30 AM - 07:00 PM	Abstract	173 - Dysmorphology in the Human Medial Superior Olive after Environmental Exposure to Pollution Kaitlyn M. Blackburn, DO
08:30 AM - 07:00 PM	Abstract	174 - Novel mutation of DARS2 gene leads to a rare and aggressive presentation of leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation (LBSL) Geetanjali S. Rathore, MD, FAAN
08:30 AM - 07:00 PM	Abstract	175 - Acute Pediatric Ischemic Stroke Management: a window for opportunity?
08:30 AM - 07:00 PM	Abstract	176 - Rapid-Onset Dystonia Parkinsonism with a rare mutation. Rachit Patil, MD
08:30 AM - 07:00 PM	Abstract	177 - Co-occurrence of pathogenic mutations in mutiple genes in 2 siblings with Brown-Vialetto-Van Laere Syndrome Type 2 phenotype. Kallol K. Set, MD
08:30 AM - 07:00 PM	Abstract	178 - Homozygous AMT mutation in a patient with neonatal onset nonketotic hyperglycinemia and hyperammonemia Jeffrey M. Kornitzer, MD, FAAN
08:30 AM - 07:00 PM	Abstract	179 - New Clinical Phenotype Caused by a Novel SLC6A1 Mutation with Marked Responsiveness to Zonisamide Ashley Helseth, MD, PhD
08:30 AM - 07:00 PM	Abstract	180 - Challenges in prenatal and neonatal diagnosis of Cornelia de Lange Syndrome: a case study Michael P. Stanley, MD
08:30 AM - 07:00 PM	Abstract	181 - Delayed versus dysmyelination in Jacobsen Syndrome Henry Osso-Rivera, MD
08:30 AM - 07:00 PM	Abstract	182 - Levodopa responsive chorea with TITF1 mutation in brain-lung-thyroid disease Vijeta Shukla, MD
08:30 AM - 07:00 PM	Abstract	183 - Sturge-Weber Syndrome Type 3 in a 44 year old woman: A Case report & review of literature. Jessica Lowe, MD
08:30 AM - 07:00 PM	Abstract	184 - Impaired Recognition of Sadness in Face or Voice Correlates with Spouses' Perception of Empathy in Frontotemporal Dementia Lauren Phillips
08:30 AM - 07:00 PM	Abstract	185 - Characterization of Primary Progressive Aphasia and Prediction of Naming Decline by Multi-Modality MRI Andreia V. Faria, MD, PhD
08:30 AM - 07:00 PM	Abstract	186 - Intonation as a disease marker in behavioral variant Frontotemporal Degeneration Naomi Nevler, MD
08:30 AM - 07:00 PM	Abstract	187 - Clinical characteristics of 32 patients with rapidly progressive dementia with Lewy bodies Claudia Z. Chou, MD
08:30 AM - 07:00 PM	Abstract	189 - Targeting Neurotoxic Tau Oligomers through Intravenous Immunoglobulin (IVIG) Antibodies for the Treatment of Alzheimer’s Disease
08:30 AM - 07:00 PM	Abstract	190 - A case of sporadic adult-onset leukoencephalopathy with neuroaxonal spheroids and pigmented glia presenting as fronto-temporal dementia Ye Hu, MD
08:30 AM - 07:00 PM	Abstract	191 - A Brief Dementia Screening Test in South Africa: Results from the Health and Aging Longitudinal Study of an INDEPTH community (HAALSI) Farrah J. Mateen, MD, PhD, FAAN
08:30 AM - 07:00 PM	Abstract	192 - Utility of Recognition Discriminability Index to Predict Conversion From Mild Cognitive Impairment to Alzheimer's Disease in the Alzheimer’s Disease Neuroimaging Initiative Maria Julieta Russo, MD
08:30 AM - 07:00 PM	Abstract	193 - Reading difficulties in a cohort of Spanish-speaking patients with Primary Progressive Aphasia. Jordi A. Matias-Guiu
08:30 AM - 07:00 PM	Abstract	194 - MCI subtypes are heterogeneous and preceded by different risk factors: A study on aMCI and naMCI incidence Andrea R. Zammit, PhD
08:30 AM - 07:00 PM	Abstract	195 - Rivastigmine and citalopram treatment for Alzheimer’s disease in every day clinical praxis.
08:30 AM - 07:00 PM	Abstract	196 - Localization of primary progressive apraxia of speech using functional MRI - a case study Danielle S. Shpiner, MD
08:30 AM - 07:00 PM	Abstract	197 - The neural basis of indirect speech act comprehension: Evidence from behavioral variant frontotemporal degeneration
08:30 AM - 07:00 PM	Abstract	198 - Late-Onset Wilson's disease, Dementia, Ekbom syndrome and whitte matter hyperintensities
08:30 AM - 07:00 PM	Abstract	199 - FDG-PET, Neuropsychiatric Symptoms and the Risk of Incident Mild Cognitive Impairment Janina Krell-Roesch, PhD
08:30 AM - 07:00 PM	Abstract	200 - Influence of dopaminergic system on manipulospatial function in persons with mild dementia and mild cognitive impairment Yutaka Tanaka, MD, FAAN
08:30 AM - 07:00 PM	Abstract	201 - Implications for Management of PET Amyloid Classification Technology (IMPACT) Norman L. Foster, MD, FAAN
08:30 AM - 07:00 PM	Abstract	202 - Novel microRNA related to learning and memory in mouse brain
08:30 AM - 07:00 PM	Abstract	203 - Gesture Comprehension and Language in Young Children with Autism Spectrum Disorder Tracey A. Knaus, PhD
08:30 AM - 07:00 PM	Abstract	204 - Asymmetric intrahemispheric connectivity between left dorsal frontal lobe and perisylvian language network Borna Bonakdarpour, MD, FAAN
08:30 AM - 07:00 PM	Abstract	205 - Network Graph Theory Analysis of Semantic Fluency in Russian - English Bilinguals Supriya Mahajan, MD
08:30 AM - 07:00 PM	Abstract	206 - Transcranial Direct Current Stimulation in Post-Stroke Aphasia: The Impact of Baseline Severity and Task Specificity Catherine Norise, MD
08:30 AM - 07:00 PM	Abstract	207 - Naming of objects and actions in Multiple Sclerosis Nicoletta Caputi, PhD
08:30 AM - 07:00 PM	Abstract	208 - Meg Localization of Cortical Activity During Language Processing Utilizing MR-Focus and Coherence Source Imaging
08:30 AM - 07:00 PM	Abstract	209 - Impaired Gesture-Language Integration in Adolescents with Autism Spectrum Disorder Tracey A. Knaus, PhD
08:30 AM - 07:00 PM	Abstract	210 - Areas Critical for Accessing Semantics from Spoken Words
08:30 AM - 07:00 PM	Abstract	211 - Overrepresentation of isolated verbal repetition deficits in aphasic males with stroke: A systematic literature review and meta-analysis
08:30 AM - 07:00 PM	Abstract	212 - Neural Bases of Dysgraphia after Acute Stroke Aishwarya Shukla
08:30 AM - 07:00 PM	Abstract	213 - Detecting language processing in traumatic disorders of consciousness: A stimulus-based EEG study
08:30 AM - 07:00 PM	Abstract	214 - Clinical and molecular effects of functional electrical stimulation /lower extremity training in Myotonic Dystrophy
08:30 AM - 07:00 PM	Abstract	215 - Correlations between Cerebral Vascular Reactivity Deficits and Brain Parenchymal Volumes after Chronic Moderate/Severe TBI Kelley A. Flesher, MD
08:30 AM - 07:00 PM	Abstract	216 - Effects of Intra-Arterial Delivery of Mesenchymal Stem Cells on Infarct Size and Neurological Outcome in Rat Middle Cerebral Artery Occlusion Model: A Systematic Review and Meta-analysis Kunakorn Atchaneeyasakul, MD
08:30 AM - 07:00 PM	Abstract	217 - Revised Constraint-Induced Aphasia Therapy (CIAT II): Neuroscience Foundations Traced from Basic Laboratory Research to Increased Spontaneous Real-World Speech and Cerebral Cortical Structure Victor W. Mark, MD
08:30 AM - 07:00 PM	Abstract	218 - Neuromodulation by task-concurrent dual transcranial direct current stimulation over the motor cortex in subacute stroke Chih-Wei Tang, MD
08:30 AM - 07:00 PM	Abstract	219 - Central Post Stroke Pain: A Systematic Review
08:30 AM - 07:00 PM	Abstract	220 - What is the Molecular Mechanism of WldS-Mediated Axon Protection? Jack T. Wang, MD, PhD
08:30 AM - 07:00 PM	Abstract	221 - NA
08:30 AM - 07:00 PM	Abstract	222 - NA
08:30 AM - 07:00 PM	Abstract	223 - Inadequacy of Benzodiazepine dosing in Status Epilepticus patients admitted to Neurointensive Care Unit Wazim Mohamed, MD
08:30 AM - 07:00 PM	Abstract	224 - Treatment of Patients in Status Epilepticus: A Retrospective Chart Review Trenton J. Tollefson, MD
08:30 AM - 07:00 PM	Abstract	225 - Quality Improvement for the Management of Pediatric Patients with Status Epilepticus Dmitry Tchapyjnikov, MD
08:30 AM - 07:00 PM	Abstract	226 - Clinical predictors and outcomes of refractory status epilepticus in a large urban hospital. Bhrugav G. Raval, MD
08:30 AM - 07:00 PM	Abstract	227 - Prolonged super-refractory status epilepticus with excellent seizure and functional outcome. Angelica M. Lee, DO
08:30 AM - 07:00 PM	Abstract	228 - Levetiracetam in Non-Convulsive Status Epilepticus Guido D. Vazquez II, PhD
08:30 AM - 07:00 PM	Abstract	230 - Convulsive status epilepticus due to all the evoluative stages of neurocysticercosis: Clinical profile and outcomes Jagarlapudi M. Murthy, MD, FAAN
08:30 AM - 07:00 PM	Abstract	231 - Is serum albumin level associated with mortality? Correlation between proteins levels with status epilepticus mortality scoring systems. Maria S. Pacha
08:30 AM - 07:00 PM	Abstract	232 - The Effects of Depression on Length of Stay and Discharge Disposition among Patients with Epilepsy Rabia Jamy, MD
08:30 AM - 07:00 PM	Abstract	233 - Suicidality in epilepsy: NDDI-E scale validation in Argentina.
08:30 AM - 07:00 PM	Abstract	234 - Are depression and anxiety disorders in epilepsy associated with atrophy of mesial temporal structures? CARLOS MAURICIO M. MILLAN, MD
08:30 AM - 07:00 PM	Abstract	235 - Drug-Resistant Focal Epilepsy and Chronic Traumatic Encephalopathy: clinical evaluation and pathological findings Amy L. Jones, MD
08:30 AM - 07:00 PM	Abstract	236 - Vitamin D and bone mineral density in epilepsy patients James W. Bathe
08:30 AM - 07:00 PM	Abstract	237 - Do neurology residents need a curriculum for learning about psychogenic nonepileptic seizures? Barbara A. Dworetzky, MD, FAAN
08:30 AM - 07:00 PM	Abstract	238 - Is a history of psychiatric illness in patients with epilepsy a risk factor for developing psychiatric adverse events on antiepileptic medications? Ai Sumida, MD
08:30 AM - 07:00 PM	Abstract	239 - Cognitive Testing and Depression scores in Patients with Epilepsy in relationship to Vitamin D levels
08:30 AM - 07:00 PM	Abstract	240 - Development and Validation of the Refractory Epilepsy Screening Tool for Lennox-Gastaut Syndrome (REST-LGS): Improving Detection of LGS
08:30 AM - 07:00 PM	Abstract	241 - Motor phenotype differentiates adult patients with Dravet Syndrome from Lennox-Gastaut Syndrome Danah T. Aljaafari, MD
08:30 AM - 07:00 PM	Abstract	242 - The controversy surrounding voltage-gated potassium channel (VGKC)-complex antibodies: Case and Discussion Jonathan R. Galli, MD
08:30 AM - 07:00 PM	Abstract	243 - Assessing the Role of the Hippocampus in Visual Naming Using Hippocampal Morphometry in Left Temporal Lobe Epilepsy Patrick M. Bauer, MD
08:30 AM - 07:00 PM	Abstract	244 - Patient Experiences with Epilepsy Treatments: Thematic Review of the Qualitative Literature Samuel Lapalme-Remis, MD
08:30 AM - 07:00 PM	Abstract	245 - Clinical Center for the Lafora Epilepsy Cure Initiative (LECI): Clinical Trial Readiness for a Global Curative Drug Trial Viet-Huong Nguyen, PharmD, MPH, MS
08:30 AM - 07:00 PM	Abstract	246 - Patterns of Drug Resistant Epilepsy in A Cohort of Adult Epilepsy Patients Taha B. A-Hakam, Sr., MD
08:30 AM - 07:00 PM	Abstract	247 - Seizure intractibility in geriatric and non-geriatric adult patients Rohit A. Marawar, MD, FAAN
08:30 AM - 07:00 PM	Abstract	248 - Self-reported antiepileptic medication adherence of adult patients with epilepsy
08:30 AM - 07:00 PM	Abstract	249 - Quantitative EEG Detects REM Sleep to Enhance Epileptogenic Zone Localization Marcus Ng, MD
08:30 AM - 07:00 PM	Abstract	250 - NA
08:30 AM - 07:00 PM	Abstract	251 - Ultrasound Criteria for Assessment of Vertebral Artery Origins Cory J. Rice, MD
08:30 AM - 07:00 PM	Abstract	252 - Retinal and Ophthalmic Artery Studies in Ischemic Stroke Patients Using Fundus Photography and Transcranial Doppler Methods Kiran Patil
08:30 AM - 07:00 PM	Abstract	253 - Cerebral blood flow and auto-regulation in acute TIA patients from a general hospital in Qatar
08:30 AM - 07:00 PM	Abstract	254 - Sigmoid Sinus Characteristics Correlate with Early Clinical and Imaging Surrogates in Anterior Circulation Ischemic Stroke Johann Sellner, MD, FAAN
08:30 AM - 07:00 PM	Abstract	255 - Infarct location predicts outcome in distal MCA occlusions Muhib Khan, MD, FAAN
08:30 AM - 07:00 PM	Abstract	256 - Factors Affecting Distal Hyperintense Vessel Sign, a Postulated Marker for Intracranial Collateral Circulation Tarun Girotra, MD
08:30 AM - 07:00 PM	Abstract	257 - Clinical and imaging characteristics of silent brain infarction and symptomatic stroke Khaled Albazli, MD
08:30 AM - 07:00 PM	Abstract	258 - Early cognitive decline in symptomatic carotid stenosis is related to plaque inflammation and concomitant intracranial stenosis Chi Hsien Tan, MBBS
08:30 AM - 07:00 PM	Abstract	259 - Vasa Vasorum Enhancement on Computerized Tomographic Angiography Correlates with Symptomatic Patients with 50% to 70% Carotid Artery Stenosis Raffaella Umeton, MD, PhD, MMSc
08:30 AM - 07:00 PM	Abstract	260 - Association between Increased Brachial-ankle Pulse Wave Velocity and Cerebral Perivascular Space
08:30 AM - 07:00 PM	Abstract	261 - Quick-brain MRI as first imaging modality to diagnose pediatric stroke Alison L. Christy, MD, PhD, FAAN
08:30 AM - 07:00 PM	Abstract	262 - Early Clinical Improvement in Central Retinal Artery Occlusion is Associated with Central Retinal Artery Recanalization Mohammed H. Alkuwaiti, MD
08:30 AM - 07:00 PM	Abstract	263 - Safety Of IV Thrombolysis For Acute Ischemic Stroke Patients With Thrombocytopenia Haris Kamal, MD
08:30 AM - 07:00 PM	Abstract	264 - Intravenous Thrombolysis for Acute Ischemic Stroke in Patients with Thrombocytopenia Ashkan Mowla, MD, FAAN
08:30 AM - 07:00 PM	Abstract	265 - Minor Strokes with proximal large vessel occlusion in anterior circulation; is intravenous thrombolysis enough Haris Kamal, MD
08:30 AM - 07:00 PM	Abstract	266 - Imaging predictors of hemorrhagic transformation following intravenous rt-PA treatment for acute ischemic stroke. Nudrat Tasneem, MBBS
08:30 AM - 07:00 PM	Abstract	268 - Patient is Taking Antiplatelet at home- Does This Increase the Risk of Post Intravenous Thrombolysis Intracranial Hemorrhage? Sandhya Mehla, MD
08:30 AM - 07:00 PM	Abstract	269 - Impact of Vascular Risk factors on Hemorrhagic Transformation Following rt-PA Administration for Acute Ischemic Stroke Amir Shaban, MD
08:30 AM - 07:00 PM	Abstract	270 - Collaborative Interventions Reduce Time-to-Thrombolysis for Acute Ischemic Stroke in an Urban, Public Hospital Zachary D. Threlkeld, MD, FAAN
08:30 AM - 07:00 PM	Abstract	271 - Intravenous Thrombolysis in Anticoagulated and Thrombocytopenic Ischemic Stroke Patients Does Not Increase the Risk of Intracerebral Hemorrhage nobl barazangi, MD, PhD
08:30 AM - 07:00 PM	Abstract	272 - Trends in Alteplase Utilization in Louisiana’s Level III Hospitals Digvijaya D. Navalkele, MD
08:30 AM - 07:00 PM	Abstract	273 - Delays in Door-to-Needle Time for Acute Ischemic Stroke in the Emergency Department: A Comprehensive Stroke Center Experience Ashkan Mowla, MD, FAAN
08:30 AM - 07:00 PM	Abstract	274 - Characteristics of patients presenting within the first 6 hours compared to historical controls Abeer A. Khoja, MD
08:30 AM - 07:00 PM	Abstract	275 - Intravenous Thrombolytic Treatment of Acute Ischemic Stroke in Patients Older and Younger than 80 Years: Experience From One Hospital Hernan Bayona, MD
08:30 AM - 07:00 PM	Abstract	276 - Risk of Symptomatic Intracranial Hemorrhage and Clinical Outcome after Intravenous Thrombolysis in Posterior Circulation Stroke: Results from the SITS-EAST Registry Roman Herzig, MD, PhD
08:30 AM - 07:00 PM	Abstract	277 - Intravenous Tissue Plasminogen Activator for Patients with Mild or Rapidly Improving Ischemic Strokes and Large Vessel Occlusions: Examining In-hospital Outcomes Jeffrey C. Wagner, MD
08:30 AM - 07:00 PM	Abstract	278 - Time Trend Analysis of Intravenous Thrombolytic Delivery across the Academic Year: an Academic Tertiary Medical Center Experience Sandhya Mehla, MD
08:30 AM - 07:00 PM	Abstract	279 - Hispanic patients have longer door-to-needle times independent of age, gender and stroke severity Jonathan Cauchi, MD
08:30 AM - 07:00 PM	Abstract	280 - Target Stroke Implementation: Best Practice Strategies Cut Thrombolysis Time to < 30 minutes in a 1,550 Bed Academic Urban County Hospital Erika T. Marulanda, MD, FAAN
08:30 AM - 07:00 PM	Abstract	281 - Increasing utilization of tissue plasminogen activator in acute ischemic stroke with staff changes Mohammed F. Majeed, MD
08:30 AM - 07:00 PM	Abstract	282 - Analysis of Diagnostic Accuracy, Workflow and Time to Treatment during In-house 'Stroke Codes' Jody Manners, MD
08:30 AM - 07:00 PM	Abstract	283 - Rapidly improving neurological deficit of stroke; case series in Academic institute, KAUH, Jeddah Abeer A. Khoja, MD
08:30 AM - 07:00 PM	Abstract	284 - Barriers to thrombolysis in a tertiary care institute in eastern India Apratim Chatterjee, MD
08:30 AM - 07:00 PM	Abstract	285 - Resident door to needle Analysis: A retrospective Chart rEview (RACE) Neil G. Patel, MD
08:30 AM - 07:00 PM	Abstract	286 - High values of baseline and 24-hour Mean Arterial Pressure are associated with lower chance of early neurological improvement in acute stroke patients treated with thrombolysis Svetlana Lorenzano, MD
08:30 AM - 07:00 PM	Abstract	287 - Can admission Brain Natriuretic Peptide level predict outcome after intravenous thrombolysis in acute ischemic stroke? Gupta V. Harsh, MD
08:30 AM - 07:00 PM	Abstract	288 - Herniation despite Decompression Hemicraniectomy in Large Hemispherical Strokes Archana Hinduja, MD
08:30 AM - 07:00 PM	Abstract	289 - Outcome of large hemispheric infarction in very elderly patients treated with medical management only Sudhir V. Datar, MD
08:30 AM - 07:00 PM	Abstract	290 - Early Decompressive Hemicraniectomy for Malignant Middle Cerebral Artery Infarction: A single centre retrospective study
08:30 AM - 07:00 PM	Abstract	292 - Seizure Incidence in Ischemic Stroke Patients Treated with and without tPA: A Single Center Study Vaishnavi L. Vaidyanathan, MD
08:30 AM - 07:00 PM	Abstract	293 - PULMONARY EMBOLISM IN ACUTE ISCHAEMIC STROKE Prasanna Venkatesan Eswaradass, MD
08:30 AM - 07:00 PM	Abstract	294 - Early Carotid Revascularization Reduces Readmission for Recurrent Ischemic Stroke in Acute Ischemic Stroke Patients: Analysis of United States Nationwide Readmissions Database Saqib A. Chaudhry, MD
08:30 AM - 07:00 PM	Abstract	295 - Is Transesophageal Echocardiogram Associated with Neurological Worsening after Ischemic Stroke? Kevin S. Attenhofer, MD
08:30 AM - 07:00 PM	Abstract	296 - Recent Nationwide Trends in Transcranial Doppler Utilization During Acute Ischemic Stroke Hospitalizations
08:30 AM - 07:00 PM	Abstract	297 - Association of splenic contraction and development of SIRS after acute ischemic stroke. Alicia Zha, MD
08:30 AM - 07:00 PM	Abstract	298 - Analysis of current clinical practice on initiation of anticoagulation in patients with acute ischemic stroke. Edgar Olivas, MD
08:30 AM - 07:00 PM	Abstract	299 - Stroke versus non-stroke neurological complications after cardiac transplant Guido D. Vazquez II, PhD
08:30 AM - 07:00 PM	Abstract	300 - Dysautonomia and symptoms aggravation in acute lacunar stroke Kyong Jin Shin, MD
08:30 AM - 07:00 PM	Abstract	301 - Stroke Associated Pneumonia: The University Hospitals-Cleveland Medical Center experience Hatim S. Attar, MD
08:30 AM - 07:00 PM	Abstract	302 - Probable rapid eye movement sleep behavior disorder and risk of stroke: a prospective study Chaoran Ma
08:30 AM - 07:00 PM	Abstract	303 - Blacks Have Higher Risk of 1-Year Recurrent Ischemic Stroke and Lower 30-day Case Mortality: An Analysis of White and Black Medicare Beneficiaries, 1999-2013 Karen C. Albright, DO, DO, PhD, MS, MPH
08:30 AM - 07:00 PM	Abstract	304 - Sex Differences in Intracerebral hemorrhage Severity and Mortality Sandro Marini, MD
08:30 AM - 07:00 PM	Abstract	305 - Intermediate-term rates of stroke following cardiac procedures: the Nationwide Readmissions Database Laura K. Stein, MD, MPH
08:30 AM - 07:00 PM	Abstract	306 - Self-perceived psychological stress and risk of all-cause mortality after stroke: the Mashhad Stroke Incidence Study (MSIS) Hamidreza Saber, MD
08:30 AM - 07:00 PM	Abstract	307 - Race/ethnic Disparities in the Time from Stroke Symptom Onset to Hospital Arrival among Stroke Patients Arriving by EMS in the Florida-Puerto Rico Stroke Registry Hannah Gardener, ScD
08:30 AM - 07:00 PM	Abstract	308 - Recurrence rate of Ischemic stroke: A single center experience Fasl Goldanne Buenaflor
08:30 AM - 07:00 PM	Abstract	309 - No association of moon phase with stroke occurrence Jori Ruuskanen
08:30 AM - 07:00 PM	Abstract	310 - Delayed Cerebral Ischemia Secondary to Arteriovenous Malformation Rupture Fawaz Al-Mufti, MD
08:30 AM - 07:00 PM	Abstract	311 - Obstructive Sleep Apnea is Associated with Improved Non-Traumatic Subarachnoid Hemorrhage Outcomes Dominique Low, MD
08:30 AM - 07:00 PM	Abstract	312 - Obstructive Sleep Apnea is Associated with Improved Ischemic Stroke Outcomes Dominique Low, MD
08:30 AM - 07:00 PM	Abstract	313 - Prevalence of spasticity in patients suffering from ischemic stroke in the internal carotid artery territory - the results of interim analysis of the national registry SONAR Petr Kanovsky, PhD
08:30 AM - 07:00 PM	Abstract	314 - Extrapyramidal involvement in ALS: a prospective population-based study Adriano Chio, MD, FAAN
08:30 AM - 07:00 PM	Abstract	315 - A Survival Model for US Patients Enrolled in the National ALS Registry Web Portal Theodore Larson
08:30 AM - 07:00 PM	Abstract	316 - From Snow to Hill to ALS: An odyssey in epidemiology Carmel Armon, MD, FAAN
08:30 AM - 07:00 PM	Abstract	317 - Validation and continuing development of a patient-reported survey of small-fiber polyneuropathy symptoms Gary Zirpoli, PhD
08:30 AM - 07:00 PM	Abstract	318 - A stratified approach for mutational analysis delineates molecular epidemiology of early-onset SCD in the Japanese population Yuka Hama
08:30 AM - 07:00 PM	Abstract	319 - Hearding: a new phenomenon affecting medical decision-making in Multiple Sclerosis care? Gustavo Saposnik, MD
08:30 AM - 07:00 PM	Abstract	320 - Air Pollution and Risk of Parkinson’s Disease in a Large Prospective Study of Men. Natalia Palacios, PhD
08:30 AM - 07:00 PM	Abstract	321 - Well-water and risk of Parkinson Disease: a case-control study of US Medicare beneficiaries Maya Silver, MD
08:30 AM - 07:00 PM	Abstract	322 - Mild Traumatic Brain Injury Is Associated with Increased Risk of Parkinson Disease in Military Veterans: A Chronic Effects of Neurotrauma Consortium Study Raquel Gardner, MD
08:30 AM - 07:00 PM	Abstract	323 - Huntington Disease in Russia: an Epidemiological Challenge? Yury Seliverstov, MD, PhD
08:30 AM - 07:00 PM	Abstract	324 - High Prevalence of Mild Cognitive Impairment and Dementia in a social vulnerable population in Argentina: A starting point for dementia prevention. Maria Julieta Russo, MD
08:30 AM - 07:00 PM	Abstract	325 - Gender Specific Outcomes and Predictors of Concussion Recovery: A Single Site 15-year Ivy League Experience Cecilia D. Davis-Hayes
08:30 AM - 07:00 PM	Abstract	326 - U.S. Burden of Hospital Admissions and Utilization of Hospice Care for Patients with Malignant Brain Tumor Benjamin P. George, MD
08:30 AM - 07:00 PM	Abstract	327 - Prevalence of primary headache disorders in Kuwait: A national study. Jasem Y. Al-Hashel, MD
08:30 AM - 07:00 PM	Abstract	328 - Risk factors for developing epilepsy in a U.S. commercially insured pediatric population Ahyuda Oh, PhD
08:30 AM - 07:00 PM	Abstract	329 - The Bayesian Risk Estimate at disease onset predicting early cognitive and physical disability in CIS and MS patients
08:30 AM - 07:00 PM	Abstract	330 - Speeded Saccadic Eye Movement Predicts Symbol Digit Modalities Test Performance in Multiple Sclerosis Natali Baner, MD
08:30 AM - 07:00 PM	Abstract	331 - Improved processing speed in multiple sclerosis during fingolimod therapy: oral Symbol Digit Modalities Test response in PREFERMS Ralph H. Benedict, PhD
08:30 AM - 07:00 PM	Abstract	332 - Brief International Cognitive Assessment in Multiple Sclerosis (BICAMS) predicts performance on instrumental activities of daily living Michael Shaw
08:30 AM - 07:00 PM	Abstract	333 - The EDSS integration with the Brief International Cognitive Assessment for Multiple Sclerosis and Orientation Tests Francesco Sacca, MD, FAAN
08:30 AM - 07:00 PM	Abstract	334 - TVA - a new technique to detect early cognitive dysfunctions Wolfgang Koehler
08:30 AM - 07:00 PM	Abstract	335 - Telerehabilitation using Remotely-Supervised Transcranial Direct Current Stimulation (RS-tDCS) Enhances the Benefit of At-Home Cognitive Training in Multiple Sclerosis Bryan Dobbs
08:30 AM - 07:00 PM	Abstract	336 - Are cognitive deficits in MS related to cortical or whole brain atrophy - a chicken-and-egg problem? Wolfgang Koehler
08:30 AM - 07:00 PM	Abstract	337 - Multiple Sclerosis: Brain Atrophy and Computerized Cognitive Testing - A Longitudinal Investigation of Changes in Disease Impact
08:30 AM - 07:00 PM	Abstract	338 - Cognitive performance in radiologically isolated syndrome Anat Achiron, MD, PhD, FAAN
08:30 AM - 07:00 PM	Abstract	339 - Thalamic functional connectivity in Multiple Sclerosis: the role of temporal thalamic sub-region in maladaptation Alessandro D'Ambrosio
08:30 AM - 07:00 PM	Abstract	340 - Longitudinal Assessment of Large-Scale Brain Functional Networks in Patients with MS: Relationship with Clinical Disability and Cognitive Impairment
08:30 AM - 07:00 PM	Abstract	342 - Maladaptive personality in multiple sclerosis and its relation to cognitive status
08:30 AM - 07:00 PM	Abstract	343 - High conscientiousness is related to less thalamic and other subcortical gray matter atrophy in multiple sclerosis
08:30 AM - 07:00 PM	Abstract	344 - Attention and Processing Speed Performance in Multiple Sclerosis is Mostly Related to Thalamic Volume Alvino Bisecco
08:30 AM - 07:00 PM	Abstract	345 - Structural and Functional MRI Predictors of Disability and Cognitive Impairment Accrual in Patients with Multiple Sclerosis
08:30 AM - 07:00 PM	Abstract	346 - Unique Within-Network Functional Connections Characterize Memory and Information Processing Speed in Multiple Sclerosis Victoria Leavitt, PhD, FAAN
08:30 AM - 07:00 PM	Abstract	347 - Pittsburgh compound-B PET and MRI biomarkers of cognition in aging MS patients
08:30 AM - 07:00 PM	Abstract	348 - Extending the Concept of Reserve from Cognitive to Physical Disability in Multiple Sclerosis James F. Sumowski
08:30 AM - 07:00 PM	Abstract	349 - Multiple Sclerosis: Brain Atrophy and Computerized Cognitive Testing - A Cross-Sectional Pilot Investigation
08:30 AM - 07:00 PM	Abstract	350 - Cerebral regions involved in executive dysfunctions in Multiple Sclerosis
08:30 AM - 07:00 PM	Abstract	351 - Looking into cognitive impairment in primary-progressive MS Maria Petracca, PhD
08:30 AM - 07:00 PM	Abstract	352 - Intra Individual Variability in Reaction Time Is Sensitive Across the Lifespan in Multiple Sclerosis William Pau
08:30 AM - 07:00 PM	Abstract	353 - Frontal structural connectivity is related to complex processing speed performance in relapsing-remitting multiple sclerosis. Riccardo Manca, Msc
08:30 AM - 07:00 PM	Abstract	354 - MS lesions demonstrating a QSM hyperintense-rim have more myelin loss compared to those without a QSM hyperintense-rim
08:30 AM - 07:00 PM	Abstract	355 - Performance Evaluation for Automated Lesion Segmentation Tool: Lesionquant
08:30 AM - 07:00 PM	Abstract	356 - Assessing T2 Lesion Stability Over Time in Multiple Sclerosis Devon Conway, MD
08:30 AM - 07:00 PM	Abstract	357 - Natural history of multiple sclerosis inflammatory brain lesions: a FLAIR and T1w post contrast MRI volumetric analysis Pietro Maggi, MD, PhD
08:30 AM - 07:00 PM	Abstract	358 - Association of Quantitative MRI to Radiological Reporting for the Evaluation of Lesion Burden Status in Multiple Sclerosis: A Multi-Center Study Annemie Ribbens
08:30 AM - 07:00 PM	Abstract	359 - Individual profiles of cortical myelin repair predict neurological disability in multiple sclerosis: a combined PET-MT approach
08:30 AM - 07:00 PM	Abstract	360 - Inhomogeneous Magnetization Transfer (ihMT) in normal-appearing tissue correlates with disability of multiple sclerosis patients.
08:30 AM - 07:00 PM	Abstract	361 - Quantitative Magnetization Transfer Imagingof the Brain at 7.0 Tesla: Post Mortem Validation and in Vivo Application in Multiple Sclerosis Francesca Bagnato, MD
08:30 AM - 07:00 PM	Abstract	362 - The combined use of 3D T1- and T2-weighted sequences improves cervical cord lesion detection in patients with multiple sclerosis: a multicenter study at 3T Loredana Storelli
08:30 AM - 07:00 PM	Abstract	364 - Subcortical gray matter atrophy is predicted by white matter lesions in directly connected tracts in multiple sclerosis
08:30 AM - 07:00 PM	Abstract	365 - In vivo characterization of grey and white matter spinal cord pathology in multiple sclerosis using ultra high field MRI Russell A. Ouellette IV
08:30 AM - 07:00 PM	Abstract	366 - A comprehensive assessment of cervical cord lesions in patients with multiple sclerosis on T1-MPRAGE at 3T: relationship with cord atrophy and disability Loredana Storelli
08:30 AM - 07:00 PM	Abstract	367 - Structural connectivity in multiple sclerosis and simulation of disconnection Paolo Preziosa
08:30 AM - 07:00 PM	Abstract	368 - Baseline hippocampal subfield volumes differ in CIS patients converting to clinically defined MS: a 1 year follow-up study Laura Cacciaguerra, MD, PhD
08:30 AM - 07:00 PM	Abstract	369 - Dynamic changes of hippocampal subfields in CIS patients: a 2-year MRI longitudinal study Laura Cacciaguerra, MD, PhD
08:30 AM - 07:00 PM	Abstract	370 - MRI Evidence of Acute Inflammation in Cortical Gray Matter of Early Multiple Sclerosis Patients Josefina Maranzano
08:30 AM - 07:00 PM	Abstract	371 - Neuroinflammatory component of gray matter pathology in multiple sclerosis: a combined 7T and 11C-PBR28 MR-PET imaging study
08:30 AM - 07:00 PM	Abstract	372 - Fingolimod-induced functional neuroplasticity in Multiple Sclerosis Nikolaos Petsas
08:30 AM - 07:00 PM	Abstract	373 - Assessment of Brain Atrophy in Multiple Sclerosis Patients in Clinical Routine: A Multi-Center Comparison Study of Radiological and Quantitative Reports Annemie Ribbens
08:30 AM - 07:00 PM	Abstract	374 - Longitudinal brain atrophy measurement techniques in clinical multiple sclerosis practice using magnetic resonance imaging Heidi N. Beadnall, MD
08:30 AM - 07:00 PM	Abstract	375 - Detecting cerebral atrophy over 5 years in multiple sclerosis: application of a variety of 3T MRI automated segmentation pipelines Renxin Chu
08:30 AM - 07:00 PM	Abstract	376 - Comparison of Brain Atrophy Measurement Techniques in a Longitudinal Study of Multiple Sclerosis Patients with Frequent MRIs Kunio Nakamura, PhD
08:30 AM - 07:00 PM	Abstract	377 - The Impact of Automated Brain Volumetric Analysis on Predicting Brain Atrophy in Patients with Multiple Sclerosis Jia Lin, MD
08:30 AM - 07:00 PM	Abstract	378 - Segmentation of the cerebral deep gray matter nuclei using 3T and 7T MRI in patients with multiple sclerosis Fawad Yousuf, MBBS
08:30 AM - 07:00 PM	Abstract	379 - Comparison of whole brain atrophy assessed by proportional vs. registration-based automated pipelines from 3T MRI in multiple sclerosis Christopher Hemond, MD
08:30 AM - 07:00 PM	Abstract	380 - Normative Reference Database for Lateral Ventricular Volume Change in Multiple Sclerosis Patients Emanuele Ghione, MD
08:30 AM - 07:00 PM	Abstract	381 - Staging of single MS patients with crossectional aquisition of global, regional and subregional brain atrophy in quantitative MRI Alaleh Raji, MD
08:30 AM - 07:00 PM	Abstract	382 - NeuroQuant® in clinical practice: longitudinal observations and platform reliability and performance Allen S. Nielsen, MD
08:30 AM - 07:00 PM	Abstract	383 - Longitudinal lateral ventricular volume measurement on clinical routine FLAIR scans is clinically relevant even across complete scanner changes Michael G. Dwyer III, MD, PhD
08:30 AM - 07:00 PM	Abstract	384 - Evaluation of No Evidence of Progression or Active Disease (NEPAD) in Patients with Primary Progressive Multiple Sclerosis in the ORATORIO Trial Jerry S. Wolinsky, MD, FAAN
08:30 AM - 07:00 PM	Abstract	385 - Prognostic value of early MRI follow-up for no evidence of disease activity (NEDA) after an initial diagnosis of acute disseminated encephalomyelitis (ADEM). Diederik L. Koelman
08:30 AM - 07:00 PM	Abstract	386 - Multimodal EPs predict no evidence of disease activity at two years of first line multiple sclerosis treatment Letizia M. Leocani, MD
08:30 AM - 07:00 PM	Abstract	387 - ABSOLUTE AND RELATIVE CHANGE IN NEDA AFTER TREATMENT WITH ORAL DISEASE MODIFYING TREATMENTS IN MS PATIENTS Dimos Dimitrios D. Mitsikostas, MD, PhD
08:30 AM - 07:00 PM	Abstract	388 - Assessing no evidence of disease activity status in patients with relapsing–remitting multiple sclerosis receiving fingolimod: results from a longitudinal, multicenter, real-world study Bianca Weinstock-Guttman, MD
08:30 AM - 07:00 PM	Abstract	389 - "No evidence of disease activity - cognition" in relapsing-remitting multiple sclerosis: recommendation for an extensive assessment of disease activity Serkan Ozakbas, MD
08:30 AM - 07:00 PM	Abstract	390 - Early switch to fingolimod for achieving no evidence of multiple sclerosis disease activity: 7-year analysis of data from the TRANSFORMS study Jeffrey A. Cohen, MD
08:30 AM - 07:00 PM	Abstract	391 - No Evidence of Disease Activity on Ocrelizumab Treatment in Patients With Early Relapsing Multiple Sclerosis: Pooled Analysis of the Phase III OPERA Studies Eva Havrdova, MD
08:30 AM - 07:00 PM	Abstract	392 - The Topographical Model of MS: First Empirical Test of the Recapitulation Hypothesis Benjamin M. Laitman
08:30 AM - 07:00 PM	Abstract	393 - 3T FLAIR* MRI improve the differentiation between multiple sclerosis and CNS vasculitis white matter lesions Pietro Maggi, MD, PhD
08:30 AM - 07:00 PM	Abstract	394 - A 20-year follow-up study of benign multiple sclerosis in Western Australian cohort
08:30 AM - 07:00 PM	Abstract	395 - Molecular-Based Diagnosis of Multiple Sclerosis and Its Progressive Stages Bibiana Bielekova, MD, FAAN
08:30 AM - 07:00 PM	Abstract	396 - 3D Shape and Surface Features Contrast Multiple Sclerosis from Non-Specific White Matter Disease Braeden D. Newton
08:30 AM - 07:00 PM	Abstract	397 - Number of OCBs in CSF at diagnosis timepoint, - predictor of long term radiological outcome in MS? Bjorn Evertsson, MD
08:30 AM - 07:00 PM	Abstract	398 - Differentiation of relapsing remitting and progressive courses of multiple sclerosis on MR Spectroscopy using Machine Learning
08:30 AM - 07:00 PM	Abstract	399 - Disability in the first 10 years of Relapse-onset MS is principally a product of relapses with incomplete recovery Wisam Elmalik, MD
08:30 AM - 07:00 PM	Abstract	400 - MRI characterization of the "central vein sign" in brain white matter lesions of patients with multiple sclerosis but possible "better explanation of the diagnosis"
08:30 AM - 07:00 PM	Abstract	401 - Exploring predictors for the transition from Relapsing to Secondary Progressive Multiple Sclerosis Antje Bischof, MD
08:30 AM - 07:00 PM	Abstract	402 - Assessment of clinical definitions of conversion of relapsing-remitting multiple sclerosis to secondary progressive multiple sclerosis Camilo Diaz-Cruz, MD
08:30 AM - 07:00 PM	Abstract	403 - Axonal degeneration is present in benign multiple sclerosis. Adil Maarouf
08:30 AM - 07:00 PM	Abstract	404 - Revealing underlying differences of NAWM from primary and secondary progressive MS Ines Ramos
08:30 AM - 07:00 PM	Abstract	405 - Gadolinium-enhanced 3D-FLAIR MRI: spectrum of pial pathology and imaging pitfalls David Titelbaum, MD
11:45 AM - 11:50 AM	Discussion	P4.101
11:50 AM - 11:55 AM	Discussion	P4.102
11:55 AM - 12:00 PM	Discussion	P4.103
12:00 PM - 12:05 PM	Discussion	P4.104
12:05 PM - 12:10 PM	Discussion	P4.105
12:10 PM - 12:15 PM	Discussion	P4.106
12:15 PM - 12:20 PM	Discussion	P4.107
12:20 PM - 12:25 PM	Discussion	P4.108
12:25 PM - 12:30 PM	Discussion	P4.109
12:30 PM - 12:35 PM	Discussion	P4.110
05:30 PM - 07:00 PM	Q&A	Poster Author Standby Time

Faculty Disclosures
Stacey Clardy, MD, PhD, FAAN	Dr. Clardy has received personal compensation for serving as an employee of Veterans Health Administration (VHA). Dr. Clardy has received personal compensation for serving as an employee of University of Utah Health. Dr. Clardy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca/Alexion. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen/Horizon. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arialys. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. Dr. Clardy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology/AAN Publications. The institution of Dr. Clardy has received research support from NIH/NINDS. The institution of Dr. Clardy has received research support from SRNA. The institution of Dr. Clardy has received research support from Alexion/AstraZeneca. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a AAN Summer Meeting CoDirector Travel and Lodging with AAN. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Travel/Lodging/Honoraria with U of Iowa, Miami, Stanford, Barrow, Beaumont Health, CCF, Emory, Penn State, Mayo Clinic, Walter Reed.
Jack T. Wang, MD, PhD	Dr. Wang has received personal compensation in the range of $0-$499 for serving as a Consultant for Guidepoint. Dr. Wang has received personal compensation in the range of $0-$499 for serving as a Consultant for Alpha Insight. Dr. Wang has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medical ��ɫ�� Speakers Network. Dr. Wang has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Sutton Pierce. Dr. Wang has received research support from AHA. Dr. Wang has received research support from Alzheimer's Association. Dr. Wang has received research support from Neurocritical Care Society. Dr. Wang has received research support from AAN.
Kayla Martin, MD	Dr. Martin has received research support from Tartar Trust. The institution of Dr. Martin has received research support from OHSU Foundation.
Ye Hu, MD	Dr. Hu has nothing to disclose.
Vaishnavi L. Vaidyanathan, MD	Dr. Vaidyanathan has nothing to disclose.
	No disclosure on file
Bianca Weinstock-Guttman, MD	Dr. Weinstock-Guttman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme &Sanofi. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving as a Reviewer with NIH.
Cynthia L. Harden, MD	Dr. Harden has received personal compensation for serving as an employee of Xenon Pharmaceuticals Inc.. Dr. Harden has stock in Xenon Pharmaceuticals Inc.. Dr. Harden has received intellectual property interests from a discovery or technology relating to health care.
Michael Althaus	Michael Althaus has received personal compensation for serving as an employee of Merz Pharmaceuticals.
Naomi Nevler, MD	No disclosure on file
William H. Mays III, MD	Dr. Mays has nothing to disclose.
Shervin Badihian, MD	Dr. Badihian has nothing to disclose.
Tanya Simuni, MD, FAAN	Dr. Simuni has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for cadia, AcureX, Adamas, AskBio, Amneal, Blue Rock Therapeutics, Caraway Therapeutics, Critical Path for Parkinson's Consortium (CPP), Denali, Michael J Fox Foundation, Neuroderm, Sanofi, Sinopia, Roche, Takeda and Vanqua Bio. Dr. Simuni has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for of Koneksa, Neuroderm, Sanofi, UCB, AcureX, Adamas, AskBio, Biohaven, Denali, GAIN, Neuron23 and Roche. Dr. Simuni has received research support from Amneal, Biogen, Neuroderm, Prevail, Roche, and UCB and an investigator for NINDS, MJFF, Parkinson's Foundation.
Gil D. Rabinovici, MD, FAAN	Dr. Rabinovici has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alector. Dr. Rabinovici has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Norodisk. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Consultant for C2N. Dr. Rabinovici has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson & Joihnson. Dr. Rabinovici has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Peerview. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medscape. Dr. Rabinovici has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Rabinovici has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA. The institution of Dr. Rabinovici has received research support from NIH. The institution of Dr. Rabinovici has received research support from American College of Radiology. The institution of Dr. Rabinovici has received research support from Alzheimer's Association. The institution of Dr. Rabinovici has received research support from Rainwater Charitable Foundation. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Topic Chair, Course Director and teacher with AAN. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with NIH. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Invited speaker with ANA.
John M. Stern, MD, FAAN	Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB Pharma. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Life Science. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurelis. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ceribell. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz Pharma. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for LivaNova. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for LivaNova. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Jazz. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Sciences. Dr. Stern has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology. Dr. Stern has stock in DEARhealth. Dr. Stern has stock in Ceribell. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care.
Katerina Mensikova	Katerina Mensikova has nothing to disclose.
Wendy Agnese	No disclosure on file
Tracey A. Milligan, MD, FAAN	Dr. Milligan has received publishing royalties from a publication relating to health care.
Jennifer G. Goldman, MD, MS, FAAN	Dr. Goldman has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Parkinson's Foundation Scientific Advisory Board. The institution of Dr. Goldman has received research support from Michael J. Fox Foundation. The institution of Dr. Goldman has received research support from Parkinson's Foundation.
Wendy Wells, PharmD	No disclosure on file
Bradford Dickerson, MD, FAAN	Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arkuda. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lantheus. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Dickerson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arkuda. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Dickerson has received publishing royalties from a publication relating to health care. Dr. Dickerson has received publishing royalties from a publication relating to health care.
Ralph L. Sacco, MD, MS, FAHA	Dr. Sacco has received personal compensation in the range of $100,000-$499,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Sacco has received research support from NIH, NINDS, NCATS, NIMHD. The institution of Dr. Sacco has received research support from FL Department of Health. Dr. Sacco has received research support from University of Washington, Seattle. Dr. Sacco has received publishing royalties from a publication relating to health care.
Hamidreza Saber, MD	No disclosure on file
Liana Apostolova, MD, FAAN	Dr. Apostolova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NIH. Dr. Apostolova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Apostolova has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Apostolova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for siemens. Dr. Apostolova has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Apostolova has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Apostolova has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Alzheimer Association. The institution of Dr. Apostolova has received research support from Roche Diagnostics. The institution of Dr. Apostolova has received research support from NIA. The institution of Dr. Apostolova has received research support from Alzheimer Association. The institution of Dr. Apostolova has received research support from AVID radiopharmaceuticals. The institution of Dr. Apostolova has received research support from Life Molecular Imaging. Dr. Apostolova has a non-compensated relationship as a advisor with FDA that is relevant to AAN interests or activities.
Lisa M. Bateman, MD, FRCPC	The institution of Dr. Bateman has received research support from NIH/NINDS.
Lily Wong-Kisiel, MD, FAAN	Dr. Wong-Kisiel has nothing to disclose.
Russell E. Bartt, MD, FAAN	Dr. Bartt has nothing to disclose.
Kristin Appleby, MD	Dr. Appleby has nothing to disclose.
Kathleen B. Mullin, MD	Dr. Mullin has received personal compensation in the range of $0-$499 for serving as a Consultant for Vorso. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impel. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Mullin has received personal compensation in the range of $0-$499 for serving as a Consultant for Theranica. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eli Lilly. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biohaven. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizer. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AbbVie.
Kevin S. Attenhofer, MD	No disclosure on file
Arianna Sartori	No disclosure on file
Andreia V. Faria, MD, PhD	No disclosure on file
Mikhail S. Shchepinov, PhD	No disclosure on file
Josefina Maranzano	The institution of Ms. Maranzano has received research support from Natural Sciences and Engineering Research Council of Canada.
Kejal Kantarci, MD	The institution of Dr. Kantarci has received research support from Eli Lilly. The institution of Dr. Kantarci has received research support from NIH. The institution of Dr. Kantarci has received research support from ADDF. The institution of Dr. Kantarci has received research support from Eisai. The institution of Dr. Kantarci has received research support from BioArctic.
Nathalie Jette, MD, MSc, FRCPC, FAAN	Dr. Jette has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ILAE Epilepsia. The institution of Dr. Jette has received research support from NIH. The institution of Dr. Jette has received research support from AES.
Matthew S. Robbins, MD, FAAN	Dr. Robbins has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Robbins has received publishing royalties from a publication relating to health care. Dr. Robbins has a non-compensated relationship as a Board of Directors member, ��ɫ�� Program speaker with American Headache Society that is relevant to AAN interests or activities. Dr. Robbins has a non-compensated relationship as a Board of Directors member, ��ɫ�� Program speaker with New York State Neurological Society that is relevant to AAN interests or activities. Dr. Robbins has a non-compensated relationship as a Editorial Board Member with Continuum, ��ɫ�� that is relevant to AAN interests or activities.
Eric C. Hall II, PhD	No disclosure on file
Aashrayata Aryal Pandit, MD	No disclosure on file
Gabriel D. Pinilla Monsalve, MD, MSc	Dr. Pinilla Monsalve has nothing to disclose.
Bruce A. Cree, MD, PhD, MAS, FAAN	The institution of Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neuron23. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Pharma. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal/Sandoz. Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic AG. The institution of Dr. Cree has received research support from Genentech. The institution of Dr. Cree has received research support from Kyverna. Dr. Cree has received publishing royalties from a publication relating to health care.
E. Ray Dorsey, MD, MBA	Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Seelos Therapeutics. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eden McCallum, LLP. Dr. Dorsey has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech/Roche. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven Pharmaceuticals. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for WebMD. Dr. Dorsey has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BioSensics. Dr. Dorsey has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Mediflix. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerevance. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kairos Cinema, LLC. Dr. Dorsey has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Mitsubishi Tanabe Pharma America Inc.. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HanAll. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Dorsey has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Advarra. Dr. Dorsey has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medrhythms. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ANA. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for HMP ��ɫ��, LLP. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ADIVO Associates France. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for University of Toronto. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Philadelphia Neurological Society. Dr. Dorsey has stock in Included Health. Dr. Dorsey has stock in Mediflix. Dr. Dorsey has stock in SemCap. Dr. Dorsey has stock in Synapticure. The institution of Dr. Dorsey has received research support from NIH/NINDS. The institution of Dr. Dorsey has received research support from Burroughs Wellcome . The institution of Dr. Dorsey has received research support from Michael J. Fox Foundation - Fox Insight. The institution of Dr. Dorsey has received research support from Michael J. Fox Foundation - Emerald. The institution of Dr. Dorsey has received research support from B. Thomas Golisano Foundation. The institution of Dr. Dorsey has received research support from Emerald Innovations, Inc.. The institution of Dr. Dorsey has received research support from Photopharmics Inc.. The institution of Dr. Dorsey has received research support from Averitas Pharma Inc.. The institution of Dr. Dorsey has received research support from DOD/Army Medical Research Acquisition Activity. The institution of Dr. Dorsey has received research support from NIH/NINDS.
Leopoldo A. DeAlvare, MD	No disclosure on file
Joseph A. Acosta, MD	No disclosure on file
Gonzalo I. Hidalgo, MD, FAAN	No disclosure on file
Federica Orlando	No disclosure on file
Dmitry Tchapyjnikov, MD	No disclosure on file
Amy Wright	No disclosure on file
Edip M. Gurol, MD	The institution of Dr. Gurol has received research support from NIH/NINDS. The institution of Dr. Gurol has received research support from Boston Scientific Corporation. The institution of Dr. Gurol has received research support from AVID (a wholly owned subsidiary of Eli Lilly). The institution of Dr. Gurol has received research support from Pfizer.
Rachit Patil, MD	Dr. Patil has nothing to disclose.
Jonathan Cauchi, MD	Dr. Cauchi has nothing to disclose.
Vincent Roy, MSc	No disclosure on file
Maxime Montembeault, PhD	Dr. Montembeault has nothing to disclose.
Enrique Alvarez, MD, PhD	Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Alvarez has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene/BMS. The institution of an immediate family member of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon.
Anup D. Patel, MD, FAAN	Dr. Patel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Patel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. The institution of Dr. Patel has received research support from PCORI. Dr. Patel has received personal compensation in the range of $10,000-$49,999 for serving as a Webinar Development with Medscape. Dr. Patel has received personal compensation in the range of $500-$4,999 for serving as a Other capacity with Guidepoint. Dr. Patel has a non-compensated relationship as a Chair Quality Committee with AAN that is relevant to AAN interests or activities. Dr. Patel has a non-compensated relationship as a Committee Member with Child Neurology Society that is relevant to AAN interests or activities. Dr. Patel has a non-compensated relationship as a Board of Directors - member with AAN Institute that is relevant to AAN interests or activities.
Yue Zhang	No disclosure on file
Stella Glasmacher	No disclosure on file
Gregory D. Cascino, MD, FAAN	Dr. Cascino has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for International League Against Epilepsy . Dr. Cascino has received intellectual property interests from a discovery or technology relating to health care. Dr. Cascino has received publishing royalties from a publication relating to health care. Dr. Cascino has received publishing royalties from a publication relating to health care.
Christopher D. Anderson, MD, PhD, FAAN	The institution of Dr. Anderson has received research support from Bayer AG. The institution of Dr. Anderson has received research support from American Heart Association. The institution of Dr. Anderson has received research support from National Institutes of Health. An immediate family member of Dr. Anderson has received publishing royalties from a publication relating to health care.
W. C. LaFrance, Jr., MD, MPH, FAAN	Dr. LaFrance has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for medico-legal work.. The institution of Dr. LaFrance has received research support from Department of Defense. Dr. LaFrance has received publishing royalties from a publication relating to health care. Dr. LaFrance has received publishing royalties from a publication relating to health care. Dr. LaFrance has a non-compensated relationship as a Steering Committee Member with Xenon that is relevant to AAN interests or activities.
Hubert H. Fernandez, MD, FAAN	Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Intrance. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Fernandez has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Fernandez has received publishing royalties from a publication relating to health care. Dr. Fernandez has received personal compensation in the range of $10,000-$49,999 for serving as a Steering Committee/Advisory Committee Member with Parkinson Study Group.
Romi Saha, MD	No disclosure on file
Jaskaren Dhillon, MD, MBBS	No disclosure on file
Christina Kourkoulis	No disclosure on file
Michelle M. Mielke, PhD	Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LabCorp. Dr. Mielke has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siemens Healthineers. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sunbird Bio. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Mielke has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novo Nordisk.
Milena Pavlova, MD	Dr. Pavlova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pear Therapeutics. Dr. Pavlova has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Oakstone. The institution of Dr. Pavlova has received research support from Jazz. The institution of Dr. Pavlova has received research support from Vanda. The institution of Dr. Pavlova has received research support from Biomobie. Dr. Pavlova has received personal compensation in the range of $500-$4,999 for serving as a Didactic article with Neurodiem.
Orhun H. Kantarci, MD	Dr. Kantarci has nothing to disclose.
Dirk W. Dressler, MD	No disclosure on file
Makoto Tanigawa	No disclosure on file
Aashrai S. Gudlavalleti, MBBS	Dr. Gudlavalleti has nothing to disclose.
Ines Ramos	No disclosure on file
Ari Green, MD	Dr. Green has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pipeline Therapeutics. Dr. Green has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Bionure. Dr. Green has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. The institution of Dr. Green has received research support from NINDS. The institution of Dr. Green has received research support from NMSS. The institution of Dr. Green has received research support from NIA. The institution of Dr. Green has received research support from Adelson Research Foundation. Dr. Green has received intellectual property interests from a discovery or technology relating to health care. Dr. Green has received personal compensation in the range of $500-$4,999 for serving as a Study Section with NINDS. Dr. Green has a non-compensated relationship as a Author with Viela Bio that is relevant to AAN interests or activities.
Toby A. Ferguson, MD	Dr. Ferguson has received personal compensation for serving as an employee of Biogen. Dr. Ferguson has received stock or an ownership interest from Biogen.
Dominique Low, MD	Dr. Low has nothing to disclose.
Svetlana Lorenzano, MD	No disclosure on file
Orrin Devinsky, MD, FAAN	Dr. Devinsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Devinsky has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for California Cannabis Enterprises. Dr. Devinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Engage. Dr. Devinsky has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Privateer Holdings. Dr. Devinsky has received personal compensation in the range of $1,000,000+ for serving on a Scientific Advisory or Data Safety Monitoring board for Receptor Holdings. Dr. Devinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rettco. Dr. Devinsky has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Silver Spike. Dr. Devinsky has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tevard. Dr. Devinsky has received personal compensation in the range of $1,000,000+ for serving on a Scientific Advisory or Data Safety Monitoring board for Tilray. Dr. Devinsky has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Engage. Dr. Devinsky has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Tevard Biosciences. Dr. Devinsky has stock in Engage. Dr. Devinsky has stock in Empatica. Dr. Devinsky has stock in California Cannabis Enterprises. Dr. Devinsky has stock in Empatica. Dr. Devinsky has stock in Silver Spike. Dr. Devinsky has stock in Docklight Brands. Dr. Devinsky has stock in Egg Rock/Papa Barkley. Dr. Devinsky has stock in Leafly. Dr. Devinsky has stock in Left Coast Ventures. Dr. Devinsky has stock in Privateer Holdings. Dr. Devinsky has stock in Receptor Holdings. Dr. Devinsky has stock in Qstate. The institution of Dr. Devinsky has received research support from GW Pharma. The institution of Dr. Devinsky has received research support from Zogenix. The institution of Dr. Devinsky has received research support from PTC Pharma. The institution of Dr. Devinsky has received research support from NIH. The institution of Dr. Devinsky has received research support from DOD. The institution of Dr. Devinsky has received research support from NIH. The institution of Dr. Devinsky has received research support from Epilepsy Foundation. The institution of Dr. Devinsky has received research support from NIH. The institution of Dr. Devinsky has received research support from NIH. The institution of Dr. Devinsky has received research support from NSF. Dr. Devinsky has received intellectual property interests from a discovery or technology relating to health care. Dr. Devinsky has received intellectual property interests from a discovery or technology relating to health care. Dr. Devinsky has received publishing royalties from a publication relating to health care.
Maria Carrillo, PhD	Ms. Carrillo has nothing to disclose.
Nabil K. El Ayoubi, MD	Dr. El Ayoubi has nothing to disclose.
Alina Masters-Israilov, MD	Dr. Masters-Israilov has received publishing royalties from a publication relating to health care.
Wei L. Chen, MD	No disclosure on file
Benjamin Sanchez, PhD	No disclosure on file
Harold P. Adams, Jr., MD, FAAN	The institution of Dr. Adams has received research support from NINDS.
Devdutt S. Deshmukh, DNB	No disclosure on file
Michael P. Stanley, MD	Dr. Stanley has received personal compensation in the range of $0-$499 for serving as a Consultant for Roon. Dr. Stanley has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology. Dr. Stanley has stock in Roon. Dr. Stanley has received personal compensation in the range of $0-$499 for serving as a writer at large with WBUR/Cognoscenti . Dr. Stanley has received personal compensation in the range of $0-$499 for serving as a Poet with Writing the Land. Dr. Stanley has received personal compensation in the range of $0-$499 for serving as a writer at large with Psyche. Dr. Stanley has received personal compensation in the range of $0-$499 for serving as a Writer at large with Wall Street Journal.
Brian Edlow, MD	Dr. Edlow has received research support from NIH.
Gavin Giovannoni, MD	Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck KGaA. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche-Genentech. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moderna. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Astoria Biologica. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zenas. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Medscape.
Katherine D. Amodeo, MD	The institution of Dr. Amodeo has received research support from Roche. The institution of Dr. Amodeo has received research support from EIP Pharma. The institution of Dr. Amodeo has received research support from Acadia. The institution of Dr. Amodeo has received research support from MJFF. The institution of Dr. Amodeo has received research support from NINDS.
Antje Bischof, MD	Dr. Bischof has nothing to disclose.
Kyle C. Smith, DO	Dr. Smith has nothing to disclose.
Laurel Jakubowski, MD	No disclosure on file
Nudrat Tasneem, MBBS	No disclosure on file
Aaron Zelikovich, MD	Dr. Zelikovich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech.
Shamik Bhattacharyya, MD, FAAN	Dr. Bhattacharyya has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuroLambda. Dr. Bhattacharyya has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Bhattacharyya has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Bhattacharyya has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Bhattacharyya has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Continuum. Dr. Bhattacharyya has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley. Dr. Bhattacharyya has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Merck. The institution of Dr. Bhattacharyya has received research support from Alexion Pharmaceuticals. The institution of Dr. Bhattacharyya has received research support from National Institute of Health. The institution of Dr. Bhattacharyya has received research support from UCB. The institution of Dr. Bhattacharyya has received research support from Genentech. Dr. Bhattacharyya has received publishing royalties from a publication relating to health care. Dr. Bhattacharyya has received publishing royalties from a publication relating to health care.
Lawrence J. Hirsch, MD, FAAN	Dr. Hirsch has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ceribell. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for marinus. The institution of Dr. Hirsch has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Natus. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rapport Therapeutics. Dr. Hirsch has received publishing royalties from a publication relating to health care. Dr. Hirsch has received publishing royalties from a publication relating to health care. Dr. Hirsch has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker; Faculty for Fellows' training course with Neuropace. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Natus.
Jorge A. Maurino, MD	No disclosure on file
CARLOS MAURICIO M. MILLAN, MD	Dr. Millan has nothing to disclose.
Preena Uppal, MD	No disclosure on file
Darin T. Okuda, MD, FAAN	Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cortechs AI. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Okuda has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Okuda has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Bioscience. Dr. Okuda has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Okuda has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Zenas BioPharma. The institution of Dr. Okuda has received research support from Novartis. The institution of Dr. Okuda has received research support from Alexion. Dr. Okuda has received intellectual property interests from a discovery or technology relating to health care.
Gupta V. Harsh, MD	No disclosure on file
Carlos Lopez Gomez, PhD	No disclosure on file
Koji Takei	No disclosure on file
Carlos A. Pardo-Villamizar, MD	The institution of Dr. Pardo-Villamizar has received research support from National Institutes of Health. The institution of Dr. Pardo-Villamizar has received research support from Bart McLean Fund for Neuroimmunology Research .
Ronald C. Petersen, MD, PhD, FAAN	Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co.. Dr. Petersen has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai, Inc.. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has a non-compensated relationship as a Board of Directors with American Brain Foundation that is relevant to AAN interests or activities.
David S. Knopman, MD, FAAN	Dr. Knopman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DIAN TU study. The institution of Dr. Knopman has received research support from NIH.
Jonathan Rosand, MD	Dr. Rosand has received personal compensation for serving as an employee of Massachusetts General Hospital. Dr. Rosand has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co. Dr. Rosand has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Rosand has received research support from NIH. The institution of Dr. Rosand has received research support from American Heart Association. Dr. Rosand has received personal compensation in the range of $0-$499 for serving as a Peer reviewer with National Institutes of Health. Dr. Rosand has a non-compensated relationship as a Trustee with Columbia University that is relevant to AAN interests or activities.
Nikolaos Petsas	No disclosure on file
Lionel Carmant, MD	No disclosure on file
Ittai Bushlin, MD, PhD	Dr. Bushlin has nothing to disclose.
Ammar Al-Chalabi, PhD, FRCP DipStat	The institution of Dr. Al-Chalabi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for OrionPharma. The institution of Dr. Al-Chalabi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics Inc. The institution of Dr. Al-Chalabi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe Pharma. The institution of Dr. Al-Chalabi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. The institution of Dr. Al-Chalabi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Quralis. Dr. Al-Chalabi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for My Name'5 Doddie Foundation. The institution of Dr. Al-Chalabi has received research support from Medical Research Council. The institution of Dr. Al-Chalabi has received research support from NIHR. The institution of Dr. Al-Chalabi has received research support from European Commission. The institution of Dr. Al-Chalabi has received research support from MND Association. The institution of Dr. Al-Chalabi has received research support from My Name'5 Doddie Foundation. Dr. Al-Chalabi has received publishing royalties from a publication relating to health care. Dr. Al-Chalabi has received publishing royalties from a publication relating to health care. Dr. Al-Chalabi has a non-compensated relationship as a SAB Member and Executive Member with TRICALS that is relevant to AAN interests or activities.
Eddie Stage, Jr.	Mr. Stage has nothing to disclose.
David S. Liebeskind, MD, FAAN	Dr. Liebeskind has received research support from Cerenovus. Dr. Liebeskind has received research support from Genentech . Dr. Liebeskind has received research support from Medtronic. Dr. Liebeskind has received research support from Stryker.
Anwar Ahmed, MD, FAAN	Dr. Ahmed has nothing to disclose.
Jozef Magdic, MD	No disclosure on file
Olivier Fortin, MD	Dr. Fortin has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Canadian Residency Matching Service. Dr. Fortin has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Fédération des médecins résidents du Québec. Dr. Fortin has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Fédération des médecins résidents du Québec. Dr. Fortin has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Association of residents of McGill.
Saud Alsahli, MD	No disclosure on file
Yuki Kitazaki	No disclosure on file
Cristina Viguera Altolaguirre, MD	Dr. Viguera Altolaguirre has nothing to disclose.
Aaron E. Miller, MD, FAAN	Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Accordant Health Services (Caremark). Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Corevitas (formerly known as Corrona). Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MAPI=Pharma. Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Viatris (Mylan). Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global. Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gerson Lehrman Group. Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen Idec. Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen (Horizon Therapeutics). Dr. Miller has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Sterne Kessler. Dr. Miller has received publishing royalties from a publication relating to health care.
Pooja Khatri, MD, FAAN	The institution of Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lumosa. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bayer. The institution of Dr. Khatri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Diamedica. Dr. Khatri has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Basking Biosciences. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Khatri has received research support from Cerenovus. Dr. Khatri has received publishing royalties from a publication relating to health care.
Mary Kay Koenig, MD	Dr. Koenig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Marinus Pharmaceuticals. Dr. Koenig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Koenig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stealth BioTherapeutics. Dr. Koenig has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Reneo Pharmaceuticals. Dr. Koenig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia Pharmaceuticals. Dr. Koenig has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Koenig has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jazz Pharmaceuticals. The institution of Dr. Koenig has received research support from Abliva AB. The institution of Dr. Koenig has received research support from EryDel SPA. The institution of Dr. Koenig has received research support from PTC Therapeutics. The institution of Dr. Koenig has received research support from Noema Pharmaceuticals. The institution of Dr. Koenig has received research support from Marinus Pharmaceuticals. The institution of Dr. Koenig has received research support from Jazz Pharmaceuticals. The institution of Dr. Koenig has received research support from Nflexion Therapeutics. The institution of Dr. Koenig has received research support from Stealth BioTherapeutics. The institution of Dr. Koenig has received research support from Astellas Pharmaceuticals. The institution of Dr. Koenig has received research support from Reneo Pharmaceuticals.
Alexa K. Craig, MD	No disclosure on file
Henry Osso-Rivera, MD	No disclosure on file
Micaela Mitolo, PhD	No disclosure on file
Apratim Chatterjee, MD	No disclosure on file
Aishwarya Shukla	No disclosure on file
Brian D. Moseley, MD	Dr. Moseley has received personal compensation for serving as an employee of UCB. Dr. Moseley has received personal compensation for serving as an employee of Neurocrine Biosciences Inc. Dr. Moseley has or had stock in UCB.
James M. Stankiewicz, MD, FAAN	Dr. Stankiewicz has received personal compensation for serving as an employee of Novartis.
Joseph S. Kass, MD, JD, FAAN	Dr. Kass has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ��ɫ�� . Dr. Kass has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Kass has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Multiple Law Firms . Dr. Kass has received publishing royalties from a publication relating to health care.
Jonathan Lipton, MD, PhD	No disclosure on file
Christopher L. Cummings, MD	No disclosure on file
Deniz Erten-Lyons, MD, FAAN	Dr. Erten-Lyons has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia Pharamceuticals.
Brad A. Racette, MD, FAAN	Dr. Racette has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for American Regent. Dr. Racette has received personal compensation in the range of $500-$4,999 for serving as a advisory council with NIEHS.
Rwoof A. Reshi, MD	Dr. Reshi has nothing to disclose.
Nandakumar Nagaraja, MD	The institution of Dr. Nagaraja has received research support from 1 Florida Alzheimer's Disease Research Center. Dr. Nagaraja has received personal compensation in the range of $500-$4,999 for serving as a stroke outcome adjudicator for WHI study with Fred Hutchinson Cancer Research Center.
Connie L. Pieper, MD	No disclosure on file
Wisam Elmalik, MD	No disclosure on file
Kaitlyn M. Blackburn, DO	No disclosure on file
Eric Klawiter, MD, FAAN	Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Galen/Atlantica. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Banner Life Sciences. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Greenwich Biosciences. Dr. Klawiter has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for OM1. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. The institution of Dr. Klawiter has received research support from Biogen. The institution of Dr. Klawiter has received research support from Abbvie. The institution of Dr. Klawiter has received research support from Genentech.
Scott S. Zamvil, MD, PhD, FAAN	Dr. Zamvil has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Zamvil has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Horizon. The institution of Dr. Zamvil has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Zamvil has received research support from Sumaira Foundation. Dr. Zamvil has received personal compensation in the range of $5,000-$9,999 for serving as a Advisory Board with Genzyme. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board with Genentech. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board with Alexion.
Nilofar Dudha, MD	No disclosure on file
Mariane de Moraes Monteiro	No disclosure on file
Emmanuelle Waubant, MD, PhD, FAAN	The institution of Dr. Waubant has received research support from NIH. The institution of Dr. Waubant has received research support from NMSS. The institution of Dr. Waubant has received research support from PCORI. The institution of Dr. Waubant has received research support from Race to Erase MS. The institution of Dr. Waubant has received research support from Roche. The institution of Dr. Waubant has received research support from Department of Defense. Dr. Waubant has received publishing royalties from a publication relating to health care.
Anisha C. Schwarz, MD	No disclosure on file
Viet-Huong Nguyen, PharmD, MPH, MS	Dr. Nguyen has nothing to disclose.
Luis Felipe Scarabelot	No disclosure on file
Roy H. Hamilton, MD, MS, FANA, FAAN	Dr. Hamilton has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Highland Instruments. Dr. Hamilton has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Cognito Therapeutics. Dr. Hamilton has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for McKnight Brain Research Foundation. The institution of Dr. Hamilton has received research support from NIH. The institution of Dr. Hamilton has received research support from Department of Defense. The institution of Dr. Hamilton has received research support from Chan Zuckerberg Initiative.
Kathryn A. Davis, MD	Dr. Davis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GW Pharmaceuticals/Jazz Pharmaceuticals. Dr. Davis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spark Therapeutics. Dr. Davis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Davis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UNEEG. Dr. Davis has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsia Open. Dr. Davis has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Pfizer. The institution of Dr. Davis has received research support from Eisai. The institution of Dr. Davis has received research support from Liminal. Dr. Davis has received publishing royalties from a publication relating to health care.
Timothy B. Saurer, PhD	Dr. Saurer has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Dr. Saurer has stock in Jazz Pharmaceuticals.
Cecilia D. Davis-Hayes	No disclosure on file
Stephen Krieger, MD, FAAN	Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Krieger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Krieger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Krieger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cycle. The institution of Dr. Krieger has received research support from Novartis. The institution of Dr. Krieger has received research support from Bristol Myers Squibb. The institution of Dr. Krieger has received research support from Biogen. The institution of Dr. Krieger has received research support from Sanofi.
Rayan Alshehri, Jr., MD	No disclosure on file
Satish Khadilkar	No disclosure on file
Natalia Betances, MD	No disclosure on file
Eve Chanson	No disclosure on file
Katherine Roche, MD	No disclosure on file
Ian Cheong, MD	No disclosure on file
Jose R. Carlo, MD, FAAN	Dr. Carlo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for sanofi. Dr. Carlo has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for various insurance companies .
Lilah M. Besser	No disclosure on file
Robert A. Bermel, MD, FAAN	Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/Genzyme. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Bermel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Bermel has received research support from Biogen. The institution of Dr. Bermel has received research support from Roche. The institution of Dr. Bermel has received research support from Novartis. Dr. Bermel has received intellectual property interests from a discovery or technology relating to health care.
Raffaella Umeton, MD, PhD, MMSc	Dr. Umeton has nothing to disclose.
Thomas R. Haven, PhD	Dr. Haven has nothing to disclose.
Bhagyadhan Patel	No disclosure on file
Zeyad Aljuhni	No disclosure on file
Gilbert Wunderlich	No disclosure on file
Kenneth Habetz, MD	No disclosure on file
Nida Akram, MBBS	No disclosure on file
Alison I. Thaler, MD	Dr. Thaler has received publishing royalties from a publication relating to health care.
Mohammad Aboulwafa	No disclosure on file
Nimish A. Mohile, MD, FAAN	The institution of Dr. Mohile has received research support from Novocure.
Charlotte A. Merrill, PhD	No disclosure on file
Michael Levy, MD, PhD, FAAN	Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Pharma. Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Levy has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms. The institution of Dr. Levy has received research support from National Institutes Health.
Steven Vernino, MD, PhD, FAAN	Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for antag. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Autonomic Neuroscience (Elsevier). The institution of Dr. Vernino has received research support from Takeda. The institution of Dr. Vernino has received research support from NIH/NHLBI. The institution of Dr. Vernino has received research support from Lundbeck. The institution of Dr. Vernino has received research support from Regeneron.
Trishna Kantamneni, MBBS	Dr. Kantamneni has nothing to disclose.
Karin Cook	No disclosure on file
Khaled Albazli, MD	Dr. Albazli has nothing to disclose.
Tugce Duran	Miss Duran has nothing to disclose.
Krishna Kandregula, MD	No disclosure on file
Gary Zirpoli, PhD	No disclosure on file
Sohini Chowdhury	No disclosure on file
Yuka Hama	No disclosure on file
Jennifer Graves, MD, PhD	Dr. Graves has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Graves has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Graves has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MSJ. The institution of Dr. Graves has received research support from Octave. The institution of Dr. Graves has received research support from Sanofi. The institution of Dr. Graves has received research support from EMD Serono.
Dannaly Reyes-Baerga, MD	No disclosure on file
Stephan Zuchner, MD, FAAN	Dr. Zuchner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Applied Therapeutics. The institution of Dr. Zuchner has received research support from Muscular Dystrophy Association. The institution of Dr. Zuchner has received research support from CMT Association. Dr. Zuchner has received intellectual property interests from a discovery or technology relating to health care.
Christina Deligianni	No disclosure on file
Grace A. Zimmerman, MPH	The institution of Ms. Zimmerman has received research support from National Institutes of Health. The institution of Ms. Zimmerman has received research support from Batten Disease Support and Research Association. The institution of Ms. Zimmerman has received research support from Greater Rochester Health Foundation.
Alma Rechnitzer	No disclosure on file
Joan Jasien, MD	No disclosure on file
Akanksha Sharma, MD	Dr. Sharma has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Generation Care Hospice. Dr. Sharma has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier . Dr. Sharma has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Curio Science. Dr. Sharma has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals. Dr. Sharma has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MDPI. Dr. Sharma has or had stock in Roon. The institution of Dr. Sharma has received research support from Chimerix. The institution of Dr. Sharma has received research support from Novocure. Dr. Sharma has a non-compensated relationship as a Advisory Board with Elevate Med that is relevant to AAN interests or activities.
Alexandra R. Santana Almansa, MD	Dr. Santana Almansa has nothing to disclose.
Pallab Bhattacharya, PhD	Dr. Bhattacharya has nothing to disclose.
Sanjib Sinha, MD	No disclosure on file
Negar Asdaghi, MD	Dr. Asdaghi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association.
Christopher Streib, MD	Dr. Streib has nothing to disclose.
Brian Silver, MD, FAAN	Dr. Silver has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Various legal firms. Dr. Silver has received intellectual property interests from a discovery or technology relating to health care. Dr. Silver has received publishing royalties from a publication relating to health care. Dr. Silver has received publishing royalties from a publication relating to health care. Dr. Silver has received publishing royalties from a publication relating to health care. Dr. Silver has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Women's Health Initiative. Dr. Silver has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Best Doctors, Inc./Teladoc, Inc.. Dr. Silver has a non-compensated relationship as a Consultant with ABPN that is relevant to AAN interests or activities. Dr. Silver has a non-compensated relationship as a Member, Regional Board of Directors with American Heart Association that is relevant to AAN interests or activities.
Celine Louapre, MD, PhD	No disclosure on file
DeWitt D. Pyburn, MD	Dr. Pyburn has nothing to disclose.
Antonio V. Delgado-Escueta, MD	Dr. Delgado-Escueta has nothing to disclose.
Yutaka Tanaka, MD, FAAN	No disclosure on file
Jeffrey W. Britton, MD, FAAN	Dr. Britton has received personal compensation in the range of $0-$499 for serving as a Online course with American Clinical Neurophysiology Society.
Bruce I. Ovbiagele, MD, MSc, FAAN	Dr. Ovbiagele has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Stroke Association. Dr. Ovbiagele has received research support from National Institutes of Health. Dr. Ovbiagele has a non-compensated relationship as a President with Society for Equity Neuroscience that is relevant to AAN interests or activities. Dr. Ovbiagele has a non-compensated relationship as a Board Member with World Stroke Organization that is relevant to AAN interests or activities.
Bruno Colombo	Bruno Colombo has nothing to disclose.
Robert Zivadinov, MD, PhD, FAAN	The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Omnicuris. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Myrobalan. Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
David Hojnacki, MD, FAAN	Dr. Hojnacki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Hojnacki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Hojnacki has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Michael G. Dwyer III, MD, PhD	Dr. Dwyer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Dwyer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Keystone Heart, Ltd. Dr. Dwyer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Dwyer has received research support from Novartis. The institution of Dr. Dwyer has received research support from Keystone Heart, Ltd. The institution of Dr. Dwyer has received research support from Bristol Myers Squibb. The institution of Dr. Dwyer has received research support from Roche.
Archana Hinduja, MD	Dr. Hinduja has nothing to disclose.
Elisabetta Pagani	Elisabetta Pagani has nothing to disclose.
James F. Sumowski	Mr. Sumowski has nothing to disclose.
Elisa Canu	The institution of Elisa Canu has received research support from Italian Ministry of Health .
Rachel Nolan	Ms. Nolan has nothing to disclose.
Alessandro Meani	Alessandro Meani has nothing to disclose.
Erin Heinzen	No disclosure on file
Grayson Baird	No disclosure on file
Elie Abdelnour	No disclosure on file
Russell A. Ouellette IV	Mr. Ouellette has nothing to disclose.
Steven Wolf, PhD, PT	Steven Wolf, PhD,PT has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Microtransponer. Steven Wolf, PhD,PT has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Enspire.
Alexander W. Dromerick, MD	No disclosure on file
Keith Carolus	No disclosure on file
Ahyuda Oh, PhD	Dr. Oh has nothing to disclose.
Chaewon Lee, MD	No disclosure on file
Pue Farooque, DO	No disclosure on file
Jack C. Rose, MD	No disclosure on file
Mario A. Saporta, MD, PhD, FAAN	Dr. Saporta has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for SwanBio. Dr. Saporta has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pharnext. Dr. Saporta has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Applied Therapeutics.
Martin L. Albert, MD, PhD	No disclosure on file
Saadat Kamran, MD	No disclosure on file
Sandeep Singh, MD	Dr. Singh has nothing to disclose.
Norman L. Foster, MD, FAAN	No disclosure on file
Vineeta Singh, MD, FAAN	Dr. Singh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for genae Americas, Inc. .
Joseph Rudolph, MD	No disclosure on file
Shnehal Patel, MD	Dr. Patel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Patel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Patel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Adamas. Dr. Patel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine.
Bhrugav G. Raval, MD	Dr. Raval has nothing to disclose.
Lucia Moiola, MD, PhD	Dr. Moiola has nothing to disclose.
Juergen H. Faiss, MD, MA	No disclosure on file
Mary M. Machulda, PhD	The institution of Dr. Machulda has received research support from NIH.
Devon Conway, MD	Dr. Conway has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Conway has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Conway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Conway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Conway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Conway has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Conway has received research support from Novartis. The institution of Dr. Conway has received research support from BMS. The institution of Dr. Conway has received research support from Biogen.
Dustin A. Heldman, PhD	Dr. Heldman has received personal compensation for serving as an employee of Great Lakes NeuroTechnologies Inc.. Dr. Heldman has stock in Great Lakes NeuroTechnologies. The institution of Dr. Heldman has received research support from NIH.
Daniel Weintraub	Daniel Weintraub has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Clintrex. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scion. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sunovion. Daniel Weintraub has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Modality.ai. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerevel. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CuraSen. Daniel Weintraub has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boehringer Ingelheim. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Daniel Weintraub has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorder Society. The institution of Daniel Weintraub has received research support from NIH. The institution of Daniel Weintraub has received research support from Fox Foundation. The institution of Daniel Weintraub has received research support from IPMDS. Daniel Weintraub has received intellectual property interests from a discovery or technology relating to health care.
Gerhard Winkler, MD	No disclosure on file
Douglas Merkitch	No disclosure on file
Jerome De Seze	Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma.
Samar F. Ahmed, MD	Dr. Ahmed has nothing to disclose.
David Bar-Or	David Bar-Or has received intellectual property interests from a discovery or technology relating to health care.
William Pau	No disclosure on file
Alex Baeta	Alex Baeta has nothing to disclose.
Mario F. Dulay, PhD	No disclosure on file
Thomas Brannagan III, MD, FAAN	Dr. Brannagan has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Brannagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Intellia. Dr. Brannagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zenica. Dr. Brannagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Annexon. The institution of Dr. Brannagan has received research support from Alnylam. The institution of Dr. Brannagan has received research support from Abcuro. The institution of Dr. Brannagan has received research support from Ionis. The institution of Dr. Brannagan has received research support from Vertex. The institution of Dr. Brannagan has received research support from NMD Pharma.
Christopher Hemond, MD	The institution of Dr. Hemond has received research support from Consorium of Multiple Sclerosis Centers. The institution of Dr. Hemond has received research support from National Institute Of Neurological Disorders And Stroke of the National Institutes of Health. Dr. Hemond has received personal compensation in the range of $0-$499 for serving as a Member of Data Safety and Monitoring Board with National Institute Of Neurological Disorders And Stroke of the National Institutes of Health.
Daniel Ontaneda, MD, PhD, FAAN	Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech/Roche. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen Idec. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. The institution of Dr. Ontaneda has received research support from NIH. The institution of Dr. Ontaneda has received research support from PCORI. The institution of Dr. Ontaneda has received research support from NMSS. The institution of Dr. Ontaneda has received research support from Genetech.
Deborah E. Barnes, PhD, MPH	The institution of Dr. Barnes has received research support from the National Institutes of Health, Department of Veterans Affairs, Department of Defense, Alzheimer's Association, and the California Department of Public Health.
Richard D. King, MD, PhD, FAAN	Dr. King has nothing to disclose.
Steven Levine, MD, FAHA	Dr. Levine has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MEDLINK. Dr. Levine has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Law Firms. The institution of Dr. Levine has received research support from NIH.
David M. Simpson, MD, FAAN	Dr. Simpson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan. Dr. Simpson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz.
Nicolas Dupre, MD, FAAN	Dr. Dupre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea Therapeutics Canada. The institution of Dr. Dupre has received research support from ARSACS Foundation. The institution of Dr. Dupre has received research support from CHUdeQuebec Foundation.
Alaleh Raji, MD	No disclosure on file
Raed Alroughani, MD, FAAN	Dr. Alroughani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen, AstraZeneca, Novartis, Merck, Roche, Sanofi. Dr. Alroughani has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for AstraZeneca, Biogen, Novartis, Merck, Roche, Sanofi.
Matthew Senjem	Matthew Senjem has received stock or an ownership interest from Align Technology, Inc.. Matthew Senjem has received stock or an ownership interest from Inovio Biomedical Corp.. Matthew Senjem has received stock or an ownership interest from Johnson & Johnson. Matthew Senjem has received stock or an ownership interest from Mesa Laboratories, Inc.. Matthew Senjem has received stock or an ownership interest from Nvidia Inc.. Matthew Senjem has received stock or an ownership interest from LHC Group, Inc.. Matthew Senjem has received stock or an ownership interest from Natus Medical Incorporated. Matthew Senjem has received stock or an ownership interest from Varex Imaging Corporation. Matthew Senjem has received personal compensation in the range of $100,000-$499,999 for serving as a IT Technical Specialist II with Mayo Clinic.
Courtney E. McIlduff, MD	The institution of Dr. McIlduff has received research support from NIH - R21NSNS118434. The institution of Dr. McIlduff has received research support from NIH - R01MH111875. The institution of Dr. McIlduff has received research support from Blavatnik Family Fund. Dr. McIlduff has received publishing royalties from a publication relating to health care.
Lesley Schofield	No disclosure on file
Paul D. Larsen, MD, FAAN	No disclosure on file
Kiyonobu Komai, MD	Dr. Komai has nothing to disclose.
David A. Marks, MD	Dr. Marks has nothing to disclose.
Gustavo C. Roman, MD, FAAN	The institution of Dr. Roman has received research support from Brain Chamistry Labs.
Rhonda Friedman, PhD	No disclosure on file
Peter Kosa, PhD	Dr. Kosa has nothing to disclose.
Judd M. Jensen, MD	Dr. Jensen has nothing to disclose.
Ricardo F. Allegri, MD, PhD, FAAN	Dr. Allegri has nothing to disclose.
Filippo Martinelli Boneschi	No disclosure on file
Jeffrey C. Wagner, MD	Dr. Wagner has nothing to disclose.
Corey McMillan, PhD	Dr. McMillan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. McMillan has received research support from Biogen. The institution of Dr. McMillan has received research support from NIH.
Sergei N. Illarioshkin, MD	No disclosure on file
William D. Honeycutt, MD	Dr. Honeycutt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Honeycutt has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Sanofi Genzyme. Dr. Honeycutt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Viela Bio. Dr. Honeycutt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Honeycutt has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen Idec. Dr. Honeycutt has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for EMD Serono. Dr. Honeycutt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Honeycutt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Celegene.
Jan Krasensky, MD	No disclosure on file
Douglas W. Scharre, MD, FAAN	Dr. Scharre has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BrainTest, Inc. Dr. Scharre has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Otsuka. Dr. Scharre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Scharre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Scharre has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eisai. Dr. Scharre has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eli Lilly. The institution of Dr. Scharre has received research support from InSightec. The institution of Dr. Scharre has received research support from Alzheimer's Therapeutic Research Institute (ATRI). The institution of Dr. Scharre has received research support from Eisai. The institution of Dr. Scharre has received research support from vTv Therapeutics. The institution of Dr. Scharre has received research support from National Institute of Health. The institution of Dr. Scharre has received research support from Eli Lilly. The institution of Dr. Scharre has received research support from Biogen. The institution of Dr. Scharre has received research support from Roche. The institution of Dr. Scharre has received research support from Percision Medicine. The institution of Dr. Scharre has received research support from Premier Research Group. The institution of Dr. Scharre has received research support from Genetch. The institution of Dr. Scharre has received research support from Avanir. The institution of Dr. Scharre has received research support from Cerevel Therapeutics. The institution of Dr. Scharre has received research support from Janssen. The institution of Dr. Scharre has received research support from Cassava. The institution of Dr. Scharre has received research support from UniQure. The institution of Dr. Scharre has received research support from Cognition Therapeutics. The institution of Dr. Scharre has received research support from Cognitive Research Corporation. The institution of Dr. Scharre has received research support from EIP. The institution of Dr. Scharre has received research support from Cognito. Dr. Scharre has received intellectual property interests from a discovery or technology relating to health care. Dr. Scharre has received intellectual property interests from a discovery or technology relating to health care.
Clifford W. Meyers, MD	No disclosure on file
Catherine Norise, MD	Dr. Norise has nothing to disclose.
Manoj Raghavan, MD, PhD	Dr. Raghavan has nothing to disclose.
Robert N. Sawyer, Jr., MD	Dr. Sawyer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Sawyer has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Leven Gouldin and Thompson.
Christina Marciniak, MD	No disclosure on file
Laura Guilhoto, MD	No disclosure on file
Christopher J. Deline, MD	No disclosure on file
Ammar M. Alobaidy, MD	No disclosure on file
Arnold J. Sansevere, MD	Dr. Sansevere has nothing to disclose.
Jean Philippe Ranjeva	No disclosure on file
Angelica M. Lee, DO	Dr. Lee has nothing to disclose.
Jonathan P. Willmer, MD	Dr. Willmer has received personal compensation for serving as an employee of Atara Biotherapeutics . Dr. Willmer has stock in Atara Biotherapeutics .
Carolyn Pizoli, MD, PhD	No disclosure on file
Katy Wright, PA	Ms. Wright has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerveau LLC. Ms. Wright has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revert Health. Ms. Wright has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Ms. Wright has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol-Myers Squibb.
Rena Vanzo	No disclosure on file
Taha B. A-Hakam, Sr., MD	Dr. A-Hakam has nothing to disclose.
Shaweta Khosa	Ms. Khosa has nothing to disclose.
Guido D. Vazquez II, PhD	Dr. Vazquez has nothing to disclose.
Peter N. Leigh, BSc, MB, FAAN	No disclosure on file
Shay Menascu, MD	No disclosure on file
Kiran Patil	No disclosure on file
Belen Pascual, PhD	The institution of Prof. Pascual has received research support from NIH. The institution of Prof. Pascual has received research support from NIH.
Sunil K. Narayan, MD, FAAN	The institution of Dr. Narayan has received research support from Indian Council of Medical Research, Ministry of Health and Family Welfare, Government of India. The institution of Dr. Narayan has received research support from Department of Biotechnlogy, Ministry of Science and Technology, Government of India. The institution of Dr. Narayan has received research support from DST-(SERB). The institution of Dr. Narayan has received research support from Ms.Gurutva Medical Technology, India. Dr. Narayan has received intellectual property interests from a discovery or technology relating to health care. Dr. Narayan has received intellectual property interests from a discovery or technology relating to health care. Dr. Narayan has received personal compensation in the range of $0-$499 for serving as a Intermediate Grants, Evaluation Expert committee Member with Department of Health Research, Government of India.
Sheryl Martin-Schild, MD, PhD, FAAN	No disclosure on file
Sandra Weintraub, PhD, FAAN	Dr. Weintraub has nothing to disclose.
Amy Kuceyeski, PhD	An immediate family member of Dr. Kuceyeski has received personal compensation for serving as an employee of Heyer Physical Therapy. The institution of Dr. Kuceyeski has received research support from National Institutes of Health. Dr. Kuceyeski has received personal compensation in the range of $500-$4,999 for serving as a Grant Panel Member with Department of Defense.
Raymond Rosales	Dr. Rosales has nothing to disclose.
Douglas L. Arnold, MD, FAAN	Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Frequency Therapeutics. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xfacto communications. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Find therapeutics. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Idorsia. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kiniksa. Dr. Arnold has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Clario.
Moses Rodriguez, MD, FAAN	Dr. Rodriguez has received intellectual property interests from a discovery or technology relating to health care.
Anat Achiron, MD, PhD, FAAN	Dr. Achiron has nothing to disclose.
Letizia M. Leocani, MD	Dr. Leocani has received personal compensation in the range of $0-$499 for serving as a Consultant for Roche . Dr. Leocani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Leocani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Leocani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Med-ex learning.
Michal T. Gostkowski, DO	The institution of Dr. Gostkowski has received research support from Medtronic.
Antonio Bosco	No disclosure on file
Oleg Y. Chernyshev, MD, PhD, FAAN	Dr. Chernyshev has nothing to disclose.
Ramy El Khoury, MD, FAAN	No disclosure on file
Vivek Rai, MD	Dr. Rai has nothing to disclose.
Farhaan S. Vahidy, MBBS, PhD	Dr. Vahidy has nothing to disclose.
Kavita Nair, PhD, FAAN	Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Meyers Squibb. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Nair has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for PhRMA Foundation. Dr. Nair has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MJH Lifesciences. Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Anylam . Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Applied Patient Experience. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Esai. Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MHJ Life Sciences. Dr. Nair has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi-Genzyme. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for ICER. The institution of Dr. Nair has received research support from Genentech. The institution of Dr. Nair has received research support from Novartis. The institution of Dr. Nair has received research support from Genentech. The institution of Dr. Nair has received research support from Phrma Foundation. The institution of Dr. Nair has received research support from Bristol Meyers Squibb. The institution of Dr. Nair has received research support from Novartis. The institution of Dr. Nair has received research support from NINDS. The institution of Dr. Nair has received research support from Sanofi Genzyme. The institution of Dr. Nair has received research support from Kyverna Therapeutcis. Dr. Nair has a non-compensated relationship as a Board Member with Center for Improving Value in Healthcare that is relevant to AAN interests or activities.
Michael Shaw	Mr. Shaw has nothing to disclose.
Anita Yun	No disclosure on file
Megan Teynor	No disclosure on file
Michael Schwarzschild, MD, PhD	The institution of Dr. Schwarzschild has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bial Biotech (indirectly, as a service of the Parkinson Study Group service). The institution of Dr. Schwarzschild has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen (indirectly, as a service of the Parkinson Study Group service). The institution of Dr. Schwarzschild has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB (indirectly, as a service of the Parkinson Study Group service). Dr. Schwarzschild has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. The institution of Dr. Schwarzschild has received research support from NIH. The institution of Dr. Schwarzschild has received research support from Parkinson's Foundation. The institution of Dr. Schwarzschild has received research support from Michael J Fox Foundation. The institution of Dr. Schwarzschild has received research support from Farmer Family Foundation. Dr. Schwarzschild has a non-compensated relationship as a Chair, Executive Committee with the Parkinson Study Group that is relevant to AAN interests or activities.
Anne Lortie, MD	No disclosure on file
Pravin Khemani, MD, FAAN	Dr. Khemani has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Cala Trio. Dr. Khemani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Khemani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine.
Yonas E. Geda, MD	The institution of Dr. Geda has received research support from NIH.
Philippe Major, MD	Dr. Major has nothing to disclose.
Siddharama Pawate, MD	The institution of Dr. Pawate has received research support from Genentech. The institution of Dr. Pawate has received research support from Biogen.
Andrea N. Leep Hunderfund, MD	The institution of Dr. Leep Hunderfund has received research support from American Medical Association. The institution of Dr. Leep Hunderfund has received research support from Kern National Network for Caring and Character in Medicine. Dr. Leep Hunderfund has received intellectual property interests from a discovery or technology relating to health care.
Samuel Lapalme-Remis, MD	Dr. Lapalme-Remis has nothing to disclose.
Bhavesh Trikamji, MD	Dr. Trikamji has nothing to disclose.
Jorge Campos, MD	No disclosure on file
Alyana Samai	No disclosure on file
Thanh Nguyen	No disclosure on file
Sara Cole, RN	Ms. Cole has nothing to disclose.
Charles B. Hall, PhD	No disclosure on file
Susan Gauthier, DO	Dr. Gauthier has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Gauthier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Gauthier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Gauthier has received research support from Genentech.
Irene R. Boniece, MD	No disclosure on file
Lauren B. Krupp, MD, FAAN	Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EBIX. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffman LaRoche. Dr. krupp has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for MMMK. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Patrick, Dolan, and Kaufman. Dr. krupp has received intellectual property interests from a discovery or technology relating to health care.
Clifford R. Jack, Jr., MD	The institution of Dr. Jack has received research support from NIH. The institution of Dr. Jack has received research support from Alexander Family Alzheimer's Disease Research Professorship of the Mayo Clinic.
Petr Kanovsky, PhD	Dr. Kanovsky has nothing to disclose.
Gaetano Perrotta, MD	No disclosure on file
Homa Ebrahimi, MD	No disclosure on file
Eva Havrdova, MD	Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi.
John H. Sladky, MD, FAAN	Dr. Sladky has nothing to disclose.
Shu-Ing Chang	No disclosure on file
Frederic Taithe	No disclosure on file
Jonathan Graff-Radford, MD, FAAN	Dr. Graff-Radford has received personal compensation for serving as an employee of Mayo Clinic. Dr. Graff-Radford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NINDS/NIH. Dr. Graff-Radford has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Graff-Radford has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Open evidence . The institution of Dr. Graff-Radford has received research support from NIH. The institution of Dr. Graff-Radford has received research support from Eisai. The institution of Dr. Graff-Radford has received research support from Cognition therapeutics. Dr. Graff-Radford has received personal compensation in the range of $5,000-$9,999 for serving as a Faculty Member with IMPACT AD .
Peter Z. Yan, MD, MS	Dr. Yan has nothing to disclose.
Fabio Nascimento, MD	Dr. Nascimento has received publishing royalties from a publication relating to health care.
Camilo Diaz-Cruz, MD	Dr. Diaz-Cruz has nothing to disclose.
Zachary Grinspan, MD	Dr. Grinspan has received personal compensation for serving as an employee of Weill Cornell Medicine. Dr. Grinspan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alpha Insights. Dr. Grinspan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biopharma LTD (South Korea). Dr. Grinspan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Encoded Therapeutics. The institution of Dr. Grinspan has received research support from SLC6A1 Connect. The institution of Dr. Grinspan has received research support from STXBP1 Foundation. The institution of Dr. Grinspan has received research support from Clara Inspired. The institution of Dr. Grinspan has received research support from Amgen. The institution of Dr. Grinspan has received research support from NINDS. Dr. Grinspan has received intellectual property interests from a discovery or technology relating to health care.
Danielle M. Andrade, MD	The institution of Dr. Andrade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Andrade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceutical. The institution of Dr. Andrade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke Therapeutics. The institution of Dr. Andrade has received research support from Epilepsy Canada. The institution of Dr. Andrade has received research support from SynGAP Research Fund. Dr. Andrade has received publishing royalties from a publication relating to health care. Dr. Andrade has a non-compensated relationship as a Former Chair of task force on Transition with International League Against Epilepsy that is relevant to AAN interests or activities. Dr. Andrade has a non-compensated relationship as a President with Canadian League Against Epilepsy that is relevant to AAN interests or activities.
Qiang J. Zhang, MD	The institution of Dr. Zhang has received research support from NIH/NIA.
Emanuele Ghione, MD	No disclosure on file
Ming Yao	Ming Yao has nothing to disclose.
Marcelo Berthier Torres, MD	No disclosure on file
Iris E. Martinez-Juarez, MD	No disclosure on file
Naim I. Haddad, MD, FAAN	Dr. Haddad has nothing to disclose.
Bonnie Scott, PhD	No disclosure on file
Elinor Ben-Menachem, MD, FAAN	Dr. Ben-Menachem has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Ben-Menachem has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arvelle. Dr. Ben-Menachem has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GW Pharma. Dr. Ben-Menachem has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Acta Neurologica Scandinvica. The institution of Dr. Ben-Menachem has received research support from zogenic.
Adil Maarouf	Adil Maarouf has nothing to disclose.
Serge G. Gauthier, MD	Dr. Gauthier has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TauRx . Dr. Gauthier has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly Canada . Dr. Gauthier has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai . Dr. Gauthier has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ENIGMA USA. Dr. Gauthier has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AmyriAD. Dr. Gauthier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medesis. Dr. Gauthier has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Alzheon. Dr. Gauthier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Karuna. Dr. Gauthier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Otsuka . Dr. Gauthier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NovoNordisk. Dr. Gauthier has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen Canada. Dr. Gauthier has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Sharon Francis Foundation . Dr. Gauthier has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JPAD. Dr. Gauthier has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Lundbeck Foundation . Dr. Gauthier has received publishing royalties from a publication relating to health care.
Mohamad A. Mikati, MD	No disclosure on file
Rodney A. Radtke, MD	No disclosure on file
Ludwig Kappos, MD, FAAN	Dr. Kappos has nothing to disclose.
Edwin B. George, MD, PhD, FAAN	No disclosure on file
Adriano Chio, MD, FAAN	Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Corcept.
Ralph H. Benedict, PhD	Dr. Benedict has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Benedict has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Benedict has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Meyers Squibb. Dr. Benedict has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunic Therapeutics. Dr. Benedict has received intellectual property interests from a discovery or technology relating to health care.
Maria A. Rocca	Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Bristol Myers Squibb, Eli Lilly, Janssen, Roche. Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AstraZaneca, Biogen, Bristol Myers Squibb, Bromatech, Celgene, Genzyme, Horizon Therapeutics Italy, Merck Serono SpA, Novartis, Roche, Sanofi and Teva. The institution of Maria Assunta Rocca has received research support from MS Society of Canada, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Deepti Zutshi, MD, FAAN	Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xenon pharmaceuticals. An immediate family member of Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aucta Pharmaceuticals. Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aucta.
Alicia S. Parker, MD	An immediate family member of Dr. Parker has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Sanara Med Tech. An immediate family member of Dr. Parker has stock in Sanara Med Tech. An immediate family member of Dr. Parker has stock in Rochal Industries. An immediate family member of Dr. Parker has stock in Rochal Parnters. The institution of Dr. Parker has received research support from Texas Alzheimer's Research and Care Consortium. The institution of an immediate family member of Dr. Parker has received research support from Rochal Industries. An immediate family member of Dr. Parker has received intellectual property interests from a discovery or technology relating to health care.
Liying Cui, PhD	No disclosure on file
Massimiliano Copetti	No disclosure on file
Todd Grinnell, PhD	Todd Grinnell, PhD has received personal compensation for serving as an employee of Sunovion Pharmaceuticals Inc..
Laura K. Stein, MD, MPH	The institution of Dr. Stein has received research support from American Heart Association.
Philippe Picaut	No disclosure on file
Michio Hirano, MD, FAAN	Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Biopharma SRL. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precision Biosciences. Dr. Hirano has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Biopharma SRL. Dr. Hirano has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Apollo Communication. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Envision Communications. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ��ɫ��. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Cure SMA. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Muscular Dystrophy Association. The institution of Dr. Hirano has received research support from UCB. The institution of Dr. Hirano has received research support from Cyclerion. The institution of Dr. Hirano has received research support from Astellas. The institution of Dr. Hirano has received research support from Tisento Therapeutics. The institution of Dr. Hirano has received research support from Stealth Biotherapeutics. The institution of Dr. Hirano has received research support from Abliva. Dr. Hirano has received intellectual property interests from a discovery or technology relating to health care. Dr. Hirano has received intellectual property interests from a discovery or technology relating to health care. Dr. Hirano has received personal compensation in the range of $0-$499 for serving as a Study Section Reviewer with NIH. Dr. Hirano has a non-compensated relationship as a Research Advisory Board member with Muscular Dystrophy Association that is relevant to AAN interests or activities. Dr. Hirano has a non-compensated relationship as a Scientific and Medical Advisory Board member with United Mitochondrial Disease Foundation that is relevant to AAN interests or activities. Dr. Hirano has a non-compensated relationship as a Scientific Advisory Board member with Barth Syndrome Foundation that is relevant to AAN interests or activities.
Karen C. Albright, DO, DO, PhD, MS, MPH	Dr. Albright has nothing to disclose.
Kevin M. Biglan, MD	Dr. Biglan has received personal compensation for serving as an employee of Eli Lilly. Dr. Biglan has received stock or an ownership interest from Eli Lilly.
Alireza Bozorgi, MD	No disclosure on file
Rahul P. Sinha, MD	No disclosure on file
M. M. Mesulam, MD, FAAN	Dr. Mesulam has received publishing royalties from a publication relating to health care.
Jason Silversteen, DO	Dr. Silversteen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche-Genentech. Dr. Silversteen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viela Bio. Dr. Silversteen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche-Genentech.
Wolfgang Koehler	Wolfgang Koehler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Minoryx. Wolfgang Koehler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vigil. Wolfgang Koehler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for United Leukodystrophy Foundation. Wolfgang Koehler has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for European Leukodystrophy Association. The institution of Wolfgang Koehler has received research support from Minoryx. The institution of Wolfgang Koehler has received research support from Vigil. The institution of Wolfgang Koehler has received research support from SwanBio. The institution of Wolfgang Koehler has received research support from Alexion.
Michael Sailer, PhDd	No disclosure on file
Gaston Baslet, MD	Dr. Baslet has received publishing royalties from a publication relating to health care. Dr. Baslet has a non-compensated relationship as a Professional Board Member with Epilepsy Alliance America that is relevant to AAN interests or activities.
Peter Bede, MD, PhD	Dr. Bede has nothing to disclose.
James C. Grotta, MD, FAAN	Dr. Grotta has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Frazer Ltd. Dr. Grotta has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Haemonetics. Dr. Grotta has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acticor. Dr. Grotta has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prolong Pharma. Dr. Grotta has received publishing royalties from a publication relating to health care. Dr. Grotta has received publishing royalties from a publication relating to health care.
Raquel Gardner, MD	Dr. Gardner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BrainBox. The institution of Dr. Gardner has received research support from NIH. The institution of Dr. Gardner has received research support from DoD.
Trung P. Nguyen, MD	The institution of Dr. Nguyen has received research support from National Institute on Aging. The institution of Dr. Nguyen has received research support from Texas Alzheimer's Research and Care Consortium. The institution of Dr. Nguyen has received research support from Biogen.
Samden Lhatoo, MD	Dr. Lhatoo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for LivaNova. The institution of Dr. Lhatoo has received research support from NIH. Dr. Lhatoo has received intellectual property interests from a discovery or technology relating to health care. Dr. Lhatoo has received publishing royalties from a publication relating to health care.
Bjorn Evertsson, MD	Dr. Evertsson has received research support from Regionstockholm.
Ian Bledsoe, MD	Dr. Bledsoe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Destum Partners. Dr. Bledsoe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie Inc. Dr. Bledsoe has received personal compensation in the range of $0-$499 for serving as a Consultant for Clarity.Co. Dr. Bledsoe has received personal compensation in the range of $0-$499 for serving as a Consultant for GLG. The institution of Dr. Bledsoe has received research support from Dystonia Medical Research Foundation. The institution of Dr. Bledsoe has received research support from NIH. The institution of Dr. Bledsoe has received research support from Michael J Fox Foundation.
Matthew H. Wong, MD	No disclosure on file
Eduardo E. Benarroch, MD, FAAN	Dr. Benarroch has nothing to disclose.
John Vissing, MD	Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne Therapeutics. Prof. Vissing has received personal compensation in the range of $0-$499 for serving as a Consultant for Denali Therapeutics. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus therapeutics. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avidity Therapeutics. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Italfarmaco. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD Pharma. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NMD Pharma. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity. Prof. Vissing has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sarepta. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Johnson & Johnson (Janssen). Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Edgewise Therapeutics. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. The institution of Prof. Vissing has received research support from Rigshospitalet. The institution of Prof. Vissing has received research support from Avidity. The institution of Prof. Vissing has received research support from Sanofi. The institution of Prof. Vissing has received research support from Roche. The institution of Prof. Vissing has received research support from AnnJi.
Matthias Schwab, PhD	No disclosure on file
Letizia G. Borges, MD	No disclosure on file
Alberto Ascherio, MD, PhD	Dr. Ascherio has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizer. Dr. Ascherio has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Ascherio has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. The institution of Dr. Ascherio has received research support from NIH and US Department of Defense .
Yi Wang, PhD	Prof. Wang has received intellectual property interests from a discovery or technology relating to health care.
Raffaella Migliaccio	Raffaella Migliaccio has nothing to disclose.
Katya Rascovsky	No disclosure on file
Geetanjali S. Rathore, MD, FAAN	Dr. Rathore has nothing to disclose.
Gabriela Cohen, MD	No disclosure on file
Eyal Muscal	Eyal Muscal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for sobi. An immediate family member of Eyal Muscal has stock in pfizer.
Subramaniam Sriram, MD	Dr. Sriram has nothing to disclose.
Basil Sharrack, MD, PhD, FAAN	Dr. Sharrack has nothing to disclose.
Ingelise Christiansen, PhD	No disclosure on file
Ilia Itin, MD	No disclosure on file
Sean I. Savitz, MD	Dr. Savitz has nothing to disclose.
Paola Valsasina	Paola Valsasina has nothing to disclose.
Victoria S. Wong, MD, FAAN	No disclosure on file
Anupama Kumar, PhD	No disclosure on file
Mika Komori	Mika Komori has received personal compensation for serving as an employee of Eli Lilly K.K..
Sandro Marini, MD	Dr. Marini has nothing to disclose.
Youmna Jalkh	Ms. Jalkh has nothing to disclose.
Mandip S. Dhamoon, MD, MPH	Dr. Dhamoon has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Faegre Baker Daniels LLP. Dr. Dhamoon has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Wellstar Health System Inc. Dr. Dhamoon has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Fabiani Cohen & Hall, LLP. Dr. Dhamoon has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Kramer, Dillof, Livingston & Moore. Dr. Dhamoon has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Robins Kaplan. Dr. Dhamoon has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Parker Waichman LLP. Dr. Dhamoon has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Heidell, Pittoni, Murphy & Bach, LLP.
Patrizia Pantano	Patrizia Pantano has nothing to disclose.
Kenneth W. Sommerville, MD, FAAN	No disclosure on file
Shannon Risacher	Shannon Risacher has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Shannon Risacher has stock in Eli Lilly. Shannon Risacher has received personal compensation in the range of $500-$4,999 for serving as a Reviewer with NIH.
Michelle Burack, MD, PhD	No disclosure on file
Brian Callaghan, MD, MS, FAAN	Dr. Callaghan has received personal compensation for serving as an employee of University of Michigan. Dr. Callaghan has received personal compensation for serving as an employee of Ann Arbor Veterans Affairs. Dr. Callaghan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dynamed. Dr. Callaghan has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ��ɫ��. Dr. Callaghan has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Medico-legal work. Dr. Callaghan has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Vaccine Injury Compensation Program. The institution of Dr. Callaghan has received research support from ��ɫ��. The institution of Dr. Callaghan has received research support from JDRF. The institution of Dr. Callaghan has received research support from NIA. Dr. Callaghan has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with NIH.
Alessandro Biffi, MD	Dr. Biffi has received personal compensation for serving as an employee of Eli Lilly And Company. Dr. Biffi has stock in Eli Lilly And Company.
Kurt E. Hecox, MD	No disclosure on file
Orla Hardiman, MD, DSc, FRCPI, MRIA, FAAN	Dr. Hardiman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Wave Pharmaceuticals. Dr. Hardiman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cytokinetics . Dr. Hardiman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hardiman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Taylor and Francis. The institution of Dr. Hardiman has received research support from Science Foundation Ireland. The institution of Dr. Hardiman has received research support from HRB.
Jeffrey D. Rothstein, MD, PhD	Dr. Rothstein has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Corcept Therapeutics. Dr. Rothstein has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly Pharmaceuticasl. Dr. Rothstein has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ALS Journal. The institution of Dr. Rothstein has received research support from ALSA. The institution of Dr. Rothstein has received research support from MDA. The institution of Dr. Rothstein has received research support from Target ALS. The institution of Dr. Rothstein has received research support from Maryland TEDCO. The institution of Dr. Rothstein has received research support from Dept of Defense. The institution of Dr. Rothstein has received research support from National Insitutes of Health. The institution of Dr. Rothstein has received research support from Corsalex. Dr. Rothstein has received intellectual property interests from a discovery or technology relating to health care.
Diego Cadavid, MD, FAAN	Dr. Cadavid has received personal compensation for serving as an employee of Verge Genomics. Dr. Cadavid has received personal compensation for serving as an employee of Vertex Pharmaceuticals. Dr. Cadavid has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novo Nordisk. Dr. Cadavid has or had stock in Verge Genomics.Dr. Cadavid has or had stock in Vertex Pharmaceuticals.
Anand Viswanathan, MD	Dr. Viswanathan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam Pharmaceuticals. Dr. Viswanathan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Viswanathan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Pharmaceuticals.
Timothy Lesnick	No disclosure on file
Tara Grabowsky	No disclosure on file
Madhuri Fletcher	No disclosure on file
Irena Pulte	Irena Pulte has received personal compensation for serving as an employee of Merz Pharmaceuticals . Irena Pulte has received intellectual property interests from a discovery or technology relating to health care.
William Gallentine, DO	No disclosure on file
Fahed Saada, MD, FAAN	No disclosure on file
Nir Giladi, MD, FAAN	Dr. Giladi has received personal compensation in the range of $0-$499 for serving as a Consultant for Sionara. Dr. Giladi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NeuroDerm. Dr. Giladi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pharma2B. Dr. Giladi has stock in Vibrant. Dr. Giladi has stock in Lysosomal Therapeutics . The institution of Dr. Giladi has received research support from The Michael J Fox Foundation. The institution of Dr. Giladi has received research support from The National Parkinson Foundation. The institution of Dr. Giladi has received research support from The European Union . The institution of Dr. Giladi has received research support from The Israel Science Foundation. The institution of Dr. Giladi has received research support from Biogen . The institution of Dr. Giladi has received research support from Ionis. The institution of Dr. Giladi has received research support from Sieratzki Family Foundation . The institution of Dr. Giladi has received research support from The Aufzien Academic Center in Tel-Aviv University.
Alberto Esquenazi, MD	Dr. Esquenazi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen and Allergan. Dr. Esquenazi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen and Allergan. The institution of Dr. Esquenazi has received research support from Ipsen, Allergan and Merz.
Michael Sweeney, MD	Dr. Sweeney has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genentech. Dr. Sweeney has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis.
Andrea C. Wasilewski, MD	Dr. Wasilewski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novocure. Dr. Wasilewski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Servier Pharmaceuticals .
Alfonso Fasano, MD, PhD, FAAN	Dr. Fasano has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. Dr. Fasano has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Fasano has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Dr. Fasano has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boston Scientific. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbott. Dr. Fasano has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ceregate. Dr. Fasano has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Inbrain Neuroelectronics. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Syneos Health. Dr. Fasano has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Annovis. Dr. Fasano has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for CADTH. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for International Parkinson and Movement Disorders Society. The institution of Dr. Fasano has received research support from Boston Scientific. The institution of Dr. Fasano has received research support from Medtronic. The institution of Dr. Fasano has received research support from Abbvie. The institution of Dr. Fasano has received research support from Canadian Institutes of Health Research (CIHR). The institution of Dr. Fasano has received research support from Michael J Fox Foundation. The institution of Dr. Fasano has received research support from Bluerock Therapeutics. Dr. Fasano has received publishing royalties from a publication relating to health care. Dr. Fasano has a non-compensated relationship as a Medical Advisory Committee with CenteR for Advancing Neurological Innovation to Application (CRANIA) that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Medical Advisory Committee with HopeNET that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Medical Advisory Committee with International Essential Tremor Foundation that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Member with Tremor Research Group that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Co-Chair with Tremor Study Group of the IPMDS that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Vice-Chair with NPH Study Group of the IPMDS that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Vice-Chair with Industry Committee of the IPMDS that is relevant to AAN interests or activities.
Hussien S. Alkully, MD	Dr. Alkully has nothing to disclose.
Fasl Goldanne Buenaflor	No disclosure on file
Carolina Gutierrez	Carolina Gutierrez has nothing to disclose.
Arminda Maria Ruano Hernandez	No disclosure on file
Sadanand Dey, MD	No disclosure on file
Fedor Panov	Fedor Panov has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for neuropace. Fedor Panov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for zimmer biomet.
Ming-Li Li	No disclosure on file
Allison L. Weathers, MD, FAAN	Dr. Weathers has received personal compensation in the range of $500-$4,999 for serving as a CME question writer, interviewer, presenter with ��ɫ��. Dr. Weathers has a non-compensated relationship as a Chair, Neurology Adult Steering Board with Epic that is relevant to AAN interests or activities. Dr. Weathers has a non-compensated relationship as a Member, Quality Informatics Subcommittee with ��ɫ�� that is relevant to AAN interests or activities. Dr. Weathers has a non-compensated relationship as a Member of the NCP Editorial Board with ��ɫ�� that is relevant to AAN interests or activities.
Wayne W. Feng, MD, FAAN	Dr. Feng has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Namsa. The institution of Dr. Feng has received research support from NIH. The institution of Dr. Feng has received research support from American heart association . The institution of Dr. Feng has received research support from Ipsen.
Jeffrey Binder, MD	No disclosure on file
Eduardo A. De Sousa, MD, FAAN	No disclosure on file
Michael Cardamone, MBBS, PhD, FRACP	No disclosure on file
Vladimir S. Kostic, MD, PhD	Dr. Kostic has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche. An immediate family member of Dr. Kostic has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Alkaloid. The institution of Dr. Kostic has received research support from Ministry of ��ɫ��, Science and Technological Development of Serbia.
Jayant N. Acharya, MD, DM, FAAN	Dr. Acharya has nothing to disclose.
Vinita J. Acharya, MD, FAAN	Dr. Acharya has nothing to disclose.
Leigh E. Charvet, PhD	Dr. Charvet has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson & Johnson. Dr. Charvet has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Springer Healthcare. Dr. Charvet has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for YBrain. Dr. Charvet has stock in Johnson&Johnson.
Jean Pelletier, MD, PhD	Dr. Pelletier has nothing to disclose.
Hyunmi Kim, MD	Dr. Kim has nothing to disclose.
Amer Malik, MD	Dr. Malik has nothing to disclose.
Lisa T. Emrick, MD	Dr. Emrick has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Arkema. The institution of Dr. Emrick has received research support from Lysogene. The institution of Dr. Emrick has received research support from PTC. The institution of Dr. Emrick has received research support from Roche. The institution of Dr. Emrick has received research support from NIH.
Sujay M. Kansagra, MD	No disclosure on file
Sudeepta Dandapat, MD	Dr. Dandapat has nothing to disclose.
Ai Sumida, MD	No disclosure on file
Daniel L. Kenney-Jung, MD	The institution of Dr. Kenney-Jung has received research support from CFC Foundation. The institution of Dr. Kenney-Jung has received research support from Advanced Medical Electronics/NIH. The institution of Dr. Kenney-Jung has received research support from Bluebird Bio. The institution of Dr. Kenney-Jung has received research support from Rare Disease Foundation.
Patrick S. Reynolds, MD, FAAN	Dr. Reynolds has nothing to disclose.
Jason Burton, MD	No disclosure on file
David Titelbaum, MD	No disclosure on file
Luis F. Torres, MD	Dr. Torres has nothing to disclose.
Maya Silver, MD	No disclosure on file
Simona M. Brambati, MD	No disclosure on file
Frank Hoffmann, MD	Dr. Hoffmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Hoffmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Hoffmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. The institution of Dr. Hoffmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hoffmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Hoffmann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Hoffmann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. Dr. Hoffmann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Hoffmann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Talecris. Dr. Hoffmann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Hoffmann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi.
Bibiana Bielekova, MD, FAAN	Dr. Bielekova has received research support from National Institutes of Allergy and Infectious Diseases. Dr. Bielekova has received intellectual property interests from a discovery or technology relating to health care. Dr. Bielekova has received publishing royalties from a publication relating to health care.
Aimee K. Boegle, MD, PhD	Dr. Boegle has received publishing royalties from a publication relating to health care.
Samia J. Khoury, MD, FAAN	Dr. Khoury has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merk. Dr. Khoury has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Khoury has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ANA. Dr. Khoury has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Clinical Immunology. The institution of Dr. Khoury has received research support from MENACTRIMS. The institution of Dr. Khoury has received research support from NMSS. The institution of Dr. Khoury has received research support from Office of Naval Research USA. An immediate family member of Dr. Khoury has received intellectual property interests from a discovery or technology relating to health care.
Neal M. Rao, MD	Dr. Rao has nothing to disclose.
Rajani Sebastian, PhD	No disclosure on file
Alirexa Faridar, MD	Dr. Faridar has nothing to disclose.
Shrikant Mishra, MD	Dr. Mishra has nothing to disclose.
Mary Kay Floeter, MD, PhD	No disclosure on file
Carlo Pozzilli	Carlo Pozzilli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Carlo Pozzilli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Carlo Pozzilli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Carlo Pozzilli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion.
Alfredo Thomson, MD	Dr. Thomson has nothing to disclose.
Susan W. Law, DO	Dr. Law has nothing to disclose.
Laurie A. Schluter, RN, MSN, FNP	No disclosure on file
Uwe Zettl	Uwe Zettl has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck Serono. Uwe Zettl has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion . Uwe Zettl has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. Uwe Zettl has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Uwe Zettl has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. The institution of Uwe Zettl has received research support from BMBF(Government).
Julyne Sandes	No disclosure on file
Catherine Schevon, MD	The institution of Dr. Schevon has received research support from NIH/NINDS. Dr. Schevon has received personal compensation in the range of $500-$4,999 for serving as a Study Section Regular Member with NIH.
Gregg D. Meekins, MD, FAAN	No disclosure on file
Victor W. Mark, MD	Dr. Mark has nothing to disclose.
Sridar Narayanan	Sridar Narayanan has received personal compensation for serving as an employee of NeuroRx Research. Sridar Narayanan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech Inc.. The institution of Sridar Narayanan has received research support from Immunotec Inc.
Barbara A. Dworetzky, MD, FAAN	Dr. Dworetzky has received publishing royalties from a publication relating to health care.
Marc Weisskopf, PhD	Prof. Weisskopf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kaiser Permanente Research Biobank. The institution of Prof. Weisskopf has received research support from ALS Network. The institution of Prof. Weisskopf has received research support from NIH. The institution of Prof. Weisskopf has received research support from Paralyzed Veterans of America. The institution of Prof. Weisskopf has received research support from CDC/ATSDR. The institution of Prof. Weisskopf has received research support from JPB Foundation.
Mitchell S. Elkind, MD, MS, FAAN	Dr. Elkind has received personal compensation for serving as an employee of American Heart Association. Dr. Elkind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Atria Academy.
Rosebud O. Roberts, MD	No disclosure on file
Andrea Falini	No disclosure on file
Nicolas Collongues, MD	Nicolas Collongues, MD has nothing to disclose.
Shahamat Tauhid, MD	Dr. Tauhid has nothing to disclose.
David P. Harris, MD	Dr. Harris has nothing to disclose.
Diego Silva, MD, PhD	No disclosure on file
Victoria A. Ebiana, MD	No disclosure on file
Noureldin Abdelhamid, MD	Dr. Abdelhamid has nothing to disclose.
Alison L. Christy, MD, PhD, FAAN	Dr. Christy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Azurity. Dr. Christy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Publishing. Dr. Christy has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MDLinx. The institution of Dr. Christy has received research support from Biohaven. The institution of Dr. Christy has received research support from Novartis / Amgen. The institution of Dr. Christy has received research support from Eli Lilly. The institution of Dr. Christy has received research support from Abbvie.
Ricardo Varela, MD	No disclosure on file
Jia Lin, MD	The institution of Dr. Lin has received research support from PPD/Contineum.
Chantal Bhan, DO	Dr. Bhan has nothing to disclose.
Ribal N. Haddad, MD	Dr. Haddad has nothing to disclose.
Scott M. Lewis, MD, PhD	No disclosure on file
John M. Hoffman, MD	No disclosure on file
Mary E. Quiceno, MD, FAAN	Dr. Quiceno has received personal compensation for serving as an employee of Prothena Biosciences. Dr. Quiceno has received personal compensation for serving as an employee of Johnson & Johnson. Dr. Quiceno has stock in Prothena Biosciences. Dr. Quiceno has stock in Johnson & Johnson.
Man Mohan Mehndiratta, MD, MBBS, FAAN	Dr. Mehndiratta has nothing to disclose.
Dana Horakova	Dana Horakova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dana Horakova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dana Horakova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dana Horakova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck.
Benjamin P. George, MD	Dr. George has nothing to disclose.
Heidi N. Beadnall, MD	Dr. Beadnall has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Beadnall has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Beadnall has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Beadnall has received research support from MSBase Foundation.
Fulton Velez	No disclosure on file
Anthony E. Lang, MD, FAAN	Dr. Lang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AbbVie, Amylyx, Aprinoia, Biogen, BioAdvance, Biohaven, BioVie, BlueRock, BMS, Denali, Janssen, Lilly, Pharma 2B, Sun Pharma, and UCB. Dr. Lang has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for medicolegal cases related to paraquat. The institution of Dr. Lang has received research support from AbbVie. Dr. Lang has received intellectual property interests from a discovery or technology relating to health care. Dr. Lang has received publishing royalties from a publication relating to health care.
Dominique Jennings	No disclosure on file
Jody Manners, MD	Dr. Manners has nothing to disclose.
Joshua P. Klein, MD, PhD, FANA, FAAN	Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Publishers. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for McGraw-Hill Publishers. Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Oakstone Publishers. Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwer Publishers. Dr. Klein has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for various law firms. Dr. Klein has received publishing royalties from a publication relating to health care.
Tanuja Chitnis, MD, FAAN	Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Chitnis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche-Genentech. Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Biosciences. Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Chitnis has received research support from Novartis. The institution of Dr. Chitnis has received research support from Sanofi. The institution of Dr. Chitnis has received research support from Octave. The institution of Dr. Chitnis has received research support from Genentech-Roche. The institution of Dr. Chitnis has received research support from Tiziana Life Sciences. The institution of Dr. Chitnis has received research support from Bristol-Myers Squibb. The institution of Dr. Chitnis has received research support from Wesley Clover.
Bader A. Alenzi, MD	Dr. Alenzi has nothing to disclose.
Padraig E. O'Suilleabhain, MD, FAAN	The institution of Dr. O'Suilleabhain has received research support from ONO pharmaceutical. The institution of Dr. O'Suilleabhain has received research support from Integrated Research Laboratories.
Laura A. Foster, MD	No disclosure on file
Kristine Yaffe, MD	Dr. Yaffe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Yaffe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Quintiles. Dr. Yaffe has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Alector. The institution of Dr. Yaffe has received research support from NIH. The institution of Dr. Yaffe has received research support from DOD. The institution of Dr. Yaffe has received research support from Veterans Affairs.
Henning Andersen, MD	Dr. Andersen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Andersen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring. Dr. Andersen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novo. Dr. Andersen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NMD Pharma. Dr. Andersen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Andersen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion . Dr. Andersen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. Dr. Andersen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx.
Jeffery Gunter	The institution of Jeffery Gunter has received research support from NIH. Jeffery Gunter has received intellectual property interests from a discovery or technology relating to health care.
Haley Huggins, MD	Dr. Huggins has nothing to disclose.
Lewis R. Sudarsky, MD	No disclosure on file
Erwin J. Nikelski, PhD	No disclosure on file
Doris A. Trauner, MD	No disclosure on file
George B. Richerson, MD, PhD	No disclosure on file
Carlos Guevara Oliva, MD	Dr. Guevara Oliva has nothing to disclose.
Mark S. Freedman, MD, FAAN	Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Actelion(Janssen/J&J). Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BiogenIdec. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS/Celgene. Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Inc. Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Actelion (Janssen/J&J). Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Atara Biotherapeutics. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer Healthcare. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for BiogenIdec. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Clene Nanomedicine. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GRI Bio. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Magenta Therapeutics. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Freedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi Genzyme. Dr. Freedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. The institution of Dr. Freedman has received research support from Sanofi Genzyme.
Kottil W. Rammohan, MD	Dr. Rammohan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Rammohan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Rammohan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Rammohan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Rammohan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genzyme. Dr. Rammohan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. The institution of Dr. Rammohan has received research support from Genentech. The institution of Dr. Rammohan has received research support from Genzyme. The institution of Dr. Rammohan has received research support from EMD Serono. The institution of Dr. Rammohan has received research support from Alexion.
Wolfgang Jost	Wolfgang Jost has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbive. Wolfgang Jost has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stada. Wolfgang Jost has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Wolfgang Jost has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Stada. Wolfgang Jost has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bial.
Bryan K. Woodruff, MD	The institution of Dr. Woodruff has received research support from National Institute on Aging.
Aaron L. Boster, MD	Dr. Boster has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for sanofi. Dr. Boster has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for roche. Dr. Boster has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for novartis. Dr. Boster has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Boster has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Serono. The institution of Dr. Boster has received research support from Sanofi. The institution of Dr. Boster has received research support from Roche.
Davorka Tomic	Davorka Tomic has stock in Meck KGaA.
Elisabeth Maillart	No disclosure on file
Tanaporn Rasameesoraj, MD	No disclosure on file
Robert Mikulik, MD	No disclosure on file
Dilip Singh, MD, MBBS	Dr. Singh has nothing to disclose.
Evan A. Jameyfield, MD	Dr. Jameyfield has nothing to disclose.
Negin Badihian, MD	Dr. Badihian has nothing to disclose.
Elisabetta Signoriello	Elisabetta Signoriello has nothing to disclose.
Nico Papinutto	No disclosure on file
Constantina Andrada Treaba, MD, PhD	Dr. Treaba has nothing to disclose.
Enrique C. Leira, MD, MS, FAAN	Dr. Leira has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AHA. The institution of Dr. Leira has received research support from NIH-NINDS.
Jamie L. Palaganas, MD, FAAN	Dr. Palaganas has nothing to disclose.
Ashley Helseth, MD, PhD	No disclosure on file
Kyong Jin Shin, MD	No disclosure on file
Pierre Branger	Pierre Branger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NOVARTIS. Pierre Branger has received personal compensation in the range of $0-$499 for serving as a Consultant for BIOGEN. Pierre Branger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MERCK. Pierre Branger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS.
Lucrecia Bandeo	Lucrecia Bandeo has nothing to disclose.
Alberto J. Espay, MD, FAAN	Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Tanabe Pharma America (formerly, Neuroderm). Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acorda. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa Kirin. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sunovion. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Herantis Pharma. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Supernus (formerly USWorldMeds). Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Synaps Dx. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bial. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NeuroDiagnostics, Inc (SYNAPS Dx). Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Intrance Medical Systems, Inc.. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Praxis Precision Medicines. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Citrus Health. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AskBio. The institution of Dr. Espay has received research support from NIH. The institution of Dr. Espay has received research support from Michael J Fox Foundation for Parkinson's Research. Dr. Espay has received intellectual property interests from a discovery or technology relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care.
Neil G. Patel, MD	No disclosure on file
Sam Yoel Ha	No disclosure on file
Kevin T. Chen	No disclosure on file
Mohammed H. Alkuwaiti, MD	No disclosure on file
Yuji Takahashi, MD, PhD	The institution of Dr. Takahashi has received research support from Nihon Medi-Physics Co. Limit.. The institution of Dr. Takahashi has received research support from Takeda Pharmaceutical Company Limited.
Manuel Toledo	Manuel Toledo has nothing to disclose.
Rabia Jamy, MD	Dr. Jamy has nothing to disclose.
James W. Bathe	No disclosure on file
Jeffrey M. Gelfand, MD, MS, FAAN	Dr. Gelfand has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Arialys. Dr. Gelfand has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ventyx Bio. An immediate family member of Dr. Gelfand has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Headache: The Journal of Head and Face Pain. The institution of Dr. Gelfand has received research support from Genentech/Roche. The institution of Dr. Gelfand has received research support from Vigil Neurosciences. An immediate family member of Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has a non-compensated relationship as a Trial Steering Committee Chairperson and member with Roche / Genentech that is relevant to AAN interests or activities.
Ashutosh P. Jadhav, MD, FAAN	Dr. Jadhav has nothing to disclose.
Sandra Reiter-Campeau, MD	Dr. Reiter-Campeau has nothing to disclose.
Francisco Javier Avendano, MD	No disclosure on file
Allison Brashear, MD, MBA, FAAN	Dr. Brashear has received personal compensation for serving as an employee of McKnight Brain Res Found. Dr. Brashear has received personal compensation for serving as an employee of American Board of Psychiatry and Neurology. Dr. Brashear has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for ABPN. Dr. Brashear has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for McKnight Brain Research Foundation i. Dr. Brashear has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Care Directions- start up . Dr. Brashear has stock in Caredirections . The institution of Dr. Brashear has received research support from NINDS. Dr. Brashear has received publishing royalties from a publication relating to health care. Dr. Brashear has received personal compensation in the range of $500-$4,999 for serving as a Special government employee and study section reviewer with NIH. Dr. Brashear has received personal compensation in the range of $0-$499 for serving as a Adminstrative board -travel reimbursement with AAMC.
Andres M. Kanner, MD, FAAN	Dr. Kanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Kanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Xenon. Dr. Kanner has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsy Foundation of America. Dr. Kanner has received personal compensation in the range of $500-$4,999 for serving as a Lecture at International meeting with Eisai.
Abdallah M. Hamdallah, MD	Dr. Hamdallah has nothing to disclose.
Colleen Schwarz	No disclosure on file
Rebecca Logan, PA	Ms. Logan has nothing to disclose.
John Boscardin	No disclosure on file
Paolo Manganotti	No disclosure on file
Sarah L. Bauer Huang, MD, PhD	No disclosure on file
Ryan Hanson, MD	Dr. Hanson has nothing to disclose.
Kallol K. Set, MD	Dr. Set has nothing to disclose.
Mandy Winkler, RN	No disclosure on file
Ryan G. Wagner, MBBS, PhD	Dr. Wagner has nothing to disclose.
Jovita Balcaitiene	No disclosure on file
Daniel Reiff	No disclosure on file
Timothy Felong, MD	No disclosure on file
Naseem Zomorodi, MD	Dr. Zomorodi has nothing to disclose.
Erika T. Marulanda, MD, FAAN	Dr. Marulanda has nothing to disclose.
Jordi A. Matias-Guiu	No disclosure on file
Adriana N. Sari, MD	Dr. Sari has nothing to disclose.
Mahmoud M. Abu-Ata, MD, FAAN	No disclosure on file
Viviane H. Zetola, MD	Dr. Zetola has nothing to disclose.
Maher Arabi, MD	Dr. Arabi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Paladin .
Hyungsub Shim	No disclosure on file
Nicoletta Caputi, PhD	No disclosure on file
Milagros Hidalgo de la Cruz	Milagros Hidalgo de la Cruz has nothing to disclose.
Nils Henninger, MD, PhD, FANA, FWSO	Dr. Henninger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Henninger has stock in United Health. Dr. Henninger has stock in Novo Nordisk. Dr. Henninger has stock in Elli Lilly. Dr. Henninger has stock in Kenvue. Dr. Henninger has stock in Voyager. Dr. Henninger has stock in Alnylam. Dr. Henninger has stock in Entrada. The institution of Dr. Henninger has received research support from NIH. Dr. Henninger has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Verge Genomics.
Anne Foundas, MD, FAAN	No disclosure on file
Kelly Andrzejewski, DO, PhD	No disclosure on file
Adriana Rebelo	No disclosure on file
Yuishin Izumi, MD, PhD	No disclosure on file
Kok Pin Ng, MD	No disclosure on file
Aashit K. Shah, MD, FAAN	Dr. Shah has stock in Abbot, Abbivie, Gilead, Johnson and Johnson, Pfizer. The institution of Dr. Shah has received research support from Xenon Pharma.
Rohit Bakshi, MD, FAAN	Dr. Bakshi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Bakshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. The institution of Dr. Bakshi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Neuroimaging. The institution of Dr. Bakshi has received research support from Bristol Myers Squibb. The institution of Dr. Bakshi has received research support from EMD Serono. The institution of Dr. Bakshi has received research support from Novartis.
Seward B. Rutkove, MD, FAAN	Dr. Rutkove has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Myolex, Inc. Dr. Rutkove has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neuorlogy . The institution of Dr. Rutkove has received research support from NIH. The institution of Dr. Rutkove has received research support from NASA. The institution of Dr. Rutkove has received research support from Blavatnik Family Foundation. Dr. Rutkove has received intellectual property interests from a discovery or technology relating to health care. Dr. Rutkove has received intellectual property interests from a discovery or technology relating to health care. Dr. Rutkove has received publishing royalties from a publication relating to health care. Dr. Rutkove has received publishing royalties from a publication relating to health care. Dr. Rutkove has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with NIH.
Nimish Thakore, MD	No disclosure on file
Giuseppe Magnani	Giuseppe Magnani has nothing to disclose.
Andrea R. Zammit, PhD	Dr. Zammit has nothing to disclose.
Elizabeth Thiele, MD	Dr. Thiele has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GW Pharma/Jazz. Dr. Thiele has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for zogenix/UCB. Dr. Thiele has received personal compensation in the range of $500-$4,999 for serving as a Consultant for nobelpharma. Dr. Thiele has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biocodex. Dr. Thiele has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke Therapeutics. Dr. Thiele has received personal compensation in the range of $500-$4,999 for serving as a Consultant for livanova. Dr. Thiele has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Noema Pharma. Dr. Thiele has received personal compensation in the range of $500-$4,999 for serving as a Consultant for pyros pharmaceutical/upsher smith. Dr. Thiele has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Marinus Pharmaceuticals. The institution of Dr. Thiele has received research support from GW Pharma/Jazz. The institution of Dr. Thiele has received research support from Zogenix/UCB. The institution of Dr. Thiele has received research support from Stoke Therapeutics. The institution of Dr. Thiele has received research support from Biocodex. Dr. Thiele has received publishing royalties from a publication relating to health care.
Sujata P. Thawani, MD	Dr. Thawani has nothing to disclose.
Richard B. Lipton, MD, FAAN	Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vedanta. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axon. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Satsuma. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cool Tech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clexio. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shiratronics. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Lipton has or had stock in Biohaven.Dr. Lipton has or had stock in Manistee.Dr. Lipton has or had stock in Axon.Dr. Lipton has or had stock in CoolTech. The institution of Dr. Lipton has received research support from Teva. The institution of Dr. Lipton has received research support from Amgen. The institution of Dr. Lipton has received research support from Allergan/Abbvie. The institution of Dr. Lipton has received research support from Gammacore. The institution of Dr. Lipton has received research support from Axsome. The institution of Dr. Lipton has received research support from Charleston Labs. The institution of Dr. Lipton has received research support from Eli Lilly. The institution of Dr. Lipton has received research support from Satsuma. The institution of Dr. Lipton has received research support from NIH . The institution of Dr. Lipton has received research support from Veterans Administration. Dr. Lipton has received publishing royalties from a publication relating to health care.
Apostolos P. Georgopoulos, MD	No disclosure on file
Donna Tippett	No disclosure on file
Constantine Farmakidis, MD, FAAN	Dr. Farmakidis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Farmakidis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for J&J. Dr. Farmakidis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Muscular Dystrophy Association.
Nadia Tenenbaum, MD	Dr. Tenenbaum has received personal compensation for serving as an employee of EMS Serono. Dr. Tenenbaum has stock in EMS Serono.
Anthony Traboulsee, MD	Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Traboulsee has received research support from Roche. The institution of Dr. Traboulsee has received research support from Consortium of MS Centers. The institution of Dr. Traboulsee has received research support from MS Canada. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving as a Workshop Chair with Consortium of MS Centers.
Chirag Gandhi	Chirag Gandhi has nothing to disclose.
Ana Arenivas, PhD	No disclosure on file
Jesus E. Pina-Garza, MD	Dr. Pina-Garza has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz. Dr. Pina-Garza has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurelis. Dr. Pina-Garza has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sk. Dr. Pina-Garza has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Pina-Garza has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Analysis Group/Acadia. Dr. Pina-Garza has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Same as consultant disclosure. Dr. Pina-Garza has received publishing royalties from a publication relating to health care.
Luca Massacesi	The institution of Luca Massacesi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Luca Massacesi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Luca Massacesi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Luca Massacesi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Luca Massacesi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck-Serono. Luca Massacesi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Johnson and Johnson. Luca Massacesi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Luca Massacesi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Horizon. The institution of Luca Massacesi has received research support from Tuscan Region Government. The institution of Luca Massacesi has received research support from Sanofi. The institution of Luca Massacesi has received research support from Roche. Luca Massacesi has received research support from Merck-Serono.
Vittorio Martinelli	Dr. Martinelli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis, Biogen, Sanofi Genzyme, TEVA and Merck. Dr. Martinelli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck .
Daniel Bandari, MD	The institution of Dr. Bandari has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Bandari has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD-Serono. The institution of Dr. Bandari has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Bandari has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD-Serono. The institution of Dr. Bandari has received research support from Genentech. The institution of Dr. Bandari has received research support from EMD-Serono.
Hernan Bayona, MD	Dr. Bayona has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Aventis. Dr. Bayona has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boehringer-Ingelheim. Dr. Bayona has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Bayer SA. Dr. Bayona has received publishing royalties from a publication relating to health care.
Kunio Nakamura, PhD	Dr. Nakamura has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for INmune Bio. The institution of Dr. Nakamura has received research support from Biogen. The institution of Dr. Nakamura has received research support from PCORI. The institution of Dr. Nakamura has received research support from NIH. The institution of Dr. Nakamura has received research support from Genzyme. The institution of Dr. Nakamura has received research support from NIH. The institution of Dr. Nakamura has received research support from Genzyme. The institution of Dr. Nakamura has received research support from Novartis. The institution of Dr. Nakamura has received research support from DOD. Dr. Nakamura has received intellectual property interests from a discovery or technology relating to health care.
Aubrey Adams, PhD	Dr. Manack Adams has received personal compensation for serving as an employee of Abbvie. Dr. Manack Adams has stock in Abbvie.
Prakash R. Paliwal, MD	No disclosure on file
Danah T. Aljaafari, MD	No disclosure on file
Muhammad Affan, MD	Dr. Affan has nothing to disclose.
Dileep R. Yavagal, MD, FAAN	Dr. Yavagal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vascular Dynamics. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Guidepoint. The institution of Dr. Yavagal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Medtronic. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Cerenovus/Johnson & Johnson. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Stryker. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Poseydon. Dr. Yavagal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Athersys. Dr. Yavagal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gravity Medical Technology. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Poseydon. Dr. Yavagal has stock in Poseydon. Dr. Yavagal has stock in Galaxy Therapeutics. Dr. Yavagal has stock in Stentrode. Dr. Yavagal has stock in Gravity Medical. Dr. Yavagal has stock in Gravity Medical Technology. Dr. Yavagal has stock in Athersys. Dr. Yavagal has stock in Rapid Medical . Dr. Yavagal has received intellectual property interests from a discovery or technology relating to health care. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Medicolegal Expert with Royal Carribean Cruise Line. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Medicolegal Consultant with Carnival Cruise Line.
Haley E. Anderson, MD	No disclosure on file
Elizabeth A. Coon, MD, FAAN	Dr. Coon has received publishing royalties from a publication relating to health care. Dr. Coon has a non-compensated relationship as a Non-Voting Member of the Board of Directors with UCNS that is relevant to AAN interests or activities.
Bakkiam Subbiah, MD	No disclosure on file
Kelley A. Flesher, MD	Dr. Flesher has nothing to disclose.
Christopher F. Calahan	No disclosure on file
William Levine	No disclosure on file
Bethany Thomas, NP	Ms. Thomas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Greenwich Bioscience. Ms. Thomas has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Ms. Thomas has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SK Life Science. Ms. Thomas has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for SK Life Science. Ms. Thomas has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Livanova. Ms. Thomas has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eisai. Ms. Thomas has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for GW Bioscience.
Alexander Thiel	No disclosure on file
Lauren Phillips	No disclosure on file
Javier Salas-Puig	No disclosure on file
James J. Riviello, Jr., MD	Dr. Riviello has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biomarin. Dr. Riviello has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for J. Kiffin Penry Foundation. An immediate family member of Dr. Riviello has received publishing royalties from a publication relating to health care. Dr. Riviello has received personal compensation in the range of $500-$4,999 for serving as a Visiting Professor with University of Utah. Dr. Riviello has received personal compensation in the range of $500-$4,999 for serving as a Visiting Professor with University of Calgary.
Mustapha A. Ezzeddine, MD, FAAN	The institution of Dr. Ezzeddine has received research support from NIH.
Susan De Santi, PhD	No disclosure on file
Chen Ye	No disclosure on file
Jun Ni	Jun Ni has nothing to disclose.
Shu-Yang Zhang	No disclosure on file
Anne-Sophie Grandoulier	No disclosure on file
Fei Han	Fei Han has nothing to disclose.
Annalena Venneri, PhD	No disclosure on file
Gary D. Clark, MD	The institution of Dr. Clark has received research support from Greewich pharmaceuticals. The institution of Dr. Clark has received research support from Novartis.
Walter F. Haupt, MD, Prof, FAAN	No disclosure on file
Dimos Dimitrios D. Mitsikostas, MD, PhD	The institution of Dr. Mitsikostas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. The institution of Dr. Mitsikostas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Mitsikostas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. The institution of Dr. Mitsikostas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Leli Lilly. The institution of Dr. Mitsikostas has received research support from Eli Lilly. Dr. Mitsikostas has a non-compensated relationship as a Co-Chair of Headache Panel with EAN that is relevant to AAN interests or activities. Dr. Mitsikostas has a non-compensated relationship as a President with Hellenic Headache Society that is relevant to AAN interests or activities. Dr. Mitsikostas has a non-compensated relationship as a Associate Editor with J Headache Pain that is relevant to AAN interests or activities. Dr. Mitsikostas has a non-compensated relationship as a Associate Editor with Frontier Neurology that is relevant to AAN interests or activities.
Karen Ho, MD	No disclosure on file
Gereon Fink	No disclosure on file
Ellen Carl, MS	No disclosure on file
Sonika Agarwal, MD, FAAN	Dr. Agarwal has nothing to disclose.
Harshit Shah, MD	No disclosure on file
Massimo Filippi, MD, FAAN	Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Martin Bares, PhD	No disclosure on file
Digvijaya D. Navalkele, MD	Dr. Navalkele has nothing to disclose.
Bassem I. Yamout, MD, FAAN	Dr. Yamout has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Yamout has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Yamout has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Yamout has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Yamout has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi.
Luis M. Negrao, MD	No disclosure on file
Bryan M. Spann, DO, PhD	No disclosure on file
Nigel P. Leigh	No disclosure on file
Annett Kunkel	No disclosure on file
Anabela L. Matos	No disclosure on file
John H. Growdon, MD	No disclosure on file
David Walk, MD, FAAN	No disclosure on file
Laura Brennan	No disclosure on file
Nicholas Blondin, MD	Dr. Blondin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure, Inc.. Dr. Blondin has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novocure, Inc..
Lael Stone, MD	No disclosure on file
Carlos A. Luciano, MD, FAAN	Dr. Luciano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi-Genzyme. Dr. Luciano has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for SIMED. Dr. Luciano has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Vazquez-Irizarry Law Office. The institution of Dr. Luciano has received research support from National Institutes of Health. Dr. Luciano has received personal compensation in the range of $100,000-$499,999 for serving as a Professor and Chair with University of Puerto Rico.
Fredy J. Revilla, MD, FAAN	Dr. Revilla has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA . Dr. Revilla has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA .
Stephen M. Rao, PhD	Stephen M. Rao, PhD has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Stephen M. Rao, PhD has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of the International Neuropsychological Society. Stephen M. Rao, PhD has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Psychologist. The institution of Stephen M. Rao, PhD has received research support from Biogen. Stephen M. Rao, PhD has received intellectual property interests from a discovery or technology relating to health care.
Yury Seliverstov, MD, PhD	No disclosure on file
Annemie Ribbens	Annemie Ribbens has received personal compensation for serving as an employee of icometrix. Annemie Ribbens has stock in icometrix. Annemie Ribbens has received intellectual property interests from a discovery or technology relating to health care.
Bhupendra O. Khatri, MD, FAAN	Dr. Khatri has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Alexion. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Khatri has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for ER Squibb (Bristol Myer Squibb). Dr. Khatri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizone. Dr. Khatri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Khatri has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genzyne. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme. Dr. Khatri has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alexion. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Seronoe. Dr. Khatri has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for E.R. Squibb. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Horizon. Dr. Khatri has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Janssen. Dr. Khatri has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TG Therapeutic. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genzyme. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Khatri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx US. The institution of Dr. Khatri has received research support from Biogen.
Pierre Clavelou, MD, PhD	Dr. Clavelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Clavelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Clavelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck.
Bruce S. Rubin, MD, FAAN	No disclosure on file
Olivier Simon	No disclosure on file
Mohammed Almekhlafi, MD	Dr. Almekhlafi has nothing to disclose.
Omar Ayoub, MBBS	No disclosure on file
David Irwin, MD	The institution of Dr. Irwin has received research support from NIH. The institution of Dr. Irwin has received research support from Prevail. The institution of Dr. Irwin has received research support from Passage Bio. The institution of Dr. Irwin has received research support from Alector. The institution of Dr. Irwin has received research support from Transposon. The institution of Dr. Irwin has received research support from Denali. The institution of Dr. Irwin has received research support from Cervo Med.
Vijay Sharma	No disclosure on file
Renxin Chu	Dr. Chu has nothing to disclose.
Maria Julieta Russo, MD	Dr. Russo has nothing to disclose.
Ninad Desai, MBBS	Dr. Desai has nothing to disclose.
Angela M. Hawkins, RN	No disclosure on file
Pino Lopez Mendez	No disclosure on file
Emily Stanford	No disclosure on file
Victor Canela	No disclosure on file
Zheng-Yu Jin	No disclosure on file
Loredana Storelli	Loredana Storelli has nothing to disclose.
Kikumi Tsuda	No disclosure on file
Laura J. Balcer, MD, MSCE, FAAN	An immediate family member of Dr. Balcer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Children's Hospital of Philadelphia.
Benjamin H. Brinkmann, PhD	Dr. Brinkmann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Dr. Brinkmann has stock in Cadence Neuroscience. The institution of Dr. Brinkmann has received research support from Epilepsy Foundation of America. The institution of Dr. Brinkmann has received research support from National Institutes of Health. The institution of Dr. Brinkmann has received research support from National Institutes of Health. The institution of Dr. Brinkmann has received research support from UNEEG A/S. The institution of Dr. Brinkmann has received research support from Seer Medical Pty. The institution of Dr. Brinkmann has received research support from Neurelis Inc. Dr. Brinkmann has received intellectual property interests from a discovery or technology relating to health care.
Laura Cacciaguerra, MD, PhD	Dr. Cacciaguerra has nothing to disclose.
Dennis N. Bourdette, MD, FAAN	Dr. Bourdette has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Magellan Health Care. Dr. Bourdette has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Best Doctor's Inc. Dr. Bourdette has stock in Authobahn Therapeutics. Dr. Bourdette has received intellectual property interests from a discovery or technology relating to health care.
Mark Gudesblatt, MD	The institution of Dr. Gudesblatt has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for genentech. The institution of Dr. Gudesblatt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.
Xavier Montalban, MD, PhD, FAAN	The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck/ EMD Serono. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hoffmann-La Roche. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Actelion/ Janssen Pharmaceuticals. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BMS/ Celgene. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/ Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BIAL PD. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PeerVoice. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung Biosys. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zenas BioPharma. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Actelion/ Janssen Pharmaceuticals. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS/ Celgene. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/ EMD Serono. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffmann-La Roche. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic Therapeutics. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viatris/ Mylan. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. The institution of Dr. Montalban has received research support from Biogen. The institution of Dr. Montalban has received research support from Hoffmann-La Roche. The institution of Dr. Montalban has received research support from Sanofi/ Genzyme. The institution of Dr. Montalban has received research support from Merck/ EMD Serono. The institution of Dr. Montalban has received research support from Novartis. The institution of Dr. Montalban has received research support from Teva Pharmaceuticals. The institution of Dr. Montalban has received research support from Actelion/ Janssen Pharmaceuticals. The institution of Dr. Montalban has received research support from BMS/ Celgene.
Argye E. Hillis, MD, MA	Dr. Hillis has received personal compensation for serving as an employee of Johns Hopkins University. Dr. Hillis has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Hillis has received research support from NIH. Dr. Hillis has received publishing royalties from a publication relating to health care. Dr. Hillis has received personal compensation in the range of $500-$4,999 for serving as a NIDCD Council Member with NIH.
Natalia Palacios, PhD	The institution of Dr. Palacios has received research support from Eisai, Inc. The institution of Dr. Palacios has received research support from NIH. The institution of Dr. Palacios has received research support from Department of Veterans Affairs. Dr. Palacios has a non-compensated relationship as a Grant Reviewer with National Institutes of Health that is relevant to AAN interests or activities. Dr. Palacios has a non-compensated relationship as a Associate Editor with Journal of Alzheimer's Disease that is relevant to AAN interests or activities. Dr. Palacios has a non-compensated relationship as a Researcher with Department of Veterans Affairs that is relevant to AAN interests or activities.
Yousef Hannawi, MD	The institution of Dr. Hannawi has received research support from NIH.
Scott Przybelski	Scott Przybelski has nothing to disclose.
James M. Noble, MD, FAAN	Dr. Noble has received stock or an ownership interest from NoMo Diagnostics. The institution of Dr. Noble has received research support from National Institute on Aging.
Andrei Ivashynka, MD, PhD	Dr. Ivashynka has nothing to disclose.
Murray Grossman, MD, FAAN	Dr. Grossman has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Grossman has received research support from NIH.
Richard B. Dewey, Jr., MD, FAAN	Dr. Dewey has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amneal. Dr. Dewey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus. The institution of Dr. Dewey has received research support from NINDS.
Todd D. Levine, MD	Dr. Levine has received personal compensation for serving as an employee of CND life sciences . Dr. Levine has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Nufactor. Dr. Levine has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for PNA. Dr. Levine has or had stock in CND Life Sciences.Dr. Levine has or had stock in Corinthian reference lab.
Elizabeth Fisher, PhD	No disclosure on file
Hock Luen Teoh	No disclosure on file
Brian C. Healy	The institution of Mr. Healy has received research support from Analysis Group. The institution of Mr. Healy has received research support from Bristol-Myers Squibb. The institution of Mr. Healy has received research support from Verily Life Sciences. The institution of Mr. Healy has received research support from Novartis. The institution of Mr. Healy has received research support from Merck Serono. The institution of Mr. Healy has received research support from Genzyme.
Joseph Giuffrida, PhD	No disclosure on file
Borna Bonakdarpour, MD, FAAN	Dr. Bonakdarpour has nothing to disclose.
Jonathan R. Galli, MD	Dr. Galli has nothing to disclose.
Bernard P. Chan, MD	The institution of Dr. Chan has received research support from National University Hospital, Singapore.
Abeer A. Khoja, MD	No disclosure on file
Reyna Duron, MD	No disclosure on file
Marko Petrovic, MD	Dr. Petrovic has nothing to disclose.
Monica Falautano	Monica Falautano has nothing to disclose.
Channa Kolb, MD	No disclosure on file
Gautam Sachdeva, MD	No disclosure on file
Haris Kamal, MD	Dr. Kamal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Microvention .
Tariq A. Gheith, MD	No disclosure on file
George Howard, PhD	Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer.
Ahmad A. Beydoun, MD	No disclosure on file
Salvatore Napoli, MD	Dr. Napoli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for biogen. Dr. Napoli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Serono. Dr. Napoli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for eisai. Dr. Napoli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for bristol myers. Dr. Napoli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Napoli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for biogen. Dr. Napoli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for bristol myers. Dr. Napoli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for serono. Dr. Napoli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for eisai. Dr. Napoli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TG Therapeutics. Dr. Napoli has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for vaccine injury.
Alan H. Yee, DO	Dr. Yee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janux Therapeutics. The institution of Dr. Yee has received research support from American Osteopathic Association .
Diego F. Tovar Quiroga, MD	No disclosure on file
nobl barazangi, MD, PhD	Dr. Barazangi has nothing to disclose.
Tyler Webb, MD	No disclosure on file
Susan Searles Nielsen	No disclosure on file
Marc Wonneberger	No disclosure on file
Hennan S. Teixeira, MD	Dr. Teixeira has nothing to disclose.
Ala P. Birca, MD	No disclosure on file
Aad Verrips, MD, PhD	No disclosure on file
Niall Pender, PhD	No disclosure on file
Susan M. Bowyer, PhD	Dr. Bowyer has nothing to disclose.
Ellen S. Lathi, MD	No disclosure on file
Stuart D. Cook, MD, FAAN	No disclosure on file
Val J. Lowe, MD	Dr. Lowe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AVID Radiopharmaceutical. Dr. Lowe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Inc. The institution of Dr. Lowe has received research support from AVID Radiopharmaceuticals.
Xiang Gao, MD, PhD	Dr. Gao has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Nutrition Journal. The institution of Dr. Gao has received research support from NIH.
Amrou Sarraj, MD	Dr. Sarraj has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca. Dr. Sarraj has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stryker Neurovascular. Dr. Sarraj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Stryker Neurovascular. The institution of Dr. Sarraj has received research support from Stryker Neurovascular.
Analia Calle	Analia Calle has nothing to disclose.
Steven Kymes	Steven Kymes has received personal compensation for serving as an employee of Lundbeck. Steven Kymes has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Journal of Ophthalmology. Steven Kymes has received research support from Emmes Corporation.
Wim Van Hecke, PhD	Dr. Van Hecke has received personal compensation for serving as an employee of icometrix.
Lynn Liu, MD, FAAN	Dr. Liu has nothing to disclose.
Michael D. Hill, MD	Dr. Hill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boehringer Ingelheim. Dr. Hill has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sun Pharma. Dr. Hill has received stock or an ownership interest from Circle Neurovascular.
Lester Y. Leung, MD	Dr. Leung has received research support from NIH.
Leonard L. Yeo, MBBS	The institution of Dr. Yeo has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Astrazeneca. The institution of Dr. Yeo has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for stryker. Dr. Yeo has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for NUHS. Dr. Yeo has received stock or an ownership interest from cereflo. The institution of Dr. Yeo has received research support from NMRC.
Claudia Z. Chou, MD	Dr. Chou has nothing to disclose.
Gloria Kim	No disclosure on file
Eva Vitkova	No disclosure on file
Michael T. Mullen, MD	Dr. Mullen has received publishing royalties from a publication relating to health care.
Sumit Verma, MD	Dr. Verma has nothing to disclose.
Pedro Rosa Neto, MD, PhD	Dr. Rosa Neto has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk.
Richa Tripathi, MD	Dr. Tripathi has nothing to disclose.
Angel Golimstok	No disclosure on file
Federica Agosta	Federica Agosta has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Philips. Federica Agosta has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier INC.
Nazely Ashikian, MD	Dr. Ashikian has nothing to disclose.
Edythe Boitnott	No disclosure on file
Eugen Trinka	Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bial. Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GW Pharmaceuticals. The institution of Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rapport. The institution of Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbott. The institution of Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Eugen Trinka has received research support from European Union. Eugen Trinka has received publishing royalties from a publication relating to health care.
Mohammad S. Alangari, MD, FAAN	No disclosure on file
John Liang, MD	Dr. Liang has nothing to disclose.
Carla LoPinto-Khoury, MD	No disclosure on file
Regine Buffels, MD	Dr. Buffels has nothing to disclose.
Jason D. Hinman, MD, PhD	Dr. Hinman has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Bertoldo, Baker, Carter & Smith. Dr. Hinman has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Koskoff, Koskoff & Bieder. Dr. Hinman has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Matthew Millea, PC. Dr. Hinman has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Popham Law Firm PC. Dr. Hinman has received stock or an ownership interest from Sage Cerebrovascular Diagnostics, Inc.. Dr. Hinman has received research support from NIH. Dr. Hinman has received research support from American Heart Association. Dr. Hinman has received research support from Reneuron. Dr. Hinman has received intellectual property interests from a discovery or technology relating to health care.
Nandakumar Narayanan, MD, PhD	Dr. Narayanan has nothing to disclose.
Tulio E. Bertorini, MD	Dr. Bertorini has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Bertorini has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Bertorini has received publishing royalties from a publication relating to health care.
Alan Pestronk, MD, FAAN	The institution of Dr. Pestronk has received research support from Jain. The institution of Dr. Pestronk has received research support from Fulcrum. The institution of Dr. Pestronk has received research support from Argenyx. The institution of Dr. Pestronk has received research support from NeuroNext.
Martin Valis, MD	Dr. Valis has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Valis has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Valis has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva.
Lonni Schultz, PhD	Dr. Schultz has nothing to disclose.
Hannah Gardener, ScD	Ms. Gardener has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Intersocietal Accreditation Commission. Ms. Gardener has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ellipse Analytics. Ms. Gardener has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Baum Hedlund. Ms. Gardener has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with A Green Slate Consulting.
Avner Thaler, MD	The institution of Dr. Thaler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ABBVIE. The institution of Dr. Thaler has received research support from MJFF.
Clement Francois	No disclosure on file
Sharon Chiang, MD, PhD	Dr. Chiang has stock in EpilepsyAI. Dr. Chiang has received research support from UCSF Clinical and Translational Science Institute UL1 TR001872. The institution of Dr. Chiang has received research support from NIH R25 NS070680 .
Philippine Dana Peralta, MD	No disclosure on file
Ashish Kulhari, MD	No disclosure on file
Tanzid Shams, MD	Dr. Shams has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Expert Institute.
David S. Saperstein, MD	No disclosure on file
Jose G. Romano, MD, FAAN	Dr. Romano has stock in Vycor Medical/NovaVision. The institution of Dr. Romano has received research support from NIH/NINDS. The institution of Dr. Romano has received research support from NIH/NHLBI.
Nancy D. Richert, MD, PhD	No disclosure on file
Stephen L. Hauser, MD	Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NGM Bio. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moderna. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BD. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pheno Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nurix Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gilead. Dr. Hauser has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Accure. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alector. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hinge Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Neurona. Dr. Hauser has a non-compensated relationship as a Clinical Trial/Primary Investigator with Roche that is relevant to AAN interests or activities. Dr. Hauser has a non-compensated relationship as a Clinical Trial/Primary Investigator with Novartis that is relevant to AAN interests or activities.
Stephen A. McGuire, MD, FAAN	No disclosure on file
Hideki Garren, MD, PhD	Dr. Garren has received personal compensation for serving as an employee of Prothena. Dr. Garren has received personal compensation for serving as an employee of Genentech. Dr. Garren has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Coya.
Alex Rovira	Alex Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofy. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. Alex Rovira has stock in Tensor Medical.
Ricky Lee, MD	No disclosure on file
Glenn T. Stebbins, PhD	Dr. Stebbins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Stebbins has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Partners Healthcare System. Dr. Stebbins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CHDI. The institution of Dr. Stebbins has received research support from Department of Defense. Dr. Stebbins has received research support from Cleveland Clinic Health Systems. Dr. Stebbins has received personal compensation in the range of $500-$4,999 for serving as a Course Director with MDS.
Navid Seraji-Bozorgzad, MD	No disclosure on file
Hannah Homafar, MD	No disclosure on file
Haseeb A. Rahman, MD	Dr. Rahman has nothing to disclose.
Allison Drake	No disclosure on file
Ratnavalli Ellajosyula, MD, DM, FAAN	Dr. Ellajosyula has nothing to disclose.
Tamara Shiner	Tamara Shiner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli lilly. Tamara Shiner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Tamara Shiner has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Tamara Shiner has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. The institution of Tamara Shiner has received research support from MJFF.
Jacqueline Rick	No disclosure on file
Xiangyi Meng, PhD	Dr. Meng has nothing to disclose.
Margaret Kasschau	No disclosure on file
Revere P. Kinkel, MD, FAAN	Dr. Kinkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Kinkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Kinkel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Kinkel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Kinkel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Kinkel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. The institution of Dr. Kinkel has received research support from Department of Defense. The institution of Dr. Kinkel has received research support from PCORI. The institution of Dr. Kinkel has received research support from Sanofi.
Rohit A. Marawar, MD, FAAN	Dr. Marawar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Marawar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SK Pharma. Dr. Marawar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Xenon. Dr. Marawar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis.
Richard P. Goddeau, Jr., DO	No disclosure on file
Yao Feng Victor Chong	No disclosure on file
Daniel Miller, MD	Dr. Miller has nothing to disclose.
April Levin, MD	No disclosure on file
Jeffrey A. Cohen, MD	Dr. Cohen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Convelo. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astoria. Dr. Cohen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viatris. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PSI. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celltrion.
Adeniyi A. Borire, MD	Dr. Borire has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for NOVARTIS.
Hans-Peter Hartung, MD, FAAN	Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS Celgene. Dr. Hartung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Geneuro. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers Neurology.
Nicola De Stefano, MD	Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck Healthcare KGaA. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunic AG. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis Pharma AG. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck Serono S.p.A. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche S.p.A.. The institution of Dr. De Stefano has received research support from Italian MS Society. The institution of Dr. De Stefano has received research support from Merck Healthcare KGaA.
Manuela Vaneckova	Manuela Vaneckova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Manuela Vaneckova has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Manuela Vaneckova has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Manuela Vaneckova has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Manuela Vaneckova has received research support from Czech Ministry of Health project—grants NU 22-04-00193 . Manuela Vaneckova has received research support from Czech Ministry of Health project - RVO VFN 64165 . Manuela Vaneckova has received personal compensation in the range of $500-$4,999 for serving as a principal investigator with Czech Ministry of Health project—grants NU 22-04-00193 .
Mei-Sheng Duh, MPH, ScD	No disclosure on file
Jori Ruuskanen	No disclosure on file
Andreas Lysandropoulos	Andreas Lysandropoulos has nothing to disclose.
Anat Mirelman	Anat Mirelman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie . Anat Mirelman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bial. The institution of Anat Mirelman has received research support from Department of Defense. The institution of Anat Mirelman has received research support from MJFF. The institution of Anat Mirelman has received research support from JPND. The institution of Anat Mirelman has received research support from EU-Horizon 2020.
Keith R. Edwards, MD, FAAN	No disclosure on file
Joseph E. Parisi, MD	Dr. Parisi has nothing to disclose.
Jerzy P. Szaflarski, MD, PhD, FAAN	Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LivaNova Inc. Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PureTech Health. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Gidley, Sarli & Marusak, LLP. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Law Firm. Dr. Szaflarski has stock in AdCel Biopharma, LLC. Dr. Szaflarski has stock in iFovea.
Jan A. Hillert, MD	Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Hillert has received research support from Biogen. The institution of Dr. Hillert has received research support from Celgene. The institution of Dr. Hillert has received research support from Merck. The institution of Dr. Hillert has received research support from Novartis. The institution of Dr. Hillert has received research support from Sanofi. The institution of Dr. Hillert has received research support from Roche.
Timothy E. Lotze, MD, FAAN	Dr. Lotze has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Department of Justice VICP. The institution of Dr. Lotze has received research support from NIH. The institution of Dr. Lotze has received research support from National MS Society. The institution of Dr. Lotze has received research support from Sarepta Therapeutics. The institution of Dr. Lotze has received research support from PTC THERAPEUTICS. The institution of Dr. Lotze has received research support from Avexis. Dr. Lotze has received publishing royalties from a publication relating to health care. Dr. Lotze has received publishing royalties from a publication relating to health care.
Leo Wolansky, MD	The institution of Dr. Wolansky has received research support from Guerbet.
Johann Sellner, MD, FAAN	Dr. Sellner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Boehringer, Celgene, Immunic, Merck, Novartis, Roche, Sanofi. Dr. Sellner has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion, Biogen, Immunic, Merck, Novartis, Roche, Sanofi. Dr. Sellner has received personal compensation in the range of $0-$499 for serving as a Reviewer with Ethics Committtee.
Olivia Tong, MD	Dr. Tong has received personal compensation for serving as an employee of Alexion Pharmaceuticals.
Junaid H. Siddiqui, MD	Dr. Siddiqui has nothing to disclose.
Xin Xin Yu, MD	No disclosure on file
Alessandro Orlando, MPH	No disclosure on file
Stefan Sillau	Stefan Sillau has nothing to disclose.
Caterina Mainero, MD, PhD	The institution of Dr. Mainero has received research support from Genentech.
Samir Belagaje, MD, FAAN	Dr. Belagaje has nothing to disclose.
Howard M. Chertkow, MD	The institution of Dr. Chertkow has received research support from Hoffmann-La Roche Limited. The institution of Dr. Chertkow has received research support from Anavex Life Sciences. The institution of Dr. Chertkow has received research support from Alector Co.. The institution of Dr. Chertkow has received research support from Lilly.
Ermelinda De Meo	Ms. De Meo has nothing to disclose.
Richard A. Rudick, MD, FAAN	Dr. Rudick has received personal compensation for serving as an employee of Biogen. Dr. Rudick has received stock or an ownership interest from Biogen. Dr. Rudick has received publishing royalties from a publication relating to health care.
Jerry S. Wolinsky, MD, FAAN	Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avotres. Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Brainstorm Cell Therapeutics. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cleveland Clinic Foundation. Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inmagene. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis/Sandoz. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Alabama Birmingham. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Wolinsky has received intellectual property interests from a discovery or technology relating to health care. Dr. Wolinsky has received intellectual property interests from a discovery or technology relating to health care.
Zoltan Mari, MD, FAAN	Dr. Mari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Mari has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ACADIA. Dr. Mari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Mari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Parkinson Study Group. Dr. Mari has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AbbVie. Dr. Mari has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for ACADIA. Dr. Mari has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for US World Meds. Dr. Mari has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Mari has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Moore and Moore PLLC. Dr. Mari has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Francis Law Firm PLLC. Dr. Mari has stock in NeuroReserve. Dr. Mari has stock in Sensory Cloud. The institution of Dr. Mari has received research support from Cerevel. The institution of Dr. Mari has received research support from AbbVie. The institution of Dr. Mari has received research support from NIH. The institution of Dr. Mari has received research support from Parkinson's Foundation. The institution of Dr. Mari has received research support from Michael J Fox Foundation. The institution of Dr. Mari has received research support from LBDA. The institution of Dr. Mari has received research support from Eli Lilly.
Wazim Mohamed, MD	Dr. Mohamed has nothing to disclose.
Ales Tomek, MD	No disclosure on file
Krzysztof W. Selmaj	Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Roman Herzig, MD, PhD	Roman Herzig, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca. Roman Herzig, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boehringer Ingelheim . Roman Herzig, MD, PhD has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Care Comm.
Prasanna Venkatesan Eswaradass, MD	Dr. Eswaradass has nothing to disclose.
Benjamin M. Laitman	No disclosure on file
Naira Goukasian	No disclosure on file
Frederik Barkhof, MD, PhD	Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Frederik Barkhof has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Combinostics. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IXICO. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EISAI.
Ashkan Shoamanesh, MD	Dr. Shoamanesh has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer AG. Dr. Shoamanesh has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Daiichi Sankyo . Dr. Shoamanesh has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Servier Inc.. Dr. Shoamanesh has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurodiem.ca. The institution of Dr. Shoamanesh has received research support from Servier Canada Inc.. The institution of Dr. Shoamanesh has received research support from Daiichi Sankyo Ltd.. The institution of Dr. Shoamanesh has received research support from Bayer AG. The institution of Dr. Shoamanesh has received research support from Bristol-Myers Squibb. The institution of Dr. Shoamanesh has received research support from Octapharma Canada .
Rodolfo Savica, MD, PhD, FAAN	The institution of Dr. Savica has received research support from ACADIA Pharmaceuticals, Inc.
Supriya Mahajan, MD	Dr. Mahajan has nothing to disclose.
Mariela Bettini, MD	Dr. Bettini has nothing to disclose.
Tatjana Rundek, MD, PhD	The institution of Dr. Rundek has received research support from NIH.
Maureen A. Mealy, PhD, RN	No disclosure on file
George Lai, MD	No disclosure on file
Dareen AlShaer, MD	No disclosure on file
David Cantu, PhD	Dr. Cantu has received personal compensation for serving as an employee of Sunovion Pharmaceuticals Inc..
Seth A. Smith, PhD	Dr. Smith has nothing to disclose.
Christopher Schwarz	The institution of Christopher Schwarz has received research support from NIH.
Parameswaran M. Iyer, Jr., MD, MBBS	No disclosure on file
Subhash Tummala, MD	No disclosure on file
Kathryn Fitzgerald, PhD	Dr. Fitzgerald has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Setpoint Medical. The institution of Dr. Fitzgerald has received research support from NIH. The institution of Dr. Fitzgerald has received research support from National MS Society.
Zara Ioannides, MD	No disclosure on file
Hiroyuki Nodera, MD	No disclosure on file
Marta Banach, MD	Dr. Banach has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz Pharmaceuticals GmbH. Dr. Banach has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merz Pharmaceuticals GmbH. Dr. Banach has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Merz Pharmaceuticals GmbH.
Ramses Ribot, MD	No disclosure on file
Carsten Lukas, MD	No disclosure on file
Costanza Giannì, MD	No disclosure on file
Kenneth D. Laxer, MD, FAAN	Dr. Laxer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for SK Lfe Sciences. Dr. Laxer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Sciences.
Gioacchino Tedeschi, MD	Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Yuri Bronstein, MD	Dr. Bronstein has nothing to disclose.
Simona Bonavita	No disclosure on file
Fen Bao	Fen Bao has nothing to disclose.
Hugh Kearney, MD, PhD	Dr. Kearney has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.
Anmar Razak, MD	Dr. Razak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceuticals.
Marijean Buhse	Marijean Buhse has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Natali Baner, MD	No disclosure on file
Braeden D. Newton	No disclosure on file
Christopher Tarolli, MD, FAAN	Dr. Tarolli has received personal compensation for serving as an employee of University of Rochester. The institution of Dr. Tarolli has received research support from National Institutes of Health. The institution of Dr. Tarolli has received research support from Biogen. The institution of Dr. Tarolli has received research support from Neuron23. Dr. Tarolli has received personal compensation in the range of $500-$4,999 for serving as a Speaker, Committee Member with ��ɫ��. Dr. Tarolli has received personal compensation in the range of $500-$4,999 for serving as a Committee member with National Board of Medical Examiners. Dr. Tarolli has a non-compensated relationship as a Committee Member with ��ɫ�� that is relevant to AAN interests or activities.
Roberto Michelucci, MD	No disclosure on file
Francisco Rocha	Francisco Rocha has received personal compensation for serving as an employee of BIAL - Portela.
Michael Shaw	No disclosure on file
Fawad Yousuf, MBBS	Dr. Yousuf has nothing to disclose.
Leopold J. Streletz, MD, FAAN	No disclosure on file
Yi-Cheng Zhu, MD, PhD	Dr. Zhu has nothing to disclose.
Chih-Wei Tang, MD	No disclosure on file
Hamza I. Maqsood, MD	Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca.
Vitor H. Pacheco, MD	Dr. Pacheco has nothing to disclose.
Naveed Akhtar, MD, FAAN	Dr. Akhtar has nothing to disclose.
Victoria Leavitt, PhD, FAAN	Dr. Leavitt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Leavitt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Leavitt has received research support from National Institutes of Health. The institution of Dr. Leavitt has received research support from National Multiple Sclerosis Society. The institution of Dr. Leavitt has received research support from Department of Defense. Dr. Leavitt has received intellectual property interests from a discovery or technology relating to health care.
Sandhya Mehla, MD	Dr. Mehla has received publishing royalties from a publication relating to health care.
Abhishek Lunagariya, MD	No disclosure on file
Vijeta Shukla, MD	No disclosure on file
Urvish K. Patel	Mr. Patel has nothing to disclose.
Silvia Basaia	Silvia Basaia has nothing to disclose.
Kye Won Park, MD	Dr. Park has nothing to disclose.
Caitlin Bell	No disclosure on file
Giacomo Lus	Giacomo Lus has nothing to disclose.
Donald Johns, MD	No disclosure on file
Chris Hackett, MA	Mr. Hackett has nothing to disclose.
Marc De Backer, MD, FBCPM, MBA	No disclosure on file
Hiroyuki Ishiura, MD	No disclosure on file
Catherine Kopil	No disclosure on file
Peter S. Chin, MD	No disclosure on file
Bryan A. Bernard, PhD	Dr. Bernard has nothing to disclose.
Francesca Bagnato, MD	Dr. Bagnato has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Bagnato has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyne. Dr. Bagnato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Bagnato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jenseen. Dr. Bagnato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merk-Serono.
Marc Debouverie, MD	Dr. Debouverie has nothing to disclose.
Tianxia Wu	Tianxia Wu has nothing to disclose.
Dominique Monlezun, Jr	No disclosure on file
Janina Krell-Roesch, PhD	Dr. Krell-Roesch has nothing to disclose.
Marco Pisa, MD	Dr. Pisa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Omar A. Khan, MD, PhD	No disclosure on file
Leo H. Wang, MD, PhD, FAAN	Dr. Wang has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AskBio. Dr. Wang has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Fulcrum Therapeutics. Dr. Wang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Wang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Wang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Wang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Avidity. Dr. Wang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Wang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lupin. Dr. Wang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. Dr. Wang has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. The institution of Dr. Wang has received research support from National Institute of Health. Dr. Wang has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with US Government.
Shigeo Murayama, MD, PhD	No disclosure on file
Jose M. Serratosa, MD, PhD	No disclosure on file
Edgar Samaniego, MD, FAAN	Dr. Samaniego has received personal compensation for serving as an employee of University of Iowa. Dr. Samaniego has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Terumo Neuro. Dr. Samaniego has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Rapid Medical. Dr. Samaniego has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for J&J Neuro. Dr. Samaniego has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Metronic. Dr. Samaniego has received personal compensation in the range of $0-$499 for serving as a Consultant for iSchemaView. Dr. Samaniego has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Society of Neurointerventional Surgery. Dr. Samaniego has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Neurointerventional Surgery.
Sigrid B. Sorensen	No disclosure on file
Mitchell M. Danesh, MD	Dr. Danesh has nothing to disclose.
David J. Thurman, MD, FAAN	No disclosure on file
Allan G. Kermode, MD, MBBS, FRACP	Dr. Kermode has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Kermode has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche.
Gustavo Saposnik, MD	Dr. Saposnik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Saposnik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NIHSS. The institution of Dr. Saposnik has received research support from Roche. The institution of Dr. Saposnik has received research support from Heart and Stroke Foundation of Canada.
Catarina Quinzii Hirano, MD	No disclosure on file
Sarlota Mesaros	Sarlota Mesaros has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Sarlota Mesaros has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca. Sarlota Mesaros has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Sarlota Mesaros has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Hemofarm. Sarlota Mesaros has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Sudhir V. Datar, MD	Dr. Datar has nothing to disclose.
Inna Keselman, MD, PhD	Dr. Keselman has nothing to disclose.
Sabrina Esposito	No disclosure on file
Joseph M. Palumbo, MD	Dr. Palumbo has received personal compensation for serving as an employee of BioVie. An immediate family member of Dr. Palumbo has received personal compensation for serving as an employee of Merck Research Laboratories. Dr. Palumbo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Stalicla SA. Dr. Palumbo has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Psychae Therapeutics Pty Ltd. Dr. Palumbo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Phocus Pharmaceuticals Inc.. Dr. Palumbo has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for BioVie. Dr. Palumbo has or had stock in BioVie. An immediate family member of Dr. Palumbo has or had stock in Merck Research Laboratories. The institution of Dr. Palumbo has received research support from United States Department of Defense. Dr. Palumbo has received intellectual property interests from a discovery or technology relating to health care. Dr. Palumbo has received intellectual property interests from a discovery or technology relating to health care. Dr. Palumbo has received intellectual property interests from a discovery or technology relating to health care.
Carlos Santiago Claverie, MD	No disclosure on file
Jun Mitsui	No disclosure on file
Payam Soltanzadeh, MD, FAAN	The institution of Dr. Soltanzadeh has received research support from Ra Pharma (UCB). The institution of Dr. Soltanzadeh has received research support from Avidity Biosciences.
Makoto Yoneda	The institution of Makoto Yoneda has received research support from Cosmic Corporation.
Hasan Huseyin Karadeli	No disclosure on file
Zahra A. Ajani, MD	No disclosure on file
Eric Rosenthal, MD	Dr. Rosenthal has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma, Inc. . Dr. Rosenthal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ceribell, Inc. . The institution of Dr. Rosenthal has received research support from Sage Therapeutics. Dr. Rosenthal has received intellectual property interests from a discovery or technology relating to health care.
Francisco Germiniani	No disclosure on file
Tara Sharma, DO	Dr. Sharma has stock in JP Morgan . Dr. Sharma has stock in Profunds.
Laura L. Lehman, MD	The institution of Dr. Lehman has received research support from Children's Tumor Foundation . Dr. Lehman has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Clinical Neurology Society of America.
Yi-Chu Liao, MD	Dr. Liao has nothing to disclose.
Cathy A. Sila, MD, FAAN	Dr. Sila has nothing to disclose.
Matilde Inglese, MD, PhD	Dr. Inglese has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SANOFI GENZYME. Dr. Inglese has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIOGEN. Dr. Inglese has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NOVARTIS. Dr. Inglese has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for MERCK-SERONO. Dr. Inglese has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE. Dr. Inglese has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MS Journal.
Dawn W. Langdon, PhD	Prof. Langdon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. Prof. Langdon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Prof. Langdon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. Prof. Langdon has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Celgene. Prof. Langdon has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Prof. Langdon has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. The institution of Prof. Langdon has received research support from Merck. The institution of Prof. Langdon has received research support from Novartis. The institution of Prof. Langdon has received research support from MS Society (UK). The institution of Prof. Langdon has received research support from Multiple Sclerosis Trust (UK).
Tamara Strohm, MD	Dr. Strohm has nothing to disclose.
Drew Young	No disclosure on file
Corrado Angelini, MD, FAAN	Dr. Angelini has nothing to disclose.
Nutan Sharma, MD, PhD, FAAN	Dr. Sharma has nothing to disclose.
Oscar Martinez, MD	No disclosure on file
Derek W. Stitt, MD	Dr. Stitt has nothing to disclose.
Daniel Savitt, MD	No disclosure on file
Anne Louise Oaklander, MD, PhD, FAAN	The institution of Dr. Oaklander has received research support from National Institutes of Health.
Melissa Brock	Melissa Brock has nothing to disclose.
Richard S. Young, MD, FAAN	Dr. Young has nothing to disclose.
Steve W. Han, MD PhD	No disclosure on file
Jeffrey M. Kornitzer, MD, FAAN	Dr. Kornitzer has nothing to disclose.
Thomas F. Scott, MD	Dr. Scott has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme-Sanofi. Dr. Scott has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Serono. Dr. Scott has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Scott has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Scott has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genzyme.
Pinky H. Agarwal, MD, FAAN	Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus. Dr. Agarwal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia Pharmaceuticals Inc. Dr. Agarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. Dr. Agarwal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe Pharma. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Agarwal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion Pharmaceuticals. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acadia. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Supernus. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie. Dr. Agarwal has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurocrine. Dr. Agarwal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AskBio. An immediate family member of Dr. Agarwal has stock in ALDEYRA THERAPEUTICS INC. An immediate family member of Dr. Agarwal has stock in Curis Inc. An immediate family member of Dr. Agarwal has stock in Citius Pharmaceuticals. An immediate family member of Dr. Agarwal has stock in Fortress Biotech. An immediate family member of Dr. Agarwal has stock in TG Therapeutics. An immediate family member of Dr. Agarwal has stock in ATYR PHARMA INC . An immediate family member of Dr. Agarwal has stock in CORVUS PHARMACEUTICALS INC . An immediate family member of Dr. Agarwal has stock in LAVA THERAPEUTICS . An immediate family member of Dr. Agarwal has stock in OVID THERAPEUTICS INC . An immediate family member of Dr. Agarwal has stock in TERNS PHARMACEUTICALS INC. An immediate family member of Dr. Agarwal has stock in VIKING THERAPEUTICS INC. Dr. Agarwal has stock in WAVE LIFE SCIENCES LTD. An immediate family member of Dr. Agarwal has stock in ProQr Therapeutics. An immediate family member of Dr. Agarwal has stock in Mind Medicine. An immediate family member of Dr. Agarwal has stock in Lyra Therapeutics. An immediate family member of Dr. Agarwal has stock in Larimer Therapeutics. An immediate family member of Dr. Agarwal has stock in Lantern Pharma. An immediate family member of Dr. Agarwal has stock in Black Diamond Therapeutics. An immediate family member of Dr. Agarwal has stock in Amylyx Pharma. An immediate family member of Dr. Agarwal has stock in Palisade Bio. An immediate family member of Dr. Agarwal has stock in Inozyme Pharma. An immediate family member of Dr. Agarwal has stock in Pyxis Oncology. An immediate family member of Dr. Agarwal has stock in Vertex Pharmaceuticals. An immediate family member of Dr. Agarwal has stock in Vyne Therapeutics. An immediate family member of Dr. Agarwal has stock in Reviva Pharmaceuticals Hld. An immediate family member of Dr. Agarwal has stock in Immuneering Corp. An immediate family member of Dr. Agarwal has stock in Imunon Inc. An immediate family member of Dr. Agarwal has stock in Enlivex Therapeutics. An immediate family member of Dr. Agarwal has stock in Candel Therapeutics. An immediate family member of Dr. Agarwal has stock in Applied Digital Corp. An immediate family member of Dr. Agarwal has stock in Atai Life Sciences. An immediate family member of Dr. Agarwal has stock in Adma Biologics. The institution of Dr. Agarwal has received research support from Biogen . The institution of Dr. Agarwal has received research support from CHDI Foundation. The institution of Dr. Agarwal has received research support from Eli Lilly. The institution of Dr. Agarwal has received research support from MJ Fox. The institution of Dr. Agarwal has received research support from Roche . The institution of Dr. Agarwal has received research support from Supernus. The institution of Dr. Agarwal has received research support from Nova Nordisc. The institution of Dr. Agarwal has received research support from Inhibikase. The institution of Dr. Agarwal has received research support from Intracellular therapeurtics.
Tomo Tarui, MD	Dr. Tarui has nothing to disclose.
Hidehiko Okazawa, MD, PhD	No disclosure on file
Fred D. Lublin, MD, FAAN	Dr. Lublin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche/Genentech. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medimmune/Viela Bio/Horizon. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Receptos/Celgene/BMS. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Labcorp. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuralight. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Entelexo. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avotres. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Lublin has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. Dr. Lublin has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Multiple entities. Dr. Lublin has stock in Avotres. Dr. Lublin has stock in Neuralight. The institution of Dr. Lublin has received research support from Brainstorm. The institution of Dr. Lublin has received research support from biogen. The institution of Dr. Lublin has received research support from NIH.
Erin M. Feinstein, DO	Dr. Feinstein has nothing to disclose.
Alida F. Griffith, MD	No disclosure on file
Allen S. Nielsen, MD	No disclosure on file
Sahil Gupta, MD	Dr. Gupta has nothing to disclose.
Diederik L. Koelman	No disclosure on file
Nicholas J. Maragakis, MD, FAAN	Dr. Maragakis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UptoDate. Dr. Maragakis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Apellis Pharmaceuticals. Dr. Maragakis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. An immediate family member of Dr. Maragakis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for National Basketball Association. Dr. Maragakis has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Akava. An immediate family member of Dr. Maragakis has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Johns Hopkins Howard County Medical Center. Dr. Maragakis has stock in Akava. The institution of Dr. Maragakis has received research support from NIH/NINDS. The institution of Dr. Maragakis has received research support from Department of Defense. The institution of Dr. Maragakis has received research support from Maryland Stem Cell Research Fund. Dr. Maragakis has received intellectual property interests from a discovery or technology relating to health care.
Connie C. Marras, MD	Dr. Marras has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine Biosciences. The institution of Dr. Marras has received research support from Theravance Inc. The institution of Dr. Marras has received research support from Centogene.
Nizar Souayah, MD, FAAN	Dr. Souayah has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Souayah has received publishing royalties from a publication relating to health care.
Theodore Larson	Theodore Larson has nothing to disclose.
Miya Bernson-Leung, MD, FAAN	An immediate family member of Dr. Bernson-Leung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG Consulting. Dr. Bernson-Leung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BioMarin. Dr. Bernson-Leung has stock in Abbott Labs. Dr. Bernson-Leung has stock in Abbvie Inc.
Valerie A. Cwik, MD	No disclosure on file
Masamichi Ikawa	No disclosure on file
Maria Petracca, PhD	Dr. Petracca has nothing to disclose.
Konrad J. Werhahn, MD	No disclosure on file
Robert P. Rubens, MD, MBA, FAAN, FAAN	Dr. Rubens has received personal compensation for serving as an employee of Takeda Pharmaceuticals. Dr. Rubens has received stock or an ownership interest from Takeda Pharmaceuticals.
Ramon R. Diaz-Arrastia, MD, PhD, FAAN	Dr. Diaz-Arrastia has stock in BrainBox, LLC. Dr. Diaz-Arrastia has stock in Nia Therpeutics. The institution of Dr. Diaz-Arrastia has received research support from National Institutes of Health. The institution of Dr. Diaz-Arrastia has received research support from Department of Defense.
Mustafa Sahin, MD, PhD	Dr. Sahin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Regenxbio . Dr. Sahin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Centene. Dr. Sahin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. Dr. Sahin has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for PTEN Research. Dr. Sahin has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Sahin has received research support from NIH. The institution of Dr. Sahin has received research support from Tuberous Sclerosis Alliance. The institution of Dr. Sahin has received research support from Charities Aid Foundation. The institution of Dr. Sahin has received research support from Simons Foundation Autism Research Initiative. The institution of Dr. Sahin has received research support from Aucta Pharmaceuticals . The institution of Dr. Sahin has received research support from Loulou Foundation.
Pablo Bonardo, MD	Dr. Bonardo has nothing to disclose.
Fatima Pantiu	No disclosure on file
Erika Silverman	Ms. Silverman has nothing to disclose.
Neda Sattarnezhad Oskouei, MD	Dr. Sattarnezhad Oskouei has received research support from National Institutes of Health (NIH). Dr. Sattarnezhad Oskouei has received research support from National Institute of Allergy and Infectious Diseases (NIAID).
Bernard M. Ravina, MD, MSCE	Dr. Ravina has received personal compensation for serving as an employee of Praxis Precision Medicines. Dr. Ravina has stock in Praxis.
Lileth Joy H. Mondok, MD	No disclosure on file
Jorg Wissel	No disclosure on file
Jennifer Petrillo Billet, PhD	Jennifer Petrillo, 14951 has received personal compensation for serving as an employee of Sage Therapeutics. Jennifer Petrillo, 14951 has received stock or an ownership interest from Sage Therapeutics.
Donna L. Masterman, MD	Dr. Masterman has received personal compensation for serving as an employee of Prothena Biosciences . Dr. Masterman has stock in Prothena Biosciences.
Louis Manganas, MD, PhD	No disclosure on file
Sandipan Pati, MD	Dr. Pati has nothing to disclose.
Paul Mehta	Paul Mehta has nothing to disclose.
Antonio Carotenuto	Mr. Carotenuto has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merk, Novartis, Roche and Almirall. The institution of Mr. Carotenuto has received research support from ALMIRALL. The institution of Mr. Carotenuto has received research support from Carotenuto Antonio.
Anibal Chertcoff	Anibal Chertcoff has nothing to disclose.
Michel Baulac, MD	No disclosure on file
Tarun Girotra, MD	Dr. Girotra has nothing to disclose.
Erik P. Pioro, MD, DPhil, FAAN	Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avanir Pharmaceutical, Inc.. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx Pharmaceuticals. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MT Pharma America, Inc.. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuroTherapia, Inc.. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MT Pharma America, Inc..
David E. Blum, MD	Dr. Blum has received personal compensation for serving as an employee of Neurona Therapeutics. Dr. Blum has stock in Neurona Therapeutics.
Randall L. Woltjer	Randall L. Woltjer has nothing to disclose.
Elka Stefanova	No disclosure on file
Alexandra Tomic	No disclosure on file
Hailong Cheng	No disclosure on file
Bertrand Audoin	No disclosure on file
Alvino Bisecco	Alvino Bisecco has nothing to disclose.
Samuel Lichtman-Mikol, BA	Mr. Lichtman-Mikol has nothing to disclose.
Mohammed F. Majeed, MD	No disclosure on file
Davut Pehlivan, MD	Dr. Pehlivan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis Pharmaceuticals.
Christopher Severson, MD	Dr. Severson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Severson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech.
Ramin Zand, MD	Dr. Zand has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for StrokeExperts. The institution of Dr. Zand has received research support from NIH. The institution of Dr. Zand has received research support from PCORI.
Raghav Govindarajan, MD, FAAN	Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MT pharma. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Govindarajan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MT pharma . Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Catalyst. Dr. Govindarajan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Argenx. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biohaven. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Takeda. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Govindarajan has received research support from Band of Hope . The institution of Dr. Govindarajan has received research support from Alexion. Dr. Govindarajan has received publishing royalties from a publication relating to health care.
Syeda L. Alqadri, MD	No disclosure on file
Shibeshih Belachew, MD	Dr. Belachew has received personal compensation for serving as an employee of Biogen Inc. Dr. Belachew has received stock or an ownership interest from Biogen Inc.
Carmel Armon, MD, FAAN	Dr. Armon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Inbal - Israeli Government Insurance Company. Dr. Armon has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Neurological Sciences. Dr. Armon has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Individual attorney offices. Dr. Armon has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Israeli Civil Courts as a court-appointed expert. Dr. Armon has received publishing royalties from a publication relating to health care.
Paul F. Teychenne, MD, FAAN	No disclosure on file
Gustavo J. Rodriguez, MD	Dr. Rodriguez has nothing to disclose.
Bonnie Glanz	The institution of Ms. Glanz has received research support from CMSC. The institution of Ms. Glanz has received research support from NIH.
Chi Hsien Tan, MBBS	No disclosure on file
Eliza M. Gordon-Lipkin, MD	No disclosure on file
David G. Clark, MD	Dr. Clark has received publishing royalties from a publication relating to health care.
Michael W. Devereaux, MD, FAAN	Dr. Devereaux has received personal compensation for serving as an employee of DigiTrace part of Sleepmed. Dr. Devereaux has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Kevin Trangle and Associates.
Steven M. Wolf, MD	Dr. Wolf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Assertio. Dr. Wolf has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for LivaNova. Dr. Wolf has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurilis. Dr. Wolf has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Wolf has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MOnteris . Dr. Wolf has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Marinus . The institution of Dr. Wolf has received research support from Neuropace. The institution of Dr. Wolf has received research support from Eisai. The institution of Dr. Wolf has received research support from Aguestive. The institution of Dr. Wolf has received research support from Neurilis . The institution of Dr. Wolf has received research support from UCB. The institution of Dr. Wolf has received research support from SKLife . The institution of Dr. Wolf has received research support from Longboard . The institution of Dr. Wolf has received research support from Takeda. The institution of Dr. Wolf has received research support from biohaven. The institution of Dr. Wolf has received research support from Assertio. Dr. Wolf has received intellectual property interests from a discovery or technology relating to health care. Dr. Wolf has received publishing royalties from a publication relating to health care.
Jouko I. Isojarvi, MD, PhD	No disclosure on file
Nazem Atassi, MD	Dr. Atassi has received personal compensation for serving as an employee of Sanofi. Dr. Atassi has stock in Sanofi.
Patricia E. McGoldrick, NP	No disclosure on file
Niels Bergsland	Prof. Bergsland has nothing to disclose.
Gabrielle A. Yeaney, MD	No disclosure on file
Katie M. Warren, DO	No disclosure on file
Pei-chien Tsai	No disclosure on file
Francesco Sacca, MD, FAAN	Dr. Sacca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Sacca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lexeo. Dr. Sacca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genpharm. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medpharma. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Madison Pharma. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zai Lab. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Reata. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neopharm Israel. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson&Johnson. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Sacca has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Astrazeneca. The institution of Dr. Sacca has received research support from AIFA. The institution of Dr. Sacca has received research support from FARA.
Danielle S. Shpiner, MD	An immediate family member of Dr. Shpiner has received personal compensation for serving as an employee of University of Miami. Dr. Shpiner has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Mission MSA. The institution of Dr. Shpiner has received research support from American Parkinson's Disease Association. The institution of Dr. Shpiner has received research support from CurePSP. The institution of Dr. Shpiner has received research support from Parkinson's Foundation. Dr. Shpiner has a non-compensated relationship as a COE Medical Director with Parkinson's Foundation that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Medtronic that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Boston Scientific that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Abbott that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Abbvie that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Ipsen that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Amneal that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Michael J. Fox Foundation that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a CoC Medical Director with CurePSP that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a COE Medical Director with Mission MSA that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Merz that is relevant to AAN interests or activities.
Keren Regev, MD	Dr. Regev has nothing to disclose.
Bryan Dobbs	No disclosure on file
Nancy L. Kuntz, MD, FAAN	Dr. Kuntz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Kuntz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenyx. Dr. Kuntz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Audentes Therapeutics. Dr. Kuntz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Kuntz has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Kuntz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Kuntz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. The institution of Dr. Kuntz has received research support from Argenx. The institution of Dr. Kuntz has received research support from Astellas. The institution of Dr. Kuntz has received research support from Biogen. The institution of Dr. Kuntz has received research support from Catalyst. The institution of Dr. Kuntz has received research support from Genentech. The institution of Dr. Kuntz has received research support from Scholar Rock. The institution of Dr. Kuntz has received research support from Regenx-Bio. The institution of Dr. Kuntz has received research support from Solid Biosciences. The institution of Dr. Kuntz has received research support from AMO. The institution of Dr. Kuntz has received research support from Novartis. The institution of Dr. Kuntz has received research support from BioHaven. Dr. Kuntz has received personal compensation in the range of $50,000-$99,999 for serving as a Sarepta Express post gene therapy advisor with Sarepta.
Irene Richard, MD, FAAN	Dr. Richard has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Katten Muchin Rosenman Law Firm. The institution of Dr. Richard has received research support from Michael J Fox Foundation for Parkinson's Research.
Amir Shaban, MD	Dr. Shaban has nothing to disclose.
Tobias Granberg, MD, PhD	The institution of Dr. Granberg has received research support from Karolinska Institutet. The institution of Dr. Granberg has received research support from Region Stockholm. The institution of Dr. Granberg has received research support from Merck. The institution of Dr. Granberg has received research support from Swedish Society for Medical Research.
Farrah J. Mateen, MD, PhD, FAAN	Dr. Mateen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Mateen has received research support from Genentech. The institution of Dr. Mateen has received research support from Amgen. The institution of Dr. Mateen has received research support from TG Therapeutics. Dr. Mateen has received intellectual property interests from a discovery or technology relating to health care.
Salvador Cruz-Flores, MD, FAAN	The institution of Dr. Cruz-Flores has received research support from University of Texas System.
Yuebing Li, MD, PhD, FAAN	Dr. Li has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Li has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Li has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Vertex. The institution of Dr. Li has received research support from Argenx.
Barbara Bumstead, NP	Ms. Bumstead has nothing to disclose.
Michelle Fabian, MD, FAAN	Dr. Fabian has nothing to disclose.
Paolo Preziosa	Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb . Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Genzyme. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Arun Krishnan, MD	Dr. Krishnan has nothing to disclose.
Brenda Deliz-Roldan, MD, FAAN	Dr. Deliz-Roldan has nothing to disclose.
Tracey A. Knaus, PhD	No disclosure on file
Reza Behrouz, DO, PhD, FAAN	No disclosure on file
Alan Lerner, MD	The institution of Dr. Lerner has received research support from Premier applied biosciences. Dr. Lerner has received publishing royalties from a publication relating to health care.
Javier Romero	Javier Romero has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Mckeen and associates.
Kristy S. Hwang, MD	No disclosure on file
Harold H. Morris III, MD, FAAN	No disclosure on file
Walter A. Kukull, PhD, FAAN	The institution of Dr. Kukull has received research support from NIH/NIA. Dr. Kukull has a non-compensated relationship as a Associate editor with Alzheimer's and Dementia TRCI (journal) that is relevant to AAN interests or activities. Dr. Kukull has a non-compensated relationship as a Editorial board with Journal of American Geriatrics Soc that is relevant to AAN interests or activities.
Marilou I. Ching, MD	Dr. Ching has nothing to disclose.
Zulfi Haneef, MD, MBBS, MRCP, FAAN	Dr. Haneef has received publishing royalties from a publication relating to health care.
Sarah R. Risen, MD	Dr. Risen has nothing to disclose.
Luisa Vuolo	No disclosure on file
Ramon Gil, MD	No disclosure on file
Gyula Acsadi, MD, FAAN	Dr. Acsadi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Acsadi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Avexis. Dr. Acsadi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Serepta. Dr. Acsadi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Acsadi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Ken Uchino, MD	Dr. Uchino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aboott Laboratories, Inc.. Dr. Uchino has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ACP JOURNAL CLUB. The institution of Dr. Uchino has received research support from NIH.
Elizabeth Crabtree-Hartman, MD	Dr. Crabtree-Hartman has nothing to disclose.
Perla C. Thulin, MD	Dr. Thulin has nothing to disclose.
David Alsop, PhD	No disclosure on file
Sharon Ash	No disclosure on file
David G. Standaert, MD, PhD, FAAN	Dr. Standaert has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie, Inc. Dr. Standaert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Curium. Dr. Standaert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Standaert has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biohaven. Dr. Standaert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CVS/Pharmacy. Dr. Standaert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HanAll Biopharma. Dr. Standaert has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. Standaert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for F. Hoffman LaRoche. Dr. Standaert has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Aventis. Dr. Standaert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theravance, Inc. Dr. Standaert has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for International Parkinson and Movement Disorder Society. The institution of Dr. Standaert has received research support from Abbvie, Inc. The institution of Dr. Standaert has received research support from American Parkinson Disease Association. The institution of Dr. Standaert has received research support from National Institutes of Health. The institution of Dr. Standaert has received research support from F. Hoffman LaRoche. Dr. Standaert has received publishing royalties from a publication relating to health care. Dr. Standaert has received personal compensation in the range of $500-$4,999 for serving as a Reviewer with National Institutes of Health. Dr. Standaert has a non-compensated relationship as a Chair, Scientific Advisory Board with American Parkinson Disease Association that is relevant to AAN interests or activities.
William Stern	No disclosure on file
Caroline Hayes-Rosen, MD	Dr. Hayes-Rosen has nothing to disclose.
Kimbra L. Kenney, MD, FAAN	Dr. Kenney has nothing to disclose.
Howard L. Weiner, MD	Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medday Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for vTv Therapeutics. Dr. Weiner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tiziana Life Sciences. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for vTv Therapeutics. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medday Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for vTv Therapeutics. Dr. Weiner has stock in vTv Therapeutics. The institution of Dr. Weiner has received research support from National Institute of Health. The institution of Dr. Weiner has received research support from National MS Society. The institution of Dr. Weiner has received research support from Genzyme Corp. The institution of Dr. Weiner has received research support from Genentech, Inc. . The institution of Dr. Weiner has received research support from Verily Life Sciences LLC. The institution of Dr. Weiner has received research support from EMD Serono, Inc..
Vincenzo Brescia Morra, MD	Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NOVARTIS. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIOGEN. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ALMIRALL. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MERK. Dr. Brescia Morra has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MERK. The institution of Dr. Brescia Morra has received research support from FISM. Dr. Brescia Morra has a non-compensated relationship as a PI with FISM that is relevant to AAN interests or activities.
Roberta Lanzillo	Roberta Lanzillo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck, Biogen. Roberta Lanzillo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen, Roche, Novartis.
Rohit Dhall, MD, FAAN	Dr. Dhall has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Best Doctors Inc. Dr. Dhall has stock in Verve Therapeutics Inc. Dr. Dhall has stock in Roche Holding Limited. Dr. Dhall has stock in Enliven Therapeutics Inc. The institution of Dr. Dhall has received research support from Amneal. The institution of Dr. Dhall has received research support from Neuroderm. The institution of Dr. Dhall has received research support from Cerevel Therapeutics. The institution of Dr. Dhall has received research support from Neurocrine. The institution of Dr. Dhall has received research support from Neuraly. The institution of Dr. Dhall has received research support from SPARC. The institution of Dr. Dhall has received research support from Pharma2B. The institution of Dr. Dhall has received research support from Alexion. The institution of Dr. Dhall has received research support from Parkinsons Foundation. The institution of Dr. Dhall has received research support from UCB Pharma. The institution of Dr. Dhall has received research support from Inhibikase Therapeutics. The institution of Dr. Dhall has received research support from Amylyx Pharma.
Derek Yuan, MD	Dr. Yuan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. Dr. Yuan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Pfizer.
Neil R. Holland, MBBS, FAAN	Dr. Holland has nothing to disclose.
Thomas Tomsick	No disclosure on file
Yi-Chung Lee, MD, FAAN	The institution of Dr. Lee has received research support from National Science and technology Council Taiwan . The institution of Dr. Lee has received research support from Taipei Veterans General Hospital Taiwan.
Nathalie Derache	Nathalie Derache has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MERCK. Nathalie Derache has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MERCK. Nathalie Derache has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS.
David K. Urion, MD, FAAN	Dr. Urion has nothing to disclose.
Amit Bar-Or, MD, FRCPC	Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merk/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for cabaletta. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. The institution of Dr. Bar-Or has received research support from Novartis. The institution of Dr. Bar-Or has received research support from Biogen. The institution of Dr. Bar-Or has received research support from Roche/Genentech.
Sonal Mehta, MD	Dr. Mehta has nothing to disclose.
Ashkan Mowla, MD, FAAN	No disclosure on file
Agustina Tamargo	No disclosure on file
Muhammad Ahmed, MD	Dr. Ahmed has nothing to disclose.
Hatim S. Attar, MD	No disclosure on file
Dejan Jakimovski, MD, PhD	Dr. Jakimovski has nothing to disclose.
Paul T. Twydell, DO, FAAN	Dr. Twydell has received publishing royalties from a publication relating to health care.
Stephan Schmidt, MD	No disclosure on file
Patrick M. Bauer, MD	Dr. Bauer has nothing to disclose.
Ryuji Kaji, MD, FAAN	Dr. Kaji has nothing to disclose.
Shailesh Male, MD	Dr. Male has nothing to disclose.
Leonardo Lopiano	No disclosure on file
Christopher Goetz, MD, FAAN	The institution of Dr. Goetz has received research support from Michael J. Fox Foundation. The institution of Dr. Goetz has received research support from NIH. The institution of Dr. Goetz has received research support from Department of Defense. Dr. Goetz has received publishing royalties from a publication relating to health care. Dr. Goetz has received publishing royalties from a publication relating to health care. Dr. Goetz has received publishing royalties from a publication relating to health care.
Jacqueline Palace	Dr. Palace has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck Serono, Medimmune, Argenx, Janssen, AMgen, UCB, Roche, Novartis, Amplo, Alexion, . Dr. Palace has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx, Sanofi. Dr. Palace has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Roche, UCB, Alexion, Amgen. Dr. Palace has or had stock in Astra Zenica. The institution of Dr. Palace has received research support from Roche, AMPLO, Alexion, UCB,. argenx, amgen. Dr. Palace has received intellectual property interests from a discovery or technology relating to health care.
Sun Ju Chung, MD, PhD, FAAN	Dr. Chung has nothing to disclose.
Carolina Ionete, MD	Dr. Ionete has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Ionete has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Zenas. Dr. Ionete has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Ionete has received research support from Genetech. The institution of Dr. Ionete has received research support from NIH.
Olga Ciccarelli, MD, PhD, FRCP	Prof. Ciccarelli has received personal compensation in the range of $0-$499 for serving as a Consultant for Lundebeck. Prof. Ciccarelli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Prof. Ciccarelli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Prof. Ciccarelli has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. Prof. Ciccarelli has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEUROLOGY Journal.
Muhib Khan, MD, FAAN	The institution of Dr. Khan has received research support from Mayo Clinic ��ɫ�� Grant . The institution of Dr. Khan has received research support from Mayo Clinic Small Grants .
Saqib A. Chaudhry, MD	Dr. Chaudhry has nothing to disclose.
Alberto Maud, MD	Dr. Maud has nothing to disclose.
Maria S. Pacha	No disclosure on file
Hyung S. Shim, MD, FAAN	Dr. Shim has nothing to disclose.
Carolyn J. Bevan, MD	Dr. Bevan has received intellectual property interests from a discovery or technology relating to health care.
Muhammed E. Ozcan, MD	No disclosure on file
Navdeep Sangha, MD	Dr. Sangha has nothing to disclose.
Douglas S. Goodin, MD	No disclosure on file
Michael J. Rivkin, MD	No disclosure on file
Jagarlapudi M. Murthy, MD, FAAN	Dr. Murthy has nothing to disclose.
Ramon L. Rodriguez Cruz, MD, FAAN	The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus . The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boston Scientific. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbott. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Acorda. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Kyoway Kirin. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amneal. The institution of Dr. Rodriguez Cruz has received research support from Cerevance. The institution of Dr. Rodriguez Cruz has received research support from Neuraly. The institution of Dr. Rodriguez Cruz has received research support from Amneal. The institution of Dr. Rodriguez Cruz has received research support from Teva. The institution of Dr. Rodriguez Cruz has received research support from Neurocrine. Dr. Rodriguez Cruz has received publishing royalties from a publication relating to health care.
Muhammad S. Hussain, MD	Dr. Hussain has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerenovus. Dr. Hussain has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tiger Medical.
Dorlan J. Kimbrough, MD	Dr. Kimbrough has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CVS.
Maysaa M. Basha, MD, FAAN	Dr. Basha has nothing to disclose.
Marisela E. Dy-Hollins, MD, MSCR, FAAN	The institution of Dr. Dy-Hollins has received research support from CNCDP-K12.
Janet Benesh, BSMT	No disclosure on file
Nirubol Tosakulwong	Nirubol Tosakulwong has nothing to disclose.
Myassar Zarif	Myassar Zarif has nothing to disclose.
GURCHARANJEET KAUR, MBBS	Dr. Kaur has nothing to disclose.
Ihtesham Qureshi, MD	No disclosure on file
Kalyan Yarraguntla, MD	Dr. Yarraguntla has nothing to disclose.
Riccardo Manca, Msc	No disclosure on file
Saahith Pochiraju	No disclosure on file
David Sabsevitz	No disclosure on file
Charlene Chen, MD	No disclosure on file
Frank Bittner, DO	Dr. Bittner has nothing to disclose.
Audrey Rico Lamy	No disclosure on file
Ahm M. Huq, MBBS, PhD	Dr. Huq has nothing to disclose.
Joon-Shik Moon, MD	Dr. Moon has nothing to disclose.
Jean-Michel Gracies, MD	No disclosure on file
Virginia J. Howard, PhD	The institution of Dr. Howard has received research support from NIH. The institution of an immediate family member of Dr. Howard has received research support from NIH.
Andrea Calvo, MD, PhD, FAAN	Dr. Calvo has nothing to disclose.
Ahsan Sattar, MD	No disclosure on file
Corneliu C. Luca, MD	Dr. Luca has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boston Scientific. Dr. Luca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Signant Health. Dr. Luca has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott.
Chiara Pane, MD	Dr. Pane has nothing to disclose.
Edward J. Gettings, DO	Dr. Gettings has nothing to disclose.
Jacob A. Sloane, MD, PhD	Dr. Sloane has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for biogen. Dr. Sloane has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Sloane has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi.
Mary R. Andriola, MD, FAAN	No disclosure on file
Irene L. Katzan, MD	Dr. Katzan has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring . The institution of Dr. Katzan has received research support from TEVA Pharmaceuticals.
Roland G. Henry, PhD	Dr. Henry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MEDDAY. Dr. Henry has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Henry has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Henry has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi/Genzyme.
Carol Moore	No disclosure on file
Suneel K. Gupta, PhD	No disclosure on file
Cory J. Rice, MD	No disclosure on file
Noa Bregman	Noa Bregman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medison. The institution of Noa Bregman has received research support from Ionis pharmaceuticals.
Christopher J. Kenney, MD, FAAN	Dr. Kenney has received personal compensation for serving as an employee of Xenon Pharmaceuticals. Dr. Kenney has or had stock in Xenon Pharmaceuticals.
Shishir K. Rao, MD	The institution of Dr. Rao has received research support from Eisai, Inc.
Jean-Francois Daneault, PhD	No disclosure on file
David French	Mr. French has nothing to disclose.
Corrado Bernasconi	Corrado Bernasconi has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Roche. Corrado Bernasconi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GeNeuro. Corrado Bernasconi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Santhera.
Michelle A. Farrar	Michelle A. Farrar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Michelle A. Farrar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Michelle A. Farrar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Michelle A. Farrar has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Michelle A. Farrar has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche.
Sergey A. Klyushnikov, MD	No disclosure on file
Susan A. Eaton, PharmD	No disclosure on file
Jesper Hagemeier	No disclosure on file
Edgar Olivas, MD	No disclosure on file
Matteo De Marco, PhD	No disclosure on file
Franck G. Amyot, PhD	Dr. Amyot has nothing to disclose.
David C. Tong, MD, FAHA	No disclosure on file
Christine S. Wong, MD	No disclosure on file
Chiadi U. Onyike, MD	Dr. Onyike has received personal compensation for serving as an employee of Rainwater Foundation. Dr. Onyike has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia Pharmaceuticals . Dr. Onyike has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Reata Pharmaceuticals. Dr. Onyike has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Goodell, DeVries, Leech & Dann. The institution of Dr. Onyike has received research support from Alector.
Angel P. Sempere, MD	Dr. Sempere has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Sempere has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Sempere has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Sempere has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Sempere has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Stanley Tuhrim, MD	No disclosure on file
Raphael Schiffmann, MD, FAAN	No disclosure on file
Robert T. Wechsler, MD, PhD, FAAN	The institution of Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Otsuka. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Life Science. The institution of Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Aquestive. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Engage. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerevel. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eisai. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sunovion. The institution of Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eliem. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Epalex. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Engrail. The institution of Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Equilibre. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rapport. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurona. Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurelis. Dr. Wechsler has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Sunovion. Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. Wechsler has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Greenwich/Jazz. Dr. Wechsler has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Eisai. Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aquestive. Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Science. Dr. Wechsler has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Epilepsy Studies Consortium. Dr. Wechsler has a non-compensated relationship as a Board President with Epilepsy Foundation of Idaho that is relevant to AAN interests or activities.
Liang Lu, MD, FAAN	Dr. Lu has nothing to disclose.
Gishlaine Alfonso, MD, FAAN	Dr. Alfonso has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion .
Bruno Stankoff, MD, PhD	The institution of Bruno Stankoff, MD, PhD has received research support from Roche, Sanofi, Serono . The institution of Bruno Stankoff, MD, PhD has received research support from Novartis.
Trenton J. Tollefson, MD	Dr. Tollefson has nothing to disclose.
Ahmed M. Yassin, MD	Dr. Yassin has nothing to disclose.
Georgia D. Montouris, MD	No disclosure on file
Edgardo Cristiano, MD	Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Neil R. Friedman, MD, MBChB	No disclosure on file
Rakesh Khatri, MD, FAAN	Dr. Khatri has received personal compensation in the range of $0-$499 for serving as a Survey consultant with Alpha insight . Dr. Khatri has received personal compensation in the range of $0-$499 for serving as a Survey consultant with Survey company .
Daniel J. Burdick, MD, FAAN	Dr. Burdick has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Praxis Precision Medicines. The institution of Dr. Burdick has received research support from AbbVie. The institution of Dr. Burdick has received research support from Athira. The institution of Dr. Burdick has received research support from Cerevel. The institution of Dr. Burdick has received research support from Merck. The institution of Dr. Burdick has received research support from Neuraly. The institution of Dr. Burdick has received research support from Pharma 2B. The institution of Dr. Burdick has received research support from Jazz Pharmaceuticals. The institution of Dr. Burdick has received research support from Praxis. The institution of Dr. Burdick has received research support from Sage Therapeutics. The institution of Dr. Burdick has received research support from Biogen. The institution of Dr. Burdick has received research support from Cerevance. The institution of Dr. Burdick has received research support from UCB.
Marcus Ng, MD	The institution of Dr. Ng has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Paladin Canada. The institution of Dr. Ng has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Paladin Canada. Dr. Ng has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neurophysiology. The institution of Dr. Ng has received research support from Eisai. The institution of Dr. Ng has received research support from Paladin Canada. Dr. Ng has received publishing royalties from a publication relating to health care.
Aravindhan Veerapandiyan, MD	Dr. Veerapandiyan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen, Novartis,Edgewise Therapeutics, Pfizer, PTC Therapeutics, Sarepta Therapeutics, Inc., UCB Pharma, Catalyst, Entrada, Lupin, Percheron, ITF. Dr. Veerapandiyan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology. Dr. Veerapandiyan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Muscle and Nerve. The institution of Dr. Veerapandiyan has received research support from AMO Pharma, Capricor Therapeutics, Edgewise Therapeutics, FibroGen, Muscular Dystrophy Association, Novartis, Parent Project Muscular Dystrophy, Pfizer, RegenxBio, SolodBio and Sarepta Therapeutics. Dr. Veerapandiyan has received personal compensation in the range of $5,000-$9,999 for serving as a MD with PPMD, MDA.
Gilles Defer, MD	Dr. Defer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Defer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen . Dr. Defer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Dr. Defer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche.
Lana Chahine, MD, FAAN	Dr. Chahine has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gray Matters Technology. The institution of Dr. Chahine has received research support from UPMC. The institution of Dr. Chahine has received research support from MJFF. The institution of Dr. Chahine has received research support from Denali/Biogen. Dr. Chahine has received publishing royalties from a publication relating to health care.
Michelle D. Lally, MD	No disclosure on file
Jeffrey Waugh, MD, PhD, FAAN	Dr. Waugh has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Two independent law firms. The institution of Dr. Waugh has received research support from AAN.
Sarah Gheuens, MD	No disclosure on file
Marcela Uribe Roca	The institution of Marcela Uribe Roca has received research support from Roche.
Andrea Boan, PhD, MSCR	No disclosure on file
Ariana M. Frontario, DO	Dr. Frontario has nothing to disclose.
Rebecca Spiegel, MD	No disclosure on file
Ruth Schneider, MD, FAAN	Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Escape Bio. The institution of Dr. Schneider has received research support from The Michael J. Fox Foundation. The institution of Dr. Schneider has received research support from NIH. The institution of Dr. Schneider has received research support from Acadia Pharmaceuticals. The institution of Dr. Schneider has received research support from CHDI. The institution of Dr. Schneider has received research support from Biohaven Pharmaceuticals. The institution of Dr. Schneider has received research support from Parkinson Study Group. The institution of Dr. Schneider has received research support from The Michael J. Fox Foundation. The institution of Dr. Schneider has received research support from Bial. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Telemedicine Evaluator with Parkinson's Foundation.
Xue Ming, MD	Dr. Ming has nothing to disclose.
Ahmed Z. Obeidat, MD, PhD	Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Obeidat has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Genentech. Dr. Obeidat has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for EMD Serono. Dr. Obeidat has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi/Genzyme . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon pharmaceuticals . Dr. Obeidat has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sandoz. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Obeidat has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alexion. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Obeidat has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for EMD Serono. Dr. Obeidat has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Banner life sciences . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi/genzyme. Dr. Obeidat has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Horizon therapeutics . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for TG Therapeutics . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AstraZeneca. The institution of Dr. Obeidat has received research support from NIH. The institution of Dr. Obeidat has received research support from NMSS and PCORI. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Expert opinion and key opinion leader with MJH life sciences . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Faculty Speaker with CMSC. Dr. Obeidat has a non-compensated relationship as a Board member with CMSC that is relevant to AAN interests or activities. Dr. Obeidat has a non-compensated relationship as a Editorial Board Member with IJMSC that is relevant to AAN interests or activities. Dr. Obeidat has a non-compensated relationship as a Reviewer Editor with Frontiers Neurology that is relevant to AAN interests or activities. Dr. Obeidat has a non-compensated relationship as a Board of Trustee Member with National MS Society that is relevant to AAN interests or activities.
David J. Adams, MD	No disclosure on file
Ricardo C. Reisin, MD	Dr. Reisin has nothing to disclose.
Shoji Tsuji, MD, PhD	The institution of Dr. Tsuji has received research support from Novelpharma Co. Ltd..
Helio Afonso G. Teive, MD, PhD, FAAN	Dr. Teive has nothing to disclose.
Elizabeth A. Ng, MD, FAAP, FAANEM, FACNS, FAES	Dr. Ng has nothing to disclose.
Marcello Moccia, MD, PhD	Marcello Moccia, 2019 has nothing to disclose.
Sajish Jacob, MBBS	No disclosure on file
Tenbit Emiru, MD	No disclosure on file
Berge A. Minassian, MD	Dr. Minassian has nothing to disclose.
Mohammad I. Alhatou, MD	Dr. Alhatou has nothing to disclose.
Serkan Ozakbas, MD	Dr. Ozakbas has nothing to disclose.
Marian L. Dale, MD, FAAN	Dr. Dale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Dale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synergic Medical Technologies . Dr. Dale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cognito Therapeutics. The institution of Dr. Dale has received research support from NIH . The institution of Dr. Dale has received research support from Collins Medical Trust.
Robert Arbuckle, MD	No disclosure on file
Ho-Yann Jong, MD	No disclosure on file
Francesca Caso, MD	Dr. Caso has nothing to disclose.
Xiaoyan Sun, MD, PhD	The institution of Dr. Sun has received research support from NIH. The institution of Dr. Sun has received research support from Dr. M. Lee Pearce Foundation.
Mohammad H. El-Ghanem, MD	Dr. El-Ghanem has nothing to disclose.
Tomas Uher	Tomas Uher has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Tomas Uher has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol myers. Tomas Uher has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Tomas Uher has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. The institution of Tomas Uher has received research support from Novartis.
Joana Moreira	Joana Moreira has received personal compensation for serving as an employee of BIAL.
Roberto Santangelo	No disclosure on file
Tharick A. Pascoal, Sr., MD, PhD	Dr. Pascoal has nothing to disclose.
Amy L. Jones, MD	No disclosure on file
Lars Markvardsen	No disclosure on file
Alicia Zha, MD	The institution of Dr. Zha has received research support from ��ɫ��. The institution of Dr. Zha has received research support from American Board of Psychiatry and Neurology.
Floriana De Angelis, MD	No disclosure on file
Nidhiben A. Anadani, MD	Dr. Anadani has nothing to disclose.
Oron Yacobi-Zeevi	No disclosure on file
Jennie Medin	No disclosure on file
Stefan Blum, PhD, FRACP	The institution of Dr. Blum has received research support from Merck. The institution of Dr. Blum has received research support from MSRA. The institution of Dr. Blum has received research support from PA Research Foundation.
Xiang Fang, MD, PhD, FAAN	Dr. Fang has nothing to disclose.
Antonio Canosa	Antonio Canosa has nothing to disclose.
Nirav Bhatt, MD	Dr. Bhatt has nothing to disclose.
Kunakorn Atchaneeyasakul, MD	No disclosure on file
Luis Guada-Delgado, MD	Dr. Guada-Delgado has nothing to disclose.
Pascal Maisonobe	Pascal Maisonobe has received personal compensation for serving as an employee of ipsen pharma. Pascal Maisonobe has received personal compensation for serving as an employee of Ipsen.
Zachary D. Threlkeld, MD, FAAN	Dr. Threlkeld has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Baim Institute for Clinical Research, Inc.. Dr. Threlkeld has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Medical Legal Consulting. Dr. Threlkeld has received publishing royalties from a publication relating to health care.
Namir Khandker, MD	No disclosure on file
Astrid Scheschonka	No disclosure on file
Juan Ignacio Rojas, MD	Dr. Rojas has nothing to disclose.
Rolla Nuoman, MD	Dr. Nuoman has nothing to disclose.
Alessandro D'Ambrosio	No disclosure on file
Barbara Iazzolino	Barbara Iazzolino has nothing to disclose.
Maria Pia Sormani	Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol meyer. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunic. Maria Pia Sormani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis, Roche. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche.
Sebastiano Galantucci	Mr. Galantucci has nothing to disclose.
Ryan M. Hodgeman	No disclosure on file
Gorazd B. Stokin, MD, PhD, FAAN	Dr. Stokin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Terumo. Dr. Stokin has received research support from CNS.
Hristelina S. Ilieva, MD	The institution of Dr. Ilieva has received research support from ALSA. Dr. Ilieva has received personal compensation in the range of $0-$499 for serving as a reviewer with DOD.
Richard D. Dortch, PhD	Dr. Dortch has nothing to disclose.
Anna Pink, PhD	No disclosure on file
Sneha Pandya	No disclosure on file
Virginija D. Karrenbauer, MD, PhD	Dr. Karrenbauer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck.
Amy M. Duhig, PhD	No disclosure on file
Jasem Y. Al-Hashel, MD	Dr. Al-Hashel has nothing to disclose.
Fawaz Al-Mufti, MD	Dr. Al-Mufti has received personal compensation in the range of $0-$499 for serving as a Consultant for Stryker. Dr. Al-Mufti has received personal compensation in the range of $0-$499 for serving as a Consultant for Cerenovus. Dr. Al-Mufti has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Revalesio .
Pietro Maggi, MD, PhD	No disclosure on file
Fariha Khalid, MD	No disclosure on file
Antonio Gallo	Antonio Gallo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Antonio Gallo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Antonio Gallo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Antonio Gallo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis.
Kevin N. Ramdas, MD	No disclosure on file
Tony J. Zhang, MD	Dr. Zhang has nothing to disclose.
Jenny Wilson, MD	The institution of Dr. Wilson has received research support from Neurocrine Biosciences. Dr. Wilson has received personal compensation in the range of $500-$4,999 for serving as a Rite question reviewer with AAN.
Kerryn A. Green, MBBS	No disclosure on file
Nicole Vrettos	Ms. Vrettos has nothing to disclose.
Rafael Rodriguez, MD	No disclosure on file
Ima M. Ebong, MD, FAAN	The institution of Dr. Ebong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. The institution of Dr. Ebong has received research support from Ad Scientiam.
Chaoran Ma	No disclosure on file
Jessica Lowe, MD	No disclosure on file

��ɫ����

��ɫ����

��ɫ��

��ɫ��